Tailored expectant management in unexplained infertility by Kersten, F.A.M.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/175284
 
 
 
Please be advised that this information was generated on 2017-12-05 and may be subject to
change.
511305-L-os-kersten Processed on: 29-6-2017
Tailored expectant 
management 
in unexplained infertility
Fleur Kersten

511305-L-bw-kersten
Processed on: 6-7-2017 PDF page: 1
Tailored expectant management 
in unexplained infertility
Fleur Kersten
511305-L-bw-kersten
Processed on: 6-7-2017 PDF page: 2
The research presented in this thesis was conducted at the department of Obstetrics and 
Gynaecology of the Radboud university medical center, Nijmegen, The Netherlands, in close 
collaboration with the department of Obstetrics and Gynaecology of the Academic Medical Center, 
Amsterdam, The Netherlands. The research was funded by an unconditional grant of ZonMw.  
The work presented in this thesis was carried out within the Radboud Institute for Health Sciences.
The printing of this thesis has been financially supported by the Radboud university medical center,  
the Radboud Institute for Health Sciences, ORIGIO, ChipSoft, Bridea Medical, Ferring, and Goodlife Pharma.
ISBN
978-94-92380-52-4
Design/lay-out  
Promotie In Zicht, Arnhem
Print
Ipskamp Printing, Enschede
© Fleur Kersten, 2017
All right are reserved. No part of this book may be reproduced, distribute, stored in a retrieval system  
or transmitted in any form or by any means, without prior written permission of the author.
511305-L-bw-kersten
Processed on: 6-7-2017 PDF page: 3
Proefschrift
Ter verkrijging van de graad van doctor aan 
de Radboud Universiteit Nijmegen op gezag 
van de rector magnificus prof. dr. J.H.J.M. van Krieken,
 volgens besluit van het college van decanen in het openbaar te verdedigen 
op dinsdag 19 september 2017 om 14.30 uur precies
door
Fleur Anne Maria Kersten
geboren op 17 november 1986
te Vierlingsbeek
Tailored expectant management 
in unexplained infertility
511305-L-bw-kersten
Processed on: 6-7-2017 PDF page: 4
Promotoren
Prof. dr. D.D.M. Braat
Prof. dr. B.W.J. Mol (The University of Adelaide, Australië)  
Copromotoren 
Dr. W.L.D.M. Nelen
Dr. R.P.G.M. Hermens 
Manuscriptcommissie 
Prof. dr. J.B. Prins (voorzitter)
Prof. dr. W.J.J. Assendelft 
Prof. dr. D. de Neubourg (Universitair Ziekenhuis Antwerpen, België)
Paranimfen 
J.A.M. Kersten
L.A.P. Kersten
511305-L-bw-kersten
Processed on: 6-7-2017 PDF page: 5
Contents
Chapter 1 Introduction 7
Part I  Expectant Management 21
Chapter 2 Cost-eﬀectiveness of ‘immediate IVF’ versus ‘delayed IVF’:  
a prospective study
Human reproduction, Vol.32, pp. 999-1008, 2017
23
Chapter 3 Expectations of the first consultation for infertility in a clinic:  
Patient and professional perspective
45
Part II  Tailored Expectant Management 63
Chapter 4.1 Overtreatment in couples with unexplained infertility
Human Reproduction, Vol.30, pp. 71-80, 2015
65
Chapter 4.2 Overbehandeling in paren met onverklaarde subfertiliteit
Nederlands Tijdschrift voor Geneeskunde, 159, A8689, 2015
87
Chapter 5 Tailored expectant management in couples with unexplained 
infertility does not influence their experiences with fertility care
Human reproduction, Vol.31, pp.108-116, 2016
103
Part III  Implementing Tailored Expectant Management 123
Chapter 6 Improving the implementation of tailored expectant management  
in subfertile couples: Protocol for a cluster randomized trial
Implement Science, Vol.53, pp.53-64, 2013
125
Chapter 7 Implementing targeted expectant management in fertility care  
using prognostic modelling; a cluster randomized trial with  
a multifaceted strategy
Human Reproduction. 2017 Jun 7:1-10. doi: 10.1093/humrep/dex213. [Epub ahead of print]
139
Chapter 8 Improving the implementation of expectant management 
in couples with unexplained infertility: a process evaluation of  
a cluster randomized trial
161
Chapter 9 General discussion 181
Chapter 10 Summary | Samenvatting 197
Appendix Portfolio
List of publications
Dankwoord
Over de auteur
217
219
221
225
511305-L-bw-kersten
Processed on: 6-7-2017 PDF page: 6
511305-L-bw-kersten
Processed on: 6-7-2017 PDF page: 7
Introduction
1
511305-L-bw-kersten
Processed on: 6-7-2017 PDF page: 8
511305-L-bw-kersten
Processed on: 6-7-2017 PDF page: 9
9
Introduction
1
Introduction
This thesis will focus on the implementation of tailored expectant management (TEM) in 
couples with unexplained infertility.  In this chapter, an introduction is given to infertility, 
unexplained infertility, TEM, and treatment options such as intra-uterine insemination (IUI) 
and in vitro fertilization (IVF). The implementation problem of TEM is discussed, as well 
as the approach to improve adherence to TEM. This chapter concludes with the outline 
of this thesis.
Infertility
Infertility is defined as the non-occurrence of conception after one year of unprotected 
intercourse (Zegers-Hochschild et al. 2009). Globally, it aﬀects approximately 9% of all 
couples of reproductive age who are trying to conceive (Boivin et al. 2007; Gnoth et al. 
2003).  Many couples seek professional care for assistance in achieving a pregnancy. In the 
Netherlands, infertile couples are usually referred by the general practitioner (GP) to 
secondary care. Of all Dutch couples, 15% visit a specialist for fertility care during their 
reproductive life (Beurskens, Maas, and Evers 1995). GPs usually perform only limited basic 
fertility workup or no workup at all and they do not prescribe fertility drugs. Secondary 
and tertiary care is provided by three diﬀerent types of fertility clinics based on the kind of 
treatment they oﬀer. Initial fertility assessment, ovulation induction (OI), and IUI are carried 
out in all Dutch clinics. In vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) 
treatments are only carried out in intermediate and licensed fertility clinics. Every Dutch 
citizen has a basic insurance coverage, which fully reimburses all treatment cycles of OI 
and IUI, with or without controlled ovarian hyperstimulation, as well as a maximum of 
three IVF or ICSI cycles. There is a national patient organization for people dealing with 
fertility problems, called Freya (www.freya.nl). 
Unexplained infertility 
After the basic fertility work-up 20% of couples is diagnosed with a mild/moderate male 
factor, 5% with a severe male factor, 20% with an ovulation disorder, 25% of couples are 
diagnosed with another diagnosis such as tubal pathology, cervical factor, endometriosis, 
and sexual disorders, while in 25% no cause is found (Brandes et al. 2010). Internationally, 
the latter category of couples is labelled as having unexplained infertility. However, 
according to the Dutch national guideline on infertility the diagnosis of unexplained 
infertility is given if the fertility work up shows no cause for the infertility or if it shows mild 
abnormalities that are not significant enough to obstruct a natural conception (NHG 
2010). These last include a cervical factor, one-sided tubal pathology, mild male infertility, 
and/or mild endometriosis. Because there is no absolute medical cause found for their 
unfulfilled childwish a targeted treatment is lacking. Nevertheless, in most countries the 
first step is to start with IUI with or without mild ovarian hyperstimulation (MOH). In case 
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Chapter 1
this treatment fails to lead to a live birth after six to twelve cycles, IVF is the next treatment 
step for these couples. However, the eﬀectiveness of both these treatments is questionable 
for couples with unexplained infertility (Veltman-Verhulst et al. 2016; Pandian, Gibreel, and 
Bhattacharya 2015). 
 Therefore, the European Society of Reproductive Medicine (ESHRE) and National 
Institute of Health and Clinical Excellence (NICE) guidelines on the management of 
infertility both emphasize that couples should not be exposed to unnecessary risks or 
ineﬀective treatments and encourage that each infertile couple should receive information 
about their chance of natural conception (ESHRE 2001; NICE 2004). The NICE guideline 
recommends two years of expectant management before IVF treatment can be 
considered.  Furthermore, it advises not to perform treatment with IUI in either a natural 
or stimulated cycle. 
IUI versus expectant management
IUI is a procedure in which semen is ‘washed’ in the laboratory and inserted in the uterine 
cavity using a small catheter. It is essential that the IUI is performed at the time of ovulation. 
For correct timing of the insemination, cycle monitoring is performed to asses ovulation. 
The rationale for performing IUI is that the motile spermatozoa can be concentrated in a 
small volume and placed directly into the uterus close to the released oocyte. In this way 
the cervix is bypassed. IUI can be performed with or without mild ovarian hyperstimulation 
(MOH). The two most commonly used drugs for MOH are clomiphene citrate (CC), 
which is an oral treatment, and gonadotropins administered by subcutaneous injection. 
The aim of MOH is to increase the number of oocytes available for fertilisation and to 
enhance accurate timing.
 However, there has been a lot of debate about the eﬀectiveness of IUI (with or 
without MOH) compared to expectant management, there is also a safety concern about 
the increase in multiple pregnancy rates with  IUI with MOH. A recent Cochrane review, 
which included 14 trials including 1867 women, did not find conclusive evidence of a 
diﬀerence in live birth or multiple pregnancy in most of the comparisons for couples with 
unexplained infertility treated with IUI (both with and without MOH) when compared 
with expectant management or timed intercourse (Veltman-Verhulst et al. 2016).
 
IVF versus expectant management
IVF involves using standard protocols for controlled ovarian stimulation, oocyte retrieval 
under ultrasound guidance, insemination in the laboratory, embryo culture and 
transcervical replacement of embryos at cleavage or blastocyst stage. IVF is an invasive 
treatment and is associated with several potential complications such as multiple pregnancy 
and ovarian hyperstimulation syndrome. However, IVF can potentially circumvent unknown 
biological deficiencies that could aﬀect conception in unexplained infertility by bypassing 
several in vivo steps that may be responsible for lack of conception. These include ovarian 
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dysfunction, cervical factors, problems with sperm and egg transport and sperm-egg 
interaction.
 There has been one study comparing IVF to expectant management. Hughes et al., 
2004 performed an RCT among 139 couples comparing one cycle of IVF to three months 
of expectant management and found higher live birth rates with IVF (Hughes et al. 2004). 
However, the quality of evidence was deemed to be low (Pandian, Gibreel, and 
Bhattacharya 2015). Furthermore, the couples they included had been trying to conceive 
for an average of four years, which is very long compared to other studies that compared 
treatment with an expectant management for couples with unexplained infertility. 
Additionally, we know from prospective studies that at least six cycles with timed 
intercourse and not just a few months are necessary to cover the period in which most of 
the conceptions should occur (Gnoth et al. 2003).
 The comparison between IVF versus no treatment for one year has never been 
investigated in a randomized trial in couples with unexplained infertility. It would be 
interesting to know if undergoing IVF immediately increases pregnancy rates compared 
to expectant management for couples with unexplained infertility. 
Chances of natural conception and tailored expectant management
The Dutch Network Guideline on Infertility makes recommendations for expectant 
management for couples with unexplained infertility based on their chance of natural 
conception within one year. In couples with unexplained infertility, the chance of natural 
conception can be calculated with the prognostic model of Hunault (Hunault et al. 2004; 
van der Steeg et al. 2007). In The Netherlands, this model is available on the website of 
the patient organisation Freya (www.freya.nl), through local electronic patient file systems, 
or with the use of a paper version. The prognostic model takes four mandatory factors 
into account: female age (years), duration of infertility (years), type of infertility (primary/
secondary): and quality of semen (percentage progressive motile sperm). Three additional 
factors are optional: referral status (general practitioner/own initiative/medical specialist), 
cervical factor (post coital test positive/negative), and diagnosis of one-sided tubal 
pathology (yes/no). If the chance of natural conception within one year is good, meaning 
a probability of 30% or more, expectant management for six to twelve months is equally 
eﬀective as treatment with IUI with MOH (figure 1) (Steures et al. 2008; Custers et al. 2012). 
Because this expectant management is restricted to couples with a good prognosis, 
we call this tailored expectant management (TEM). 
 In the Netherlands, the National Network Guideline on Infertility for gynecologists 
and GPs explicitly recommends the use of prognostic models and subsequent TEM for 
couples with unexplained or mild infertility (NHG 2010). Figure 2 shows the flowchart 
of the guideline recommendations on TEM. However, previous research showed that 
adherence to TEM prior to the dissemination of the guideline in 2010 was poor. A Dutch 
multicenter cohort study showed overtreatment in 36% of the couples that were 
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Chapter 1
recommended an expectant management of six to twelve months, i.e., 36% of the couples 
with a good prognosis eligible for TEM (>30% chance of natural conception in one year) 
already started medically assisted reproduction (MAR) before the expectant period ended 
(van den Boogaard, Oude Rengerink, et al. 2011).
 This overtreatment in infertile couples is worrisome for several reasons. First, fertility 
treatment still leads to a considerable number of multiple pregnancies, which are associated 
with a higher morbidity and mortality in both mothers and neonates (Helmerhorst et al. 
2004). Second, fertility treatment carries a significant physical and psychological burden and 
accompanying productivity loss (Verberg et al. 2008; Verhaak et al. 2002; Verhaak et al. 2007; 
Bouwmans et al. 2008). Third, fertility treatment and its complications are expensive and put 
considerable financial strain on societies where MAR is reimbursed or on the infertile 
couples in societies where MAR is not or only partially reimbursed (Custers et al. 2012). 
Figure 1  Tailored expectant management versus IUI with MOH
Ref: Steures et al. Lancet 2006
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Implementation of TEM
Despite the guideline recommendations on TEM, implementation of TEM in clinical 
practice has not been optimal so far. Poor implementation of new guideline recommen-
dations is not uncommon. Grol et al. 2003 describe that it is essential to use a systematic 
approach to promote practice of new guidelines in clinical practice (Grol and Grimshaw 
2003). This approach consists of the following steps: getting insight in current practice, 
identification of potential determinants that predict adherence, analysis of barriers and 
facilitators for implementation, development of an implementation strategy (based on 
the barriers and facilitators), and a thorough evaluation of the implementation strategy. 
In this thesis we will use this approach to improve implementation of guideline recom-
mendations on TEM.
Current practice 
Despite the previous research that showed that many couples who were advised TEM still 
received treatment too soon, there has not been an evaluation of adherence to the 
guideline recommendations on TEM since the guideline was published in 2010. The 
insight on the current uptake of the guideline recommendations is necessary to take the 
next steps to improve adherence to TEM.  
Barriers and facilitators 
The next step to improve guideline adherence on TEM and reduce overtreatment is to 
gain insight into barriers and facilitators. There has been a previous qualitative and 
quantitative study among patients and professionals to gain insight in the barriers and 
facilitators for adherence to TEM. The main barriers among infertile couples were lack of 
confidence in natural conception, perception that expectant management is a waste of 
Figure 2  Flowchart of the Dutch guideline recommendations on TEM
Clear cause
No clear cause:
 Unexpained infertility
 Mild male infertility.
 Cervical factor
 Mild endometriosis
 One-sided tubal pathology
Prognostic  
model
Chance < 30%
 
in 12 months
Chance > 30%
in 12 months
Expectant 
management of at 
least 6-12 months
Basic fertility work-up Fertility treatment
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time, inappropriate expectations prior to the first secondary care consultation, and an 
overestimation of the success rates of treatment. Both couples and professionals regarded 
the lack of patient information materials as an important barrier. Among the professionals, 
limited knowledge about prognostic models and limited communication skills to convince 
the couple, both leading to a decision in favor of treatment, were recognized as main 
barriers. Facilitators experienced by the professionals were better management of 
patients’ expectations, local consensus, and the presence of a local protocol and local 
fertility meetings (van den Boogaard, van den Boogaard, et al. 2011; van den Boogaard, 
Oude Rengerink, et al. 2011). 
The expectations of patients and the management of these expectations is an important 
recurrent item among the barriers and facilitators. However, we do not know what exactly 
the expectations of patients are and how professionals manage them currently. To tackle 
this barrier and to improve adherence to TEM is it important to get more insight in this 
matter. 
Furthermore, if the barriers on TEM are not addressed properly, it can lead to uncomfortable 
situations between couples and their physicians when TEM is advised and it can finally 
result in non-adherence. It can also cause conflicts between patients and their physicians, 
patients dissatisfied with the care they receive, shopping for fertility treatment in other 
clinics, and even discontinuation of care (Brandes et al. 2009). The question is, do couples 
who were eligible for TEM and actually followed an expectant management have 
experienced care in a diﬀerent way than couples that were also eligible for TEM but started 
treatment immediately? 
Improving implementation of tailored expectant management 
The next step in the approach to improve implementation of guideline recommendations 
on TEM would be to develop a multifaceted implementation strategy based on the 
barriers and facilitators. The best way to evaluate such a strategy would be with a cluster 
randomized trial. The final step in the approach to improve implementation of TEM is an 
extensive process evaluation to get more insight in the usefulness of the diﬀerent strategy 
elements and patients’ and professionals’ experiences with the strategy.
Study objectives
In the first part of this thesis we study the eﬀect of IVF compared to expectant management 
and we address a possible additional barrier for expectant management. In the second 
part we aim to provide an overview of the current status and views on tailored expectant 
management in fertility care in the Netherlands. In the third part, we study the eﬀect of a 
multifaceted strategy to improve the implementation of tailored expectant management. 
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Main questions:
PART I
1. How does the cost-eﬀectiveness of immediate IVF compared with postponing IVF for 
one year, depend on prognostic characteristics of the couple? (chapter 2)
2. To what extent exist diﬀerences in couples’ expectations of their first visit to a clinic 
for infertility problems and how professionals perceive these expectations? (chapter 3)
PART II
3. What is the percentage of overtreatment, i.e. fertility treatment started too early, 
in couples with unexplained infertility who were eligible for tailored expectant 
management? (chapter 4)
4. Do couples who were eligible for TEM and did not start treatment within six months 
after the fertility work-up, have diﬀerent experiences with care than couples that 
were also eligible for TEM but started treatment right after the fertility work-up? 
(chapter 5)
PART III 
5. What is the eﬀectiveness of a multifaceted implementation strategy compared to 
usual care on improving the adherence to guideline recommendations on expectant 
management for couples with unexplained infertility? (chapter 6 and 7)
6. What is the relationship between the adherence to TEM and couples’ and professionals’ 
exposure to the implementation strategy? (chapter 8)
Outline of the thesis
The cost-eﬀectiveness of immediate IVF versus postponing IVF for one year is assessed 
with a prospective waiting list study in chapter 2. We take into the cause of infertility, 
age of the woman, and duration of infertility. 
To further explore one of the main barriers for TEM, i.e. the expectations of the patients 
and addressing these expectations by the professional, we performed a mixed-method 
study among 26 couples and their professionals in three clinics (chapter 3).
In chapter 4 we evaluate the adherence to the Dutch Network Guideline on Infertility 
 recommendations on TEM in a retrospective cohort study in 25 clinics among 544 couples. 
Multilevel regression analyses are performed to investigate associations of non-adherence 
with patient and clinic characteristics.
To assess how adherence to TEM aﬀect couples’ experiences with care, we perform a 
retrospective cross-sectional study in chapter 5 among the couples that are included in 
chapter 4. We use patient’s questionnaires to collect data on the couples’ experience with 
care (patient-centeredness of care and patients’ trust in the physician).
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Chapter 1
We developed an implementation strategy based on the known barriers and facilitators 
to improve adherence to guideline recommendations on TEM. In chapter 6 we describe a 
study protocol of a cluster randomized trial to test the eﬀectiveness of this implementation 
strategy and in chapter 7 we describe the results of the cluster randomized trial. 
In chapter 8 we report on the process evaluation of the cluster randomized trial. We get 
more insight in the couples’ and professionals’ exposure to the implementation strategy 
elements and their experiences with the diﬀerent elements. We will also assess if diﬀerent 
levels of exposure to the strategy aﬀect the eﬀectiveness of the strategy on adherence 
to TEM.
This thesis concludes with a general discussion in chapter 9. We will reflect on the results 
from the previous chapters and will present the main conclusions of this thesis and discuss 
the implications for future practice and research.
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Chapter 2
Abstract
Study question: How does the cost-eﬀectiveness (CE) of immediate IVF compared with 
postponing IVF for 1 year, depend on prognostic characteristics of the couple?
Summary answer: The CE ratio, i.e. the incremental costs of immediate versus delayed 
IVF per extra live birth, is the highest (range of €15 000 to >€60 000) for couples with 
unexplained infertility and for them depends strongly on female age and the duration of 
infertility, whilst being lowest for endometriosis (range €8 000-€23 000) and, for such 
patients, only slightly dependent on female age and duration of infertility.
What is known already: A few countries have guidelines for indications of IVF, using the 
diagnostic category, female age and duration of infertility. The CE of these guidelines is 
unknown and the evidence base exists only for bilateral tubal occlusion, not for the other 
diagnostic categories.
Study design, size, duration: A modelling approach was applied, based on the literature 
and data from a prospective cohort study among couples eligible for IVF or ICSI treatment, 
registered in a national waiting list in The Netherlands between January 2002 and 
December 2003.
Participants/materials, setting, methods: A total of 5962 couples was included. Chances 
of natural ongoing pregnancy were estimated from the waiting list observations and 
chances of ongoing pregnancy after IVF from follow-up data of couples with primary 
infertility that began treatment. Prognostic characteristics considered were female age, 
duration of infertility, and diagnostic category. Costs of IVF were assessed from a societal 
perspective and determined on a representative sample of patients. A cost-eﬀectiveness 
comparison was made between two scenarios: (I) wait one more year and then undergo 
IVF for 1 year and (II) immediate IVF during 1 year, and try to conceive naturally in the 
following year. Comparisons were made for strata determined by the prognostic factors. 
The final outcome was a live birth.
Main results and the role of chance: The gain in live birth rate of the immediate IVF 
scenario versus postponed IVF increased with female age, and was independent from 
diagnostic category or duration of infertility. By contrast, the corresponding increase in 
costs primarily depended on diagnostic category and duration of infertility. The lowest CE 
ratio was just below €10 000 per live birth for endometriosis from age 34 onwards at 1 year 
duration. The highest CE ratio reached €56 000 per live birth for unexplained infertility at 
age 30 and 3 years duration, dropping to values below € 30 000 per live birth from age 32 
onwards. It reached values below €20 000 per live birth with 3 years duration at age 34 
and older. The CE ratio was in between for the three other diagnostic categories (i.e. Male 
infertility, Hormonal and Immunological/Cervical).
Limitations, reasons for caution: We applied estimates of chances with IVF, excluding 
frozen embryos, for which we had no data. Therefore, we do not know the eﬀect of frozen 
embryo transfers on the CE.
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Wider implications of the findings: The duration of infertility at which IVF becomes 
cost-eﬀective depends, firstly, on the level of society’s willingness to pay for one extra live 
birth, and secondly, given a certain level of willingness to pay, on the woman’s age and the 
diagnostic category. In current guidelines, the chances of a natural conception should 
always be taken into account before deciding whether to start IVF treatment and at which 
time.
Study funding/competing interest(s): Supported by Netherlands Organisation for 
Health Research and Development (ZonMW, grant 945-12-013). ZonMW had no role in 
designing the study, data collection, analysis and interpretation of data or writing of the 
report. Competing interests: none.
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Introduction
A few countries have guidelines for providing IVF (NVOG, 2010; Fields et al. 2013). The 
guidelines recommend at which duration of infertility IVF should be started for given 
combinations of reason for infertility (i.e. diagnostic category) and female age. The cost-ef-
fectiveness (CE) of these guidelines, i.e. the extra costs per live birth of starting IVF 
treatment immediately at a certain duration of infertility, compared with postponing IVF 
for 1 year, has never been assessed.
 The indications for IVF have been widened considerably since its introduction in 1978. 
Whereas, in earlier days, bilateral tubal occlusion was seen as the only reason to perform 
IVF, IVF is currently used for virtually any infertility diagnostic category. Yet, evidence of CE 
from a randomized controlled trial is available only for the tubal indication group (Soliman 
et al. 1993). For other diagnostic categories such as unexplained, mild male or cervical 
infertility the evidence base for an increased eﬀectiveness of IVF compared with the 
eﬀectiveness of expectant management or IUI with or without stimulation is considered 
to be weak or lacking (Hughes et al. 2004; Pandian et al. 2015).
 For tubal pathology, endometriosis and for severe male infertility, the choice of 
treatment is limited to two options: either trying for a natural conception or starting IVF. 
There are few alternative treatment options for the other diagnostic categories: for 
unexplained, mild male or cervical infertility, IUI with or without mild ovarian hyperstimu-
lation (MOH) is the only treatment option prior to IVF. The usefulness of IUI/MOH compared 
with expectant management is however being debated and further, it is not self-evident 
that a couple should start IVF directly after failed IUI/MOH; a waiting time could be 
indicated to profit from a remaining pregnancy chance before IVF treatment is 
commenced, given the high cost and burden of IVF (Pashayan et al. 2006; Steures et al. 
2008; van den Boogaard et al. 2014). Furthermore, studies have shown that a pregnancy 
after IVF results in more multiple pregnancies and even singleton pregnancies are more 
prone to preterm birth, low and very low birth weight, small for gestational age and 
perinatal mortality compared with spontaneously conceived pregnancies (Okun and 
Sierra 2014).
 Therefore, an evidence-based comparison of expectant management versus IVF is 
needed for all diagnostic categories. Within current practice, a randomized comparison 
would not be feasible because it would be very diﬃcult to recruit couples for a study that 
might make them delay their IVF treatment for 1 year. However, in the Netherlands there 
were waiting lists for IVF when the increasing demand for IVF exceeded the supply by the 
few clinics that were licensed to perform IVF treatments. Therefore, we were able to use 
the waiting period before the actual start of IVF to estimate the natural pregnancy chances 
of couples that are going to start IVF. Some couples received prior treatment such as IUI/
MOH whereas others had no treatment prior to the waiting period for IVF.
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Pregnancy chances with IVF depend on female age and duration of infertility but not on 
the infertility diagnostic category (Templeton et al. 1996; Lintsen et al. 2007). Natural 
pregnancy chances also depend on female age and duration of infertility, but in this case 
diﬀer substantially between diagnostic categories. Because the same factors are predictive 
for both natural pregnancy and pregnancy after IVF, we might infer that the relative 
eﬃcacy of IVF over expectant management would depend only slightly or not at all on 
patient characteristics. In a modeling exercise, Mol et al. (2000) showed that the CE strongly 
depends on the female age. However, this remains to be assessed on prospective data 
and for other predictive factors (Mol et al. 2000).
 Therefore, the aim of the current study is to determine the cost-eﬀectiveness of 
immediate IVF compared with postponing IVF for 1 year in couples with primary infertility, 
according to the prognostic factors female age, duration of infertility and diagnostic 
category.
Materials and Methods
Subjects
Between 1 January 2002 and 31 December 2003, a national cohort study was conducted 
in the Netherlands so that all patients in IVF clinics on a waiting list were prospectively 
registered by their gynaecologist at the moment of indication for IVF or ICSI. In 2004, the 
registered data were cross-checked with the IVF treatment registries of the clinics in order 
to see whether the patients had actually started IVF or not. Patients that could not be 
identified in the IVF registries were tracked manually by searching the patient medical 
records in the IVF clinics: detailed patient data were collected, and the reason for not 
starting IVF was registered, including the occurrence and timing of a natural pregnancy. 
We only included data from couples with primary infertility because for secondary 
infertility we could not distinguish between couples who had undergone IVF for the first 
pregnancy, for whom the decision for IVF is no longer questionable, and couples who had 
a treatment-independent first pregnancy. From the data collected, prediction models 
were developed for the chance of treatment-independent pregnancy, as observed during 
the period on the waiting list (Eijkemans et al. 2008) and for the chance to become 
pregnant with IVF/ICSI (Lintsen et al. 2007). The costs of IVF/ICSI were determined on a 
representative sample of patients undergoing treatment in five participating clinics 
(Eijkemans et al. 2008). The current study integrates all these findings.
Ethical approval
Ethical approval was obtained from the institutional review boards of the leading 
participating centre, and a local check on feasibility from all other participating centres, 
according to regulations in the Netherlands.
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Definitions
Throughout this paper, we will use ‘infertility’ to indicate that a couple has been trying 
to conceive without success for a period of at least 1 year. The duration of infertility was 
defined as the period between the start of the couples’ pregnancy attempts and the 
moments at which the decision was made to start IVF or wait for another 12 months. 
Primary infertility is defined as no prior pregnancy in this partnership. Age refers to the age 
of the female partner at the decision moment to start or postpone IVF. The diagnostic 
categories considered are unexplained infertility, male infertility, endometriosis, hormonal 
and immunological/cervical infertility. The male category does not diﬀerentiate between 
a mild male factor and a severe factor requiring ICSI, because these subcategories were 
not registered on the waiting list. We excluded the tubal infertility group because the 
waiting list data did not discriminate between couples with absolute two-sided tubal 
pathology, who have no chance of conceiving without treatment, and couples with 
relative one-sided tubal pathology, who do have a chance of conceiving without 
treatment.
Cost-effectiveness analysis
The aim of this study was to assess the CE of immediate IVF compared with postponing 
IVF for 1 year, for subgroups of patients. The methodology followed is similar to the one 
used in a previous study in anovulatory patients (Eijkemans et al. 2005): comparisons 
between treatment scenarios were made for subgroups of couples with primary infertility 
defined by the prognostic factors female age, duration of infertility and diagnostic 
category. Two treatment scenarios were compared: (I) wait 1 year, then 1 year of IVF and (II) 
immediate IVF during 1 year, then 1 year no treatment. The time horizon of the analysis 
was therefore 2 years, and is the same for both scenarios. We do not have immediate 
observations of outcomes for both scenarios, because no randomized data are available. 
As a second best option, the relevant chances of the periods with and without treatment 
in both scenarios may be obtained from our prediction models on IVF chances (Lintsen et 
al. 2007) and on chances on the waiting list (Eijkemans et al. 2008). These models predict 
the chances of an ongoing pregnancy.
 The eﬀectiveness measure of the study was a live birth. Our data (from the registry 
and/or medical records) contained ongoing pregnancy and not live birth. To convert 
ongoing pregnancy rates to live birth rates, we used the published data of Arce et al. 2005. 
In our study, ongoing pregnancy is defined as foetal heart activity on ultrasound after at 
least eight weeks gestation. Therefore, most ultrasounds were conducted between 8 
and 10 weeks of gestation. Arce defined ongoing pregnancy as foetal heart activity on 
ultrasound at 12 weeks and states that 92% result in a live birth (95% confidence interval: 
88–96%). Furthermore, they state that a viable pregnancy confirmed by ultrasounds at 
6 weeks gestation results in a live birth in 84% (Arce, Nyboe Andersen, and Collins 2005). 
Because the risk of miscarriage is higher in early pregnancies we decided to use the 
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conversion of ongoing pregnancy to live birth rate as stated by Arce (92%). Both a singleton 
and a twin live birth were counted as one success.
 The prediction models for natural pregnancy (‘treatment-independent’ model) 
(Eijkemans et al. 2008) and for pregnancy following IVF (IVF model) (Lintsen et al. 2007) 
were converted to live birth and subsequently used to compare the live birth chances of 
the two treatment strategies for various patient profiles (Table I). 
 Figure 1 shows the principle, for a couple with primary unexplained subfertility, age = 
30 years and duration = 2 years. In the first year, Scenario I starts with rather low natural 
pregnancy chances, and lags far behind Scenario II (immediate IVF). However, in the 
second year, Scenario I almost catches up.
 Comparisons were made for patient profiles determined by the factors in the 
prediction models. Reference case analyses were performed using four ‘example’ patient 
profiles: both unexplained infertility and endometriosis at female ages 30 and 38 years, 
always with primary infertility of 3 years duration.
 The health economic perspective was that of society. We therefore included direct 
and indirect medical and non-medical costs. The costs of trying to become pregnant 
without treatment was assumed to be zero. The direct medical costs of IVF/ICSI were 
determined from the per-cycle cost estimates from Bouwmans et al. 2008b. To this, we 
added an estimate of €596 per cycle as direct non-medical costs due to absence from 
work (Bouwmans et al. 2008a). The resulting total cost per cycle was applied to the data 
from all patients starting IVF/ICSI treatment used in the study from Lintsen et al. (2007) and 
for each patient, the costs over a 1-year period of treatment were aggregated. On these 
data, a prediction model for the costs of IVF over a 1-year period was developed using the same 
four factors as used in the prediction models for pregnancy chances, using linear regression 
analysis. The resulting model equations are available from the authors on request.
 In case of an ongoing pregnancy leading to live birth, the costs of pregnancy, 
subsequent delivery and neonatal care were added to the costs of treatment. We used the 
estimates from Lukassen et al. 2004 for IVF conceived pregnancies: €2549 for a singleton 
and €13 469 for a twin pregnancy. In a sensitivity analysis, we used cost estimates for 
delivery and neonatal care following IVF and naturally conceived pregnancies from 
Chambers et al. 2007. The age-standardized estimates for singletons were €4624 and 
€4098 (diﬀerence: €526) with IVF and naturally conceptions, respectively. For twin 
pregnancies, the estimates were €14 114 and €13 350 (diﬀerence: €764), respectively. 
The cost-diﬀerences between IVF and treatment-independent pregnancies found 
by Chambers et al. (2007) were also applied in the standard analysis with costs of IVF 
pregnancies from Lukassen et al. (2004). We further assumed that 6.6% of IVF pregnancies 
were twins, as registered for the Netherlands in 2012, and 1% of treatment-independent 
pregnancies (NVOG 2013, Chambers, Adamson, and Eijkemans 2013).
 All costs were updated to the price level of 2014, using the national price index for 
the Netherlands from the Dutch Bureau of Statistics.
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Table I   Chances of pregnancy leading to live birth of the two strategies, for four 
selected example patient profiles
Patient profiles with primary subfertility of 3 years and:
Diagnostic category
Age
Unexplained
30
Unexplained
38
Endometriosis
30
Endometriosis
38
Treatment-independent chance  
in year 1
12.7% 8.9% 3.7% 2.6%
Treatment-independent chance  
in year 2
11.1% 7.9% 3.2% 2.3%
IVF chance in year 1 49.5% 32.3% 42.3% 26.8%
IVF chance in year 2 48.4% 27.3% 41.3% 22.6%
Chance with Scenario I, postponing 
IVF 1 year*
55.0% 33.8% 43.5% 24.6%
Chance with Scenario II, direct IVF* 55.1% 37.6% 44.2% 28.5%
Chance diﬀerence II – I (Delta P) 0.1% 3.8% 0.7% 3.9%
* Pregnancy chances leading to live birth per scenario are calculated from the relevant year-specific chances 
applied to those couples that didn’t become pregnant in the previous year. E.g. Pregnancy chance with 
Scenario II, direct IVF = 49.5 + (100-49.5)*0.111 = 55.1.
Figure 1   Cumulative chances of ongoing pregnancy leading to live birth, against time 
with 2 diﬀerent scenarios for IVF
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The CE comparison was made between Scenarios (II) (immediate IVF) and (I) (first wait for 
1 year). The diﬀerence in live birth rate (eﬀectiveness) between the scenarios was 
calculated as well as the diﬀerence in costs. The CE ratio, the cost diﬀerence divided by the 
eﬀectiveness diﬀerence, indicates the extra costs per extra live birth of (II) versus (I). 
In order to translate the CE ratio to a policy recommendation, for each age the duration of 
infertility was determined at which a pre-specified threshold for the CE ratios is attained. 
Following standard methodology in economic appraisals, costs and eﬀects were 
discounted to present values. A discount rate of 3.5% was used for both costs and eﬀects, 
as recommended by NICE (NICE 2013).
 The statistical uncertainty in the results was assessed by a bootstrapping method 
with 5000 replications. We used samples from the original waiting list cohort data, 
including the subsequent IVF treatment data, and re-estimated the prediction models for 
treatment- independent pregnancy chances and for pregnancy chances and costs of IVF 
on each sample. The resulting model predictions for the four base-case patient profiles 
were used to assess the diﬀerence in costs and eﬀects of the two scenarios. From these 
resampled diﬀerences in costs and eﬀects, a CE acceptability curve was derived that 
shows how, for the four patient profiles, the proportion of samples in which immediate 
IVF is cost-eﬀective depends on the threshold value for the CE ratio.
 An overview of the input parameters for the base-case analyses and the sensitivity 
analyses can be found in Supplementary Table SI.
Results
Characteristics of the study inclusion have been published before (Eijkemans et al. 2008). 
Briefly, there were 6221 patients rightfully included on the waiting list. From 259 patients, 
we could not find any data in the IVF clinics. Of 5962 patients, the follow-up could be 
established, and they formed the basis of analysis. The estimated proportion of treatment- 
independent ongoing pregnancies after 12 months was 9% (Eijkemans et al. 2008). Further, 
4928 couples started IVF, resulting in an ongoing pregnancy rate of 45% within 12 months 
(Lintsen et al. 2007).
Live birth rates compared between the two scenarios
Table I shows, for the four reference case patient profiles, the treatment-independent live 
birth rates in the first and second year, the IVF live birth rates in the first and second year 
and the comparison between the two scenarios. The chances of a treatment-independent 
live birth diﬀer between diagnostic categories and are lower for older age. IVF chances 
also decline with age, but they show less dependence on diagnostic category. All chances 
are lower in the second year than in the first year, but the diﬀerences vary over patient 
profiles. The chances with the direct IVF Scenario (II) are slightly higher than with the 
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postpone IVF Scenario (I) and the diﬀerence depends more strongly on age than on the 
diagnostic category. The diﬀerence varies from 0.001 for unexplained infertility at 30 years 
to 0.039 for endometriosis at 38 years. 
 Diﬀerences in live birth rates compared for all possible combinations of couple 
 characteristics, restricted to female ages above 30 and primary infertility, are depicted in Fig. 2. 
The diﬀerence becomes larger with age, reaching a maximum at age 38, declining thereafter. 
The diﬀerence at a given age is almost the same for the various diagnostic categories or 
durations of infertility. The diﬀerence in costs between the two scenarios (not shown) did 
depend mainly on diagnostic category and on the duration of infertility, less on age.
Table II   Costs of IVF treatment and costs of delivery and neonatal period of the two 
strategies, for four selected patient profiles (Euros)
Diagnostic category patient profiles with primary subfertility 
of 3 years 
Unexplained Endometriosis
Age 30 38 30 38
Costs of IVF treatment in year 1
Costs of IVF treatment in year 2
Costs of Scenario I, postponing IVF 1 year
 IVF treatment 
 Delivery and neonatal period 
 Total 
Costs of Scenario II, direct IVF
 IVF treatment 
 Delivery and neonatal period 
 Total
Total cost diﬀerence II – I (∆-Costs)
4,036
4,062
3,545
3,247
6,792
4,036
3,343
7,379
586
5,067
5,173
4,711
1,984
6,695
5,067
2,264
7,331
635
4,273
4,299
4,139
2,648
6,787
4,273
2,712
6,985
198
5,304
5,410
5,271
1,489
6,759
5,304
1,743
7,047
287
Cost eﬀectiveness (CE) ratio 
 (∆-Costs / ∆-Eﬀectiveness *)
 discounting (C and E) with 3.5% per year
Sensitivity analyses:
 discounting C with 4%, E with 1.5% per year
 discounting (3.5%), alternative costs**
 discounting (3.5%), Twins count for 2***
544,500
56,500
120,800
58,300
50,200
16,800
16,600
18,700
18,800
15,800
30,300
19,400
33,000
21,600
18,300
 
7,300
 8,700
10,200
11,000
8,500
* ∆-Eﬀectiveness = Chance diﬀerence between scenarios II and I, from Table I. ** Costs for delivery and 
neonatal care from Chambers et al.16. *** Twin live births count as two successes in the CE ratio
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Costs and cost-effectiveness
Table II shows the costs and the CE comparison for the four reference case patient profiles. 
With older age, IVF becomes more costly, because more treatment cycles are needed 
to compensate for the decreased chances per cycle, and because the cost of medication 
per cycle increases (Bouwmans et al. 2008b). For each patient profile, the costs of IVF as well 
as the costs of delivery and neonatal period are higher in Scenario II, direct IVF, than in 
Scenario I, postponing IVF. Therefore, in total, direct IVF is more costly than postponing IVF. 
The undiscounted CE ratio, obtained by dividing the cost diﬀerence by the live birth rate 
diﬀerence, is very high for unexplained infertility at age 30: one extra live birth gained 
by direct IVF as compared with postponing IVF costs €544 500. The ratio is lowest for 
endometriosis at age 38: €7300 per live birth. When twins were regarded as two successes, 
CE ratios became lower, as expected, but the changes were minor. Discounting has a 
profound impact, making the very high ratio considerably lower. Using the costs for 
delivery and neonatal care from Chambers et al. (2007) had little impact on the CE ratios.
Figure 2   Diﬀerence in live birth chances between ‘Immediate IVF’ and ‘Delayed IVF  
for 1 year’, in relation to female age. Separate panels for diagnostic categories 
and separate curves for duration of infertility
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The statistical uncertainty of the estimated diﬀerences in costs and eﬀects, derived from 
5000 bootstrap samples from the original cohort data, was assessed for the four patient 
profiles. The corresponding uncertainty in CE ratios is represented as CE acceptability 
curves in Fig. 3. At age 38, we may be more than 95% certain that direct IVF is cost-eﬀective at 
a €13 000 per live birth threshold level for endometriosis and at a €28 000 per live birth 
level for unexplained infertility. 
 The CE ratio comparisons for all possible combinations of couple characteristics, 
restricted to female ages above 30 and primary infertility, are depicted in Fig. 4. The CE of 
direct IVF is mainly dependent on diagnostic category and age and less on the duration 
of infertility. A steep decline with age is visible, followed by a slight increase from age 36 
onwards. This pattern is clearly related to the patterns in eﬀect-diﬀerences from Fig. 2 and 
the cost-diﬀerences. For example, when we take a couple with an average duration of 
unexplained infertility and an average female age (based on the background characteristics 
described in Lintsen et al., 2007), at 4 years duration of infertility and age 34.8 years, 
the ratio is between €15 000 and €20 000 per live birth. For couples with an infertility 
duration of 1 year, it reaches €25 000–30 000 per live birth. The highest level of cost- 
Figure 3   Results of a bootstrapping procedure with 5000 replications from the original 
cohort data (n = 5962): cost-eﬀectiveness acceptability curves, representing 
the chance that immediate IVF is cost-eﬀective against Society’s willingness to 
pay for a live birth
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eﬀectiveness reaches €56 000 per live birth for unexplained infertility at age 30 and 3 years 
duration. At a €10 000 per live birth level, direct IVF is only cost-eﬀective for endometriosis 
at age 34 onwards, at 1 year duration and age 32 onwards with 4 year duration. For the 
other indications, the CE ratio stays above €10 000 per live birth, for all ages at a duration 
of 1–2 years of infertility.
Discussion
We conducted a CE analysis of starting IVF in couples with primary infertility versus 
postponing IVF for 1 year, stratifying on diagnostic category, age and duration of infertility. 
Observations from a large prospective study on IVF pregnancy chances and costs in the 
Netherlands, including estimates of treatment-independent pregnancy chances while on 
the waiting list for IVF, formed the empirical basis of the study. Results showed that the CE 
of IVF is most plausible for endometriosis, irrespective of the duration of infertility or age. 
For unexplained infertility, IVF may be postponed for women under 32 until the duration 
Figure 4   The CE ratio between ‘Immediate IVF’ and ‘Delayed IVF for 1 year’, in relation to 
female age. Separate panels for diagnostic categories and separate curves for 
duration of infertility. CE, cost-eﬀectiveness
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of infertility reaches >3 years, mainly because treatment-independent chances are still 
considerable while IVF chances after 1 year will hardly have decreased.
 The loss in chance of a live birth due to postponing IVF for 1 year is always <6% and 
mainly depends on age (Fig. 2 and Table II). The couples that would otherwise have a live 
birth with IVF in the first year will either have a live birth from a natural pregnancy during 
the first year or from a pregnancy after IVF in the following year. The main eﬀect of direct 
IVF compared with postponing IVF is therefore that some natural pregnancies are replaced 
by IVF pregnancies, against considerable extra costs. In a simulation study, Habbema et al. 
(2009) found a similar result.
 From the present results, we can evaluate the current guideline for IVF in the 
Netherlands  (NHG 2010). According to this guideline, the time when to start IVF or ICSI 
treatment depends on the cause of infertility, the duration of infertility and woman’s age. 
When the problems are caused by pathology of the tubal function, such as tubal blockage 
or severe endometriosis, IVF should be oﬀered directly. For severe male infertility (total 
motile count <3 million), there is also a direct indication for IVF or ICSI. In case of ovulation 
disorders (mainly caused by polycystic ovary syndrome, PCOS), at least 12 cycles of 
ovulation induction should precede IVF. For unexplained infertility, the treatment depends 
on the prognosis of a natural conception within a year based on the prognostic model of 
Hunault, which is based on female age, type of infertility, duration of infertility and motility 
of sperm (Hunault et al. 2004), if this is good, i.e. 30% or higher, an expectant management 
has to be advised for at least 6–12 months. If the chance of a spontaneous conception 
within 1 year is lower than 30%, or if the expectant management did not lead to a 
conception, IUI with MOH for three to nine cycles should precede IVF. Minimal 
endometriosis, one-sided tubal pathology, a cervical factor (cervical hostility or 
immunological infertility) and mild male infertility (total motile sperm count between 3 
and 10 million) are treated as unexplained infertility. In all couples with an ovulation 
disorder or with unexplained infertility, IVF can be oﬀered immediately if women are 38 
years or older. The absolute (Dutch legal) age limit for IVF is 45 years of age, but the 
guideline advises not to treat women over 42 years of age, because of poor treatment 
outcome.
 For the diagnostic category endometriosis, starting IVF directly according to the 
Dutch guideline coincides with a relatively low cost-eﬀectiveness ratio for all durations of 
infertility (from 1 to 4 years, the ratio is below €10 000 per live birth). For couples with 
unexplained infertility, the duration of the infertility has a great impact on the cost-eﬀec-
tiveness. This coincides with the current Dutch guideline because it recommends that for 
couples with unexplained infertility the advise to start treatment or not depends on the 
chance of natural conception within 1 year. This chance becomes increasingly lower with 
a longer duration of infertility. For example, in couples with a female age of 32 and good 
semen motility the chance of natural conception only drops below 30% with a duration of 
at least 3 years, which is reason to start treatment. This coincides with a CE ratio of €29 310 
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per live birth. For couples with a duration of infertility of 1 and 2 years, the chance of 
natural conception is higher than 30% and the guideline advises to follow an expectant 
management of 6–12 months. If this advice is not followed and treatment is started than 
the CE ratio would be as high as €48 000 per live birth. For male infertility, one should be 
careful to conclude CE from our results. There was no diﬀerentiation on the waiting list 
between couples with mild male infertility, who will be treated with IVF, and couples with 
severe male infertility, who require ICSI. The cost-eﬀectiveness ratio for the severe male 
group will therefore be lower than our results for the male category show. For the mild 
male group, the CE ratio is likely to be somewhere between the results that we found and 
the results for unexplained infertility.
 The costs per extra live birth were above €10 000 for most combinations of diagnostic 
category, age and duration. Depending on the threshold level of the CE ratio per live birth, 
direct IVF becomes cost-eﬀective, but this depends on the female age: the cost-eﬀectiveness 
ratio decreases with age, reaching a minimum around age 35–37, after which it increases 
again. There is no consensus on the level of costs per extra live birth that is acceptable. 
This is in contrast with the standard in health economics, with the Quality Adjusted Life 
Years (QALY) as eﬀectiveness measure. There, a threshold between €20 000 and €30 000 
per QALY is generally considered as the limit of acceptability (NICE 2013). Up till now, no 
studies have been published that translated a pregnancy leading to birth of a child into a 
gain in QALY for the parents. Neither the individuals’ willingness to pay, which heavily 
depends on the persons income, nor the societal economic perspective of the child that 
is born (Neumann and Johannesson 1994; Connolly et al. 2009) should play a role here. 
Consensus is lacking on what the right perspective should be (ESHRE Capri Workshop 
Group 2015). We have restricted ourselves to the classical societal perspective used in 
other medical problems.
Limitations of our study are the following:
We applied estimates of chances with IVF, excluding frozen embryos, for which we had no 
data. However, it is plausible that the same factors influencing IVF pregnancy chances will 
aﬀect the chances with frozen embryos. Concerning the calculation of costs, we added 
the costs due to absence from work to the direct medical costs of an IVF cycle (Bouwmans 
et al., 2008a). However, these costs only comprised the treatment period, and not the 
pregnancy period. Here, we implicitly assumed that the indirect non-medical costs of 
pregnancy and delivery are the same in the two scenarios. It may be questioned whether 
these costs are the same for singleton and twin pregnancies, but Polinder et al.(2008), in a 
randomized trial, did not find a significant diﬀerence for these costs. Next, our cost 
calculations include a ‘punishment’ in the costs of pregnancy and delivery for twins, which 
mainly result from transferring two embryos after IVF. Yet on the eﬀect side, twins were 
counted as one success, just like singletons. Counting a twin as two successes would give 
an advantage to the direct IVF scenario. However, twins have more morbidity than 
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singletons, and there is a growing tendency to abandon double embryo transfer. Currently 
in the Netherlands, dual embryo transfer is performed only after two fresh IVF treatments 
with single embryo transfer that did not lead to an ongoing pregnancy or for couples with 
a female age of at least 38 years from the first IVF treatment. This has not aﬀected the 
pregnancy rates because this resulted in more pregnancies from frozen embryo transfers 
(McLernon et al. 2010), it has however resulted in less twin pregnancies. Because we did 
not include the results and costs for frozen embryo transfers in our data we do not know 
the exact result this new policy has on the CE. There are more costs from frozen embryo 
transfers but the pregnancies resulting from it also prevent couples from starting more 
fresh IVF cycle(s).
 Another limitation is that when calculating the costs we did not consider the 
diﬀerences in the intrauterine foetal death rate between pregnancies after ART and 
spontaneous pregnancies. We based our cost estimates for delivery and neonatal care 
following IVF and natural conceived pregnancies on the study of Chamber et al. (2007). 
Unfortunately, the foetal deaths were excluded from that study.
 Finally, the key aspect of our approach is in comparing two strategies: ‘immediate’ IVF 
versus ‘delayed’ IVF. A more simple comparison would be to compare 12-month chances 
with IVF with 12-month chances of expectant management. However, that comparison 
would be rather naive since it ignores that after 12 months couples with expectant 
management would start IVF anyway after that year. Nevertheless, our approach, using 
prediction models over a 12-month time horizon, is rather simplistic compared with more 
sophisticated approaches to CE analyses, such as Markov models with monthly chances. 
Although the latter may give more insight into what happens during the 12-month 
periods, the results after 2 year will be the same. Since we had to multiple subgroups, the 
emphasis in our analysis is on the overall results per sub group rather than details within 
subgroups.
 Our calculations of treatment-independent pregnancy chances were based on data 
from a waiting list for IVF (Eijkemans et al. 2008) that comprised exposure time up to 2 
years. We assumed that the treatment-independent chances after unsuccessful IVF are the 
same as for couples who never had IVF. A Danish 5-year cohort study in 818 couples 
starting ART found that 156 (19%) had delivered from a natural pregnancy, mostly after 
start of treatment (134 couples) (Pinborg et al. 2009). Likewise, Cahill et al. (2005), in a 3-year 
follow-up study, found that 18% of couples conceived naturally after unsuccessful IVF. 
These data seem consistent with, and in support of, our assumption on the pregnancy 
chances after IVF.
 Just as was found previously by Mol et al. (2000), our results were highly sensitive to 
the application of a discount rate, particularly at ages around 30. IVF pregnancy chances 
do not, or only slightly diminish at that age, which means that there is no loss in pregnancy 
chances when postponing IVF for 1 year, but that there is a saving in costs of unnecessary 
IVF treatments. Therefore, CE ratio of immediate IVF is very high. When discounting future 
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live births and costs, we imply that the preference for a child now would be higher than 
that of a child next year, leading to a larger diﬀerence between the scenarios in chances of 
pregnancy leading to live birth and consequently lower CE ratio. In support of applying 
discounting to future live births, a willingness-to-pay study using the direct choice 
experiment method found evidence of this time preference (Ryan 1996). Further, it is likely 
that couples aged over 35 will feel a time pressure, especially when they consider having 
more than one child.
We conclude that the duration at which IVF becomes cost-eﬀective depends, firstly on the 
level of society’s willingness to pay for one extra live birth, and secondly, given a certain 
level of willingness to pay, on the female age and the diagnostic category. Couples with 
unexplained infertility and a female partner aged 31 or younger must have been waiting 
3 years before IVF can be considered.
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Supplementary table I   Input parameters for the base-case analyses and the 
sensitivity analyses
Expectant management IVF
Probabilities Value Source Value Source
Chances ongoing 
pregnancy within 
12 months
prediction 
model 
Eijkemans  
et al. 2008
prediction 
model 
Lintsen  
et al. 2007
Conversion 
ongoing 
pregnancy to live 
birth rate
92% Arce  
et al. 2005.
92% Arce  
et al. 2005.
Chances of twin 
pregnancy
1% Dutch registry 
2012
6,6% Dutch registry 
2012
Discounting,  
per year 
3,5 % NICE 3,5 % NICE 
Costs:
Treatment,  
per cycle
zero No treatments Direct and 
indirect 
medical costs 
Bouwmans  
et al. 2008.
Treatment,  
per year
zero No treatments Prediction 
model
Lintsen  
et al. 2007
Pregnancy and 
delivery
Single: € 2,023 
Twin: € 12,705 
Lukassen  
et al. 2004, 
Chambers  
et al 2007
Single: € 2,549 
Twin: € 13,469 
Lukassen  
et al. 2004
Updating over 
time
price level of 
2014
national price 
index for the 
Netherlands
price level of 
2014, 
national price 
index for the 
Netherlands
Sensitivity 
analyses:
Discounting,  
per year
Costs:  4%, 
Eﬀects: 1,5%
Dutch guideline Costs:  4%, 
Eﬀects: 1,5%
Dutch 
guideline
Alternative costs 
pregnancy and 
delivery
Singleton:  
€ 4,098 
Twin: € 13,350 
Chambers  
et al. 2007
Singleton:  
€ 4,624 
Twin: € 14,114 
Chambers  
et al. 2007
Twin pregnancy Counting as
 two successes 
(two live births)
- Counting as 
two successes
(two live births)
-
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Abstract
Study question: Are there diﬀerences between couples’ expectations of their first 
consultation to a clinic for infertility problems and how professionals perceive these 
expectations?
Summary answer: There are diﬀerences between the couples’ expectations and how 
professionals perceive them. Professionals underestimated the couples expectations 
‘I want to receive more information on diagnostic options and treatment options’, ‘I want 
reassurance’ and ‘I want to be treated’. Professionals accurately interpreted that couples 
made the appointment to get pregnant as soon as possible. 
What is known already: Management of expectations of couples with unexplained infertility 
prior to the first visit to a professional in secondary care is important and might improve 
communication, counseling, and the possible implementation of  expectant management. 
Study design, size, duration: A mixed-method study was conducted with the use of 
patients’ and professionals’ questionnaires on the patients’ expectations and semi- structured 
in-depth interviews on couples’ expectations and experiences in three Dutch clinics. 
Participants/materials, setting, methods: A total of 26 couples who were referred to 
secondary care for infertility problems by their general practitioner were included. These 
couples did not have any prior known cause for their infertility (such as anovulation, tubal 
pathology or low semen quality). Outcomes were couples’ expectations, professionals 
perceptions of these expectations, and couples’ experiences with the first consultation. 
Patients completed a questionnaire consisting of six items with a 5-point Likert scale on 
their expectations before the first consultation and professionals completed the same 
questionnaire after the consultation. Both were analyzed by calculating mean scores per 
item and diﬀerences between the scores of the couples and their professional. Pre- and 
post consultation semi-structured interviews were performed with the couples concerning 
their expectations and experiences, respectively. 
Main results and the role of chance: The couples scored highest on the expectations 
‘I made the appointment to undergo diagnostics’ (4,4) and ‘I made the appointment 
because I want to get pregnant as soon as possible’ (4,4). They scored lowest on the 
expectation ‘I made the appointment because I want to be treated’ (3,3). Professionals 
underestimated couples’ expectations on four out of the six items of the questionnaire. 
In particular the expectations of couples on the information they want to receive on 
diagnostics and treatment options were interpreted lower (0.7 and 0.8 points respectively). 
They accurately estimated that the couple made the appointment to get pregnant as 
soon as possible. The interviews showed that for 65% of the couples, their expectations 
matched with the experience they had during the consultation. In 19% of the consultations, 
couples were asked about their expectations. In 65% of consultations, couples were 
counseled for the possibility of an expectant management and appreciated this. 
Information on diﬀerent treatment options was not suﬃcient in 61% of the consultations. 
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Limitations, reasons for caution: The interviews were conducted by two diﬀerent 
interviewers which might have influenced the content of the questions and answers. 
However, an interview guide was used to minimize this eﬀect. In each clinic there was one 
type of professional tasked with the consultations. Therefore, we cannot analyze if the 
results were influenced by the way fertility care was organized and provided in each clinic 
or by the diﬀerent types of professionals.
Wider implications of the findings: This study shows that there is a need for 
improvement for the professional to interpret and manage couples’ expectations. A 
further quantification of the couples’ expectations and possible determinants is needed 
to measure if the interpretation of expectations is clinic- or professional-dependent. 
Study funding/competing interest(s): Supported by Netherlands Organisation for 
Health Research and Development (ZonMW, project number 171203005).  No competing 
interests.
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Introduction
Knowledge of patients’ expectations of care is important for professionals (Kravitz 1996). 
Exploring the patients’ expectations enhances the patients’ active role in the medical 
relationship and produces greater satisfaction with care, which has been correlated with 
greater compliance to therapy (Greenfield, Kaplan, and Ware 1985; Sherbourne et al. 1992; 
O’Brien, Petrie, and Raeburn 1992). However, patients’ expectations can be unreasonable 
and care provided based on these expectations may increase health care utilization and 
costs while it does not improve eﬀectiveness of care (Woolf and Kamerow 1990). Therefore, 
assessing unreasonable expectations may help to guide educational eﬀorts focused on 
reducing these expectations. [6]
 In fertility care, assessing expectations is a very important part of counseling. The 
causes of infertility can vary greatly and consequently also the types of fertility treatments 
provided. Herewith, the aims of counseling are to explore, understand, and resolve issues 
arising from infertility so professionals can deal with them eﬀectively. These issues can be 
in the field of diagnostics, treatment, and reassurance of couples. It is likely that a better 
knowledge of couples’ expectations prior to the first visit to a professional in secondary 
fertility care improves communication, counseling, and a better adherence to the 
proposed treatment course. Especially in fertility care the counseling process should 
consider the expectations of both the woman and her partner because infertility is a 
problem that they share together (ESHRE 2001).
 There has been previous research in fertility care on professionals’ perceptions of 
their patients’ experiences with fertility care. (Aarts et al. 2011). This study showed that 
professionals cannot adequately evaluate their own performance regarding patient-cen-
teredness of care. However, they did not address the couples’ expectations prior to the 
first visit and whether professionals explore and perceive these expectations correctly. 
Therefore, matching the expectations of the couples with the perceptions of the 
professionals on the expectations will reveal the possible discrepancies between these 
two. Feedback on the discrepancies will help professionals to get insight in the assumptions 
that they make on patient expectations prior to the first clinic visit and whether or not 
these are accurate. It can motivate professionals to better explore couples’ expectations 
on diagnostics, treatment, and psychological support and to discuss these with their 
patients.
 Because we expect couples who are referred by a general practitioner without a 
known cause for their infertility have various expectations, we decided it would be most 
interesting to focus on this group of patients. For these couples it is unclear whether they 
will need any treatment at all and if so what kind of treatment. For couples with diagnosed 
unexplained infertility and a good chance of natural conception, an expectant 
management of six to twelve months is recommended by (inter) national guidelines on 
infertility (NVOG 2010; Fields et al. 2013). A previous study identified main barriers and 
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facilitators of expectant management. One of the main barriers amongst couples are 
inappropriate expectations prior to the first consultation. Accordingly, among professionals, 
the main facilitator is better management of patients’ expectations (van den Boogaard 
et al. 2011). 
 Therefore, the aim of this study is to investigate the expectations of couples prior to 
the first consultation, if the professionals perceive the expectations of couples correctly, 
and couples’ experiences with the first consultation. 
Materials and Methods
A mixed method study was conducted with the use of a patients’ and professionals’ 
questionnaire and semi-structured in-depth interviews with patients in three Dutch clinics.
Setting
In the Netherlands couples with infertility are referred by a general practitioner (GP) to 
secondary care. The GPs perform only limited basic fertility work-up or no work-up at all. 
All 101 Dutch hospitals perform fertility work-up and can advise TEM. 
Population
We included three Dutch clinics. The first participating clinic is a non-academic clinic in 
which the first consultation is performed by gynaecologists. The second is an academic 
clinic in which gynaecologists in training perform the first consultation and the third is a 
non-academic clinic in which specialized fertility nurses perform the first consultation. 
 Eligible couples were recruited from the three participating clinics. We included 
couples with an unfulfilled childwish of at least one year who were referred by a GP for 
fertility care. Based on the referral letter from the GP we excluded couples with a female 
age older than 38 years or if they already had a clear reason for the infertility, i.e. irregular 
menstrual cycle ( < 25 days - > 35 days), severe male infertility (VCM < 3x106), sexual 
problems, and a positive chlamydia antibody titer. 
 Professionals participated when they performed the first consultation with the 
included couples. 
Outcome measures
· Expectations of couples
· Perception of couples’ expectations by professionals
· Experiences of couples
· Background characteristics
· Pre-consultation information 
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Data collection
Expectations of infertile couples
Prior to the consultation couples were asked to complete a questionnaire with six items to 
be scored with a a 5-point Likert scale about their expectations prior to the first visit; 
information about the diagnostic options, information on treatment options, reassurance, 
diagnostics during consultation, wanting a treatment, and conceiving as soon as possible. 
The couples could choose among ‘strongly disagree (1), disagree, neutral, agree and 
strongly agree (5). Example of item on the questionnaire: ‘I made the appointment 
because I want more information on the diﬀerent diagnostic options’ (score 1 to 5). 
The full questionnaire is provided in the appendix. In addition, pre-consultation semi- 
structured interviews were performed to reveal the in-depth information on the couples´  
expectations; expectations in general, which diagnostics would take place, what 
information they hoped and wanted to receive, what questions they had and how long 
the consultation would last. The topics were based on data from literature and on experts’ 
experiences working in fertility care (Hunault CC 2004; NVOG 2010; van den Boogaard 
et al. 2012; van den Boogaard et al. 2011). 
Figure 1  Flowchart of data collection
GP
Arrival in clinic
Couple receives information from 
the clinic
Consultation
1. Complete questionnaire on 
expectations
2. pre-consultation interview with 
couple (5 min)
Home
Post-consultation interview with 
couple (30 min)
CoupleProfessional
Complete questionnaire on 
couples’ expectations
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Perception of couples’ expectations by professional
After the first consultation the professional completed a similar questionnaire as the 
couples completed prior to the consultation with the same six items. Professionals were 
asked to fill in their perception on how the couple scored their expectations prior to the 
consultation. Professionals were not made aware of the content of the questionnaire they 
had to complete on the couples’ expectations before the consultation started.
 Example of item on the questionnaire: ‘I expect that the patient wants more 
information on the diﬀerent diagnostic options’ (score 1 to 5).
Experiences of couples
The experiences of couples with the consultation were assessed with post-consultation 
semi-structured in-depth interviews. Information was gathered on if their expectations 
were met during the consultation, if (un)expected explanation on diagnostics and 
treatment was given, if explanation of possible expectant management was given, and 
whether a couple was willing to accept expectant management when they would be 
eligible for it.
 To prevent couples from giving social desirable answers, we told them explicitly that 
the interview would be analyzed anonymously and would not be discussed with their 
care professional (doctor or nurse).
Background characteristics
The background characteristics were obtained from the post-consultation semi-struc-
tured interviews. Background characteristics are age of the female partner, female ethnic 
background (Dutch/non Dutch), female education level (high/medium/low), type of 
infertility (primary/secondary), and duration of infertility (months). 
Pre-consultations information 
The information that was provided by the GP on diagnostics, expectant management, 
referral to the clinic, and what to expect of the first consultation in the clinic was assessed 
in the post-consultation semi-structured interviews. The information that was provide by 
the clinic prior to the consultation was assessed by asking the clinics what information 
they sent to the couples. In the post-consultation semi-structured interviews couples 
were asked their opinion on the information they received. 
Analysis
Patients and professionals questionnaires on the couples’ expectations
The questionnaires were analyzed by means of descriptive statistics in SPSS for each item 
(IBM SPSS Statistics for Windows, Version 20.0. Armonk, NY: IBMCorp). Means and standard 
deviations of the score of both couples and professionals were assessed for each item of 
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the questionnaire individually. The perception by the professionals was analyzed by the 
diﬀerence in item score between the couple and their professional. Subsequently, the 
mean of all the diﬀerences between the included couples and their professional was 
calculated. A negative value meant that the professional underestimated couples’ expectations 
and a positive value meant that the professional overestimated couples’ expectation. 
Expectations and experiences of couples
The semi-structured in-depth interviews were recorded and word by word transcribed to 
ensure no information was missing. The texts were imported in qualitative research 
software and analysis took place by means of Atlas.ti (version 7.1.5, Berlin) (Weitzman 1999). 
A set of codes was developed to describe groups of words or categories to provide an 
overview of all mentioned expectations. The codes were refined and used to generate 
themes. The themes contained characteristics of the expectations of couples. All interview 
transcripts were independently coded by two researchers (M.B. and E.S.) to increase the 
reliability and limit the researchers bias. Discrepancies were discussed by the researchers 
until consensus was reached. An answer is relevant when it is mentioned five times or 
more by diﬀerent couples or when it is notably diﬀerent with respect to other couples.
Background characteristics
Background characteristics of the couples were analyzed by means of descriptive statistics 
(median and frequencies).
Pre-consultation information 
The information provision by the GP was analyzed by generating themes containing 
question on the information given on diagnostics, expectant management, the referral to 
the clinic, and about what the couple can expect in the clinic. The information provision 
by the clinic prior to the consultation was analyzed by the generated themes on this item. 
We calculated per theme the percentage of couples that were given certain information.
Results
In total, 26 couples from three clinics participated, 10 from the academic clinic and 16 from 
the non-academic clinics. Two male partners did not participate in the interviews. 
Background characteristics are presented in Table I and show that almost all female 
participants had a medium or high education level (96,2%) and most females had a Dutch 
ethnic background. The median age was 32,5 years and the median duration of infertility 
was 18 months. 
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Expectations of couples
Questionnaire
The items ‘I made the appointment because I want to have diagnostics’ and ‘I made the 
appointment because I want to get pregnant as soon as possible’ were scored highest 
(4,38) and the item ‘I made the appointment because I want to be treated’ lowest (3,23), as 
is shown in Table II.
Pre-consultation semi structure interview
In the interviews most couples told that they expected to get clarity and more information on 
the cause of their infertility in the first consultation. Couples expected to have diagnostics, 
in particular a gynaecological examination (i.e. vaginal ultrasound) and a sperm analysis. 
Four women did not expect to have diagnostics. They expected to be told by the professional 
what the next steps in the fertility process (including diagnostics phase) are and the diﬀerent 
treatment options. Although five other couples hoped to be reassured that there is no cause 
and three of these couples hoped to be recommended an expectant management. 
Both partners of a couple had the same expectations on the first consultation since most 
couples discussed together beforehand what they could expect. 
Table I   Background characteristics
Characteristcs N (%)
Female age, median(range) 32.5 (24-37)
Female ethic background: Dutch 22 (85%)
 Non Dutch 4 (15%)
Female education level: High 13 (50%)
 Medium 12 (46.2%)
 Low 1 (3.8%)
Type of infertility: Primary 19 (73.1%)
 Secondary 7 (26.9%)
Duration of infertility in months, median (range) 18 (12-60)
Consultations by: Gynaecologist (non-academic clinic) 8 (30.8%)
 Gynaecologist in training (academic clinic) 10 (38.4%)
 Specialized fertility nurse (non-academic clinic) 8 (30.8%)
1  Low: primary school, low vocational education; Medium:  intermediate vocational education, high general 
secondary school; High: high vocational education, university.
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Interpretation by professionals
Table II shows that on five of six items professionals underestimated patients’ expectations. 
The items ‘more information on diagnostics’ and ‘more information on treatment options’ 
were scored lower by professionals with 0.7 and 0.8 points. This means that couples 
expected to have more information from their professional than their professional 
thought. The items ‘I want reassurance’ and ‘I want to be treated’ were on average scored 
lower by the professional with 0.6 and 0.5 points. Professionals accurately interpreted that the 
couple made the appointment to get pregnant as soon as possible. The results per clinic 
showed that in the academic clinic (gynaecologist in training) the couples’ expectations 
were underestimated the most in general and on all items. The grossest underestimations 
are  on the three items ‘information on treatment’(-1.6), ‘receive treatment’(-1.6), and 
‘information on diagnostic options’(-1.0).  In one non-academic clinic (gynaecologist) the 
couples’ expectations on reassurance and information on diagnostics were most under-
estimated (-1.1 and -0.9). In the other non-academic clinic (fertility nurses) the couples’ 
expectations were estimated the most accurate. 
Experiences of couples
The consultations of 65%of  the couples (17/26) matched their expectations. Unexpected 
items for some couples were diagnostics during the first consultation and that they would 
already undergo the next steps in the fertility process: 
Table II   Likert Scales: mean scores, mean diﬀerence and significance of patients 
versus professionals
Likert scale1 item Mean 
patients
(n = 22)
Mean 
professional2
(22)
Mean diff. 
interpretation 
per consult
I made the appointment because I want:
More information on the diﬀerent  
diagnostic options  
4.1 (1.03) 3.5 (1.21) -  0.7
More information on the diﬀerent 
treatment options
4.1 (0.95) 3.3 (1.13) -  0.8
Reassurance 3.7 (1.16) 3.1 (0.95) -  0.6
To have diagnostics 4.4 (0.94) 4.1 (0.82) -  0.3
To be treated 3.3 (1.08) 2.8 (1.06) -  0.5
To get  pregnant as soon as possible 4.4 (0.80) 4.3 (0.60) -  0.1
1 Scale of 1-5. 1; strongly disagree, 2; disagree, 3; neutral, 4; agree, 5; strongly agree
2 Professionals include gynaecologists, training doctors and fertility nurses
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‘Yes, that we would come in a fertility work-up already and that they would check my blood, 
those are things we did not expect’ (Int 5).
Five couples were directly asked what their expectations were during the consultation 
(19%). Fourteen couples (54%) received extensive information on the diagnostic options 
and ten couples (38%) received extensive information on the treatment options. Most 
couples wanted to have information on the diﬀerent treatment options: 
‘That might be important, that couples are told what they could expect on diﬀerent treatment 
options, then they can think about it already’ (Int 11). 
Seventeen couples (65%) were counseled for the possibility of an expectant management. 
Couples appreciated this because then it would not be a surprise and disappointment 
when they eventually are recommended an expectant management. After counseling on 
expectant management by the interviewer, fourteen (54%) couples would accept it when 
their chance of natural conception within one year was still high. Of all couples, nine (35%) 
said they wanted treatment, of which six couples were not counseled for expectant 
management by the professional. 
Pre-consultation information 
Eighteen GPs (69%) performed diagnostics. Couples who did not undergo diagnostics at 
primary care also did not expect that the GP would have done this. Two GPs (8%) counseled 
on the chance of an expectant management. Couples would have appreciated if GPs 
provided some information on expectant management: 
‘Yes, because then you know what to prepare for, what lies ahead’ (Int 18). 
Most GPs gave no explanation on the referral and what to expect at the first consultation. 
Half of the couples who did not receive explanation would have liked to have more 
information on what to expect, either from the GP or the clinic: 
‘Yes actually, I slept badly for two nights because I am nervous. You think to yourself I never 
experienced it (consultation with a gynaecologist) before. I would have liked that, I would 
appreciated some more information’ (Int 13).
The information that couples receive prior to the consultation varies. Prior to the 
consultation in one non-academic clinic (gynaecologist) couples receive a letter with 
information that a vaginal ultrasound will be performed. The letters of the other two 
participating clinics tells couples that they will have a semen analyses, that both partners 
will have a physical examination, and details of a follow-up appointment where the results 
will be discussed. Half of the couples would have appreciated more information from the 
clinic prior to the consultation. 
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Discussion
We identified there are diﬀerences between how couples score their expectations on the 
first consultation compared to how professionals perceive these and score the couples’ 
expectations. Professionals underestimated the couples expectations to receive more 
information on diagnostic and treatment options, to be reassured, and to be treated. 
Professionals accurately interpreted that the couple made the appointment to get 
pregnant as soon as possible. Couples scored highest on the expectations that they made 
the appointment to have diagnostic tests and because they want to get pregnant as soon 
as possible. They scored the expectation ‘I made the appointment because I want to be 
treated’ lowest. In 65% of the couples, their expectations matched with the experience 
they had during the consultations. However, only one in five couples were asked about 
their expectations. 
 The diﬃculty for professionals to accurately interpret their patients expectations and 
their priorities is congruent with previous research which showed that there are similarities 
between the priorities of patients and their GPs but that in many areas of primary care 
they vary substantially (Jung et al. 2002). Our results from the interviews with the couples 
prior to the consultation to get more in-depth knowledge of their expectations are also 
congruent with previous findings. Most of the couples said that they expected to have 
clarity and more information on the cause of their infertility. This is congruent with the 
results of  a nationwide survey conducted among couples with unexplained infertility 
who were counseled for expectant management, 88% expected that a cause for their 
infertility would be found (van den Boogaard et al. 2012). Furthermore, the expectations of 
our study population are congruent with a survey study that has assessed the expectations 
of patients in general care prior to the consultation at a clinic. Those patients also expect 
to have a physical examination, diagnostics, reassurance about their condition, explanation 
on the cause of their problem and explanation on treatment options (Bowling, Rowe, 
and McKee 2013). 
 During the interviews after the consultation with the couples it became clear that 
most couples (81%) were not asked about their expectations. This is in line with results of 
a previous study on the barriers and facilitators of expectant management, in which the 
main facilitator among professionals was a better management of patients’ expectations 
(van den Boogaard et al. 2011). Not exploring couples’ expectations can be a cause for 
overtreatment of couples. Only 65% of the couples were counseled for a possible 
expectant management. Of all couples, on third want to be treated when they would be 
eligible for expectant management of whom two third were not counseled for it by their 
professional. This means that when couples were counseled by the professional they were 
more willing to accept an expectant management. 
 Our results also showed that most couples did not receive information from their GP 
on what to expect during the first consultation in the clinic. Patients’ desire for information 
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is high, in our study half of the couples would have liked to have more information prior 
to the consultation from their GP (Nease and Brooks 1995). This is congruent with previous 
studies that showed that GPs underestimate their patients’ need for information and 
information provision by a professional is in need for improvement (Zemencuk et al. 1998; 
Mourad et al. 2009). 
 A strength of our study is the recruitment of couples in three diﬀerent clinics where 
the consultations are performed by three diﬀerent types of professionals. This gives us 
insight in the variation per clinic and per type of professional.
 Another strength is that the in-depth interviews took place directly after the 
consultation so the recall bias is minimal and all, but two, women were interviewed 
together with their partner, which also minimizes recall bias. 
 This study also has some limitations. First, the interviews were performed by two 
interviewers. One interviewer performed the interviews with couples who visited the 
gynaecologists, the other the couples who visited the gynaecologists in training and the 
fertility nurses. This might influence the content of the questions and answers, although 
an interview guide was used and the questions asked were close to similarity, so the 
influence is thought negligible. 
 Second, our results showed that there is a diﬀerence in the professionals interpretation 
between the participating clinics. In each clinic there was one type of professional tasked 
with the consultations. Therefore, we cannot analyze if the results were influenced by 
the way fertility care was organized and provided in each clinic (information provision before 
consultations, duration of consultation etc.) or by the way the diﬀerent types of professionals 
provide fertility care. Of all types of professionals more than one person performed the 
consultation, so it is not person-dependent which care is provided. However, to further 
quantify the determinant for interpretations of couples’ expectations a bigger study needs 
to be conducted among more patients from more clinics and more diﬀerent professionals. 
 Finally, bias could have occurred by diﬀerent interpretation of the interview transcripts. 
Therefore, all interview transcripts were independently coded by two researchers and 
discrepancies were discussed. 
 This study shows that professionals are not always aware of the couples expectations 
and that more knowledge about the expectations could help the professional to manage 
the couples’ expectations better and thereby prevent dissatisfaction of patients and 
possible overtreatment. A previous study shows that audit and feedback alone are not 
suﬃcient to achieve improvement (Huppelschoten et al. 2013). Increasing professionals’ 
desire to change and improve communication and counseling skills can be achieved by 
awareness and knowledge about the expectations of couples. As mentioned before, a 
further quantification of the expectations and possible determinants is needed to 
measure if the perception of expectations is clinic- or professional-dependent. 
 In summary, professionals should be aware of their underestimation of the 
expectations of couples with infertility. The expectations are influenced mostly by the 
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information provision by the GP and clinic, which has been shown as insuﬃcient in our study. 
Managing couples’ expectations is very important, because that will help professionals in 
their communication with patients, stimulate a better patient-doctor relationship, and ultimately 
treatment adherence.
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Appendix
Likert scale 
Expectations of the patient (or professional) regarding the first consultation
1.  I made the appointment because I want ( I expect that the patient wants) more 
information on the diﬀerent diagnostic options:
 strongly disagree  disagree neutral agree strongly agree
 1 2 3 4 5
2.  I made the appointment because I want ( I expect that the patients wants) more 
information on the diﬀerent treatment options:
 strongly disagree  disagree neutral agree strongly agree
 1 2 3 4 5
3.  I made the appointment because I want (I expect that the patients wants) to be 
reassured:
 strongly disagree  disagree neutral agree strongly agree
 1 2 3 4 5
4.  I made the appointment because I want (I expect that the patients wants) to have 
diagnostics:
 strongly disagree  disagree neutral agree strongly agree
 1 2 3 4 5
5.  I made the appointment because I want (I expect that the patient wants) to be 
treated:
 strongly disagree  disagree neutral agree strongly agree
 1 2 3 4 5
6.  I made the appointment because I want (I expect that the patient wants) to get 
pregnant as soon as possible:
 strongly disagree  disagree neutral agree strongly agree
 1 2 3 4 5
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Abstract
Study question: What is the percentage of overtreatment, i.e. fertility treatment started 
too early, in couples with unexplained infertility who were eligible for tailored expectant 
management?
Summary answer: Overtreatment occurred in 36% of couples with unexplained infertility 
who were eligible for an expectant management of at least 6 months.
What is known already: Prognostic models in reproductive medicine can help to identify 
infertile couples that would benefit from fertility treatment. In couples with unexplained 
infertility with a good chance of natural conception within 1 year, based on the Hunault 
prediction model, an expectant management of 6–12 months, as recommended in 
international fertility guidelines, prevents unnecessary treatment.
Study design, size, duration: A retrospective cohort study in 25 participating clinics, 
with follow-up of all couples who were seen for infertility in 2011–2012.
Participants/materials, setting, methods: In all, 9818 couples were seen for infertility in 
the participating clinics. Couples were eligible to participate if they were diagnosed with 
unexplained infertility and had a good prognosis of natural conception (>30%) within 
1 year based on the Hunault prediction model. Data to assess overtreatment were collected 
from medical records. Multilevel regression analyses were performed to investigate 
associations of overtreatment with patient and clinic characteristics.
Main results and the role of chance: Five hundred and forty-four couples eligible for 
expectant management were included in this study. Among these, overtreatment, i.e. 
starting medically assisted reproduction within 6 months, occurred in 36%. The underlying 
quality indicators showed that in 34% no prognosis was calculated and that in 42% 
expectant management was not recommended. Finally, 16% of the couples for whom 
a correct recommendation of expectant management for at least 6 months was made, 
started treatment within 6 months anyway. Overtreatment was associated with childlessness, 
higher female age and a longer duration of infertility. No associations between over -
treatment and clinic characteristics were found.
Limitations, reasons for caution: The response rate was low compared with other 
fertility studies. Evaluation of possible selection bias showed that responders had a higher 
socio-economic status than non-responders.
Wider implications of the findings: Our findings show that developing and publishing 
guideline recommendations on tailored expectant management (TEM) is not enough 
and that overtreatment still occurs frequently. Future research should focus on tailored 
eﬀorts to implement guideline recommendations on TEM.
Study funding/competing interest(s): Supported by Netherlands Organisation for Health 
Research and Development (ZonMW). ZonMW had no role in designing the study, data 
collection, analysis and interpretation of data or writing of the report. Competing interests: none.
Trial registration number: www.trialregister.nl NTR3405.
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Introduction
Over recent decades, the use of medically assisted reproduction (MAR) has increased 
enormously (Ferraretti et al. 2013). At a time where health care costs have increased greatly, 
it becomes even more important that fertility care is not only clinically eﬀective and safe, 
but also cost-eﬀective (Leavitt 2001; Appleby 2012). Regrettably, many MAR cycles are 
performed without evidence that such treatment is indicated or likely to be eﬀective 
(Bensdorp et al. 2007; Steures et al. 2006; Veltman-Verhulst et al. 2012). Despite the growing 
use of MAR, the pregnancy and delivery rates have not increased over the last few years 
(Ferraretti et al. 2013). Due to the increasing costs not all societies can bear the costs of 
fertility care any longer (Chambers et al. 2012). Only a few societies fully reimburse fertility 
care (Jones et al. 2011). One important way to minimize societal costs, without a negative 
impact on couples with infertility, is to prevent overtreatment in infertile couples by 
reducing unnecessary MAR and related costs (van den Boogaard et al. 2013).
 As well as the economic aspects, the reduction of unnecessary MAR is important to 
avoid exposing couples to the risks, complications and burdens associated with invasive 
treatments, which will not improve the chance of conception or decrease the time to 
pregnancy (Verhaak et al. 2002; Helmerhorst et al. 2004; Steures et al. 2006; Verberg et al. 
2008; Custers et al. 2012).
 To achieve a reduction of unnecessary MAR, it is important to distinguish couples 
who would actually benefit from MAR from the couples who do not, e.g. by the use of 
prognostic models (Brandes et al. 2011; Van Geloven et al. 2013). In infertile couples where 
no underlying cause of the infertility is found, the chances of a spontaneous pregnancy 
can be calculated with the Hunault prognostic model (Hunault et al. 2004; van der Steeg 
et al. 2007). If the chance of a natural conception within 1 year is good, meaning 30% or 
higher, fertility treatment does not increase the chance of an ongoing pregnancy 
compared with an expectant management of 6–12 months (tailored expectant 
management, TEM) (Steures et al. 2006; Custers et al. 2012). Therefore, for couples with 
unexplained infertility and a good prognosis, TEM is equally as eﬀective as MAR and it 
does not expose couples to all the associated risks. Furthermore, the increasing costs of 
fertility care are making it necessary to improve the cost-eﬀectiveness of current care. 
Therefore, current European guidelines recommend TEM for 6–12 months (e.g. National 
Institute of Clinical Excellence (NICE) and the Dutch Society for Obstetrics and Gynaecology 
(NVOG, www.nvog.nl)). Adherence to these guidelines with regard to TEM helps to prevent 
overtreatment.
 However, previous studies have shown that implementation of TEM is limited by both 
professional and patient-related factors (van den Boogaard et al. 2011). The main barriers 
amongst professionals are limited knowledge about prognostic models and TEM, and 
diﬃculties in counselling couples for TEM. Barriers on the patient level include a lack of 
confidence in natural conception and not understanding the reason for expectant 
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management. Furthermore, previous research in fertility care as well as other fields of care 
showed that a variety of patient and clinic characteristics can explain poor adherence to 
guidelines (Fine et al. 2002; Schouten et al. 2005; Hermens et al. 2011; van den Boogaard 
et al. 2012). However, evidence for characteristics related to TEM is scarce. More knowledge 
on these characteristics is important to help tailoring interventions to minimize over-
treatment.
 This study aims to assess overtreatment (i.e. started MAR too early) in couples with 
unexplained infertility that were eligible for TEM. Furthermore, we will evaluate the 
 characteristics on patient and clinic level associated with overtreatment. The study will 
provide more insight in current care and will help to develop a strategy to prevent couples 
from starting fertility treatment too early in the future.
Materials and Methods
Study design
We conducted a retrospective cohort study in 25 Dutch clinics using medical records and 
a professionals’ questionnaire. Furthermore, we evaluated a possible selection bias between 
responders and non-responders by conducting semi-structured telephone interviews 
with non-responders in six clinics.
Ethical approval
The institutional ethics committee of Radboud university medical center provided ethical 
approval for this study (CMO no. 2012/130).
Setting
Dutch fertility care
In Dutch fertility care, referral of infertile couples to secondary or tertiary care is mainly 
done by general practitioners (GPs), fertility doctors (medical doctors specialized in 
assisted reproduction), medical specialists, or on the patients’ own initiative. Initial fertility 
work up, ovulation induction (OI) and intrauterine insemination (IUI) are carried out in all 
Dutch clinics. Intermediate clinics can start and monitor the IVF and ICSI treatment. 
The laboratory phase of IVF and embryo transfer has to be carried out in a fully licensed 
fertility clinic. To ensure that the 25 clinics were representative for Dutch fertility care, we 
selected six fully licensed fertility clinics, eleven intermediate fertility clinics and eight 
clinics with no IVF facilities, spread across the country, to participate. In the Netherlands, 
the compulsory basic insurance coverage fully reimburses all treatment cycles of OI and 
IUI, as well as a maximum of three IVF or ICSI cycles.
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Dutch Network Guideline on Infertility
The Dutch Network Guideline on Infertility makes specific recommendations on TEM 
(www.nvog.nl). These recommendations are based on three steps.
- The first step is correctly diagnosing and identifying couples that are eligible for TEM, 
i.e. calculating the chance of a natural conception within 1 year for couples with 
unexplained infertility with the prognostic model of Hunault (Hunault et al. 2004). 
The prognostic model takes four mandatory factors into account, female age (years), 
duration of infertility (years), type of infertility (primary/secondary) and quality of semen 
(percentage progressive motile sperm). Three factors are optional, referral status (GP/
own initiative/professional), cervical factor (post-coital test positive/negative) and 
diagnosis of one-sided tubal pathology (yes/no). Professionals can have access to the 
prognostic model via a patient website (www.freya.nl), through local electronic patient 
file systems, or with the use of a paper version.
- The second step is to recommend TEM for at least 6–12 months for couples with a good 
prognosis (>30% in 1 year) after finalizing the fertility work up.
- The third step is to adhere to the advised expectant period of at least 6 months.
The first two steps have to be done by the professional. They have to correctly diagnose 
and identify the couple as being eligible for TEM, and subsequently have to advise an 
expectant management of at least 6–12 months. However, the third step is dependent on 
both the professional and the couple. If TEM is advised by the professionals, the guideline 
recommends that the couple is educated on the most fertile period, optimal coital frequency 
and healthy lifestyle factors to optimize the couples’ chance of natural conception.
Study population
Couples were eligible to participate in our study when they have been diagnosed with 
unexplained infertility and had a good prognosis of a natural conception within 1 year 
based on Hunault’s prediction model (Hunault et al. 2004). According to the Dutch fertility 
guidelines, the diagnosis of unexplained infertility is given if the fertility work up shows 
no cause for the infertility or if it shows mild abnormalities that are not significant enough 
to obstruct a natural conception. These include a cervical factor, one-sided tubal 
pathology, mild male infertility (total motile sperm count [TMSC] 3–10 million), and/or 
mild endometriosis (American Society of Reproductive Medicine stage I/II) (NVOG 2010). 
Couples with previous fertility treatments, female age over 38 years, bilateral tubal 
pathology, anovulation or a severe male factor (TMSC <3 million) were excluded.
Recruitment
To assess overtreatment in current fertility care in the Netherlands, we aimed at including 
a broad patient cohort from the participating clinics. To include eligible participants, 
potential couples were selected by means of each clinics’ financial DBC (Diagnosis/
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Treatment Combination code) registration database. In this national database, all patients 
undergoing diagnostics or treatment for infertility are identified with a specific Fertility- 
code for new patients (F11-code). It is not possible to distinguish patients with unexplained 
infertility from patients with a clear cause for their infertility with the existing databases. 
In order to select as many potential participants as possible we approached all couples 
who had an active F11-code anytime between March 2011 and February 2012. All couples 
were sent an informed consent form with an information letter, including five questions 
regarding the exclusion criteria, i.e. What is the age of the woman?, Have you had fertility 
treatment before 2011?, Are both Fallopian tubes occluded?, Do you usually have a regular 
menstrual cycle between 25 and 35 days (without medication)?, Have you been treated 
with ICSI since 2011?. If couples had no exclusion criteria based on these five questions, 
they were invited to participate in this study and give informed consent for accessing their 
medical record. Non-responders were sent one reminder after 3–4 weeks.
Non-responders
To evaluate a possible selection bias we compared responders to non-responders in six 
clinics. We selected six clinics with the lowest response rate, all types of fertility clinics 
were found to be represented (no/intermediate/full IVF facilities) and the clinics were 
spread across the country. A sample size of 15% of the non-responders in each clinic is 
necessary to retain a representative sample (Ronmark et al. 1999). In order to achieve this 
target, we decided to select a random, computer generated, sample of 20% of the 
non-responders in these clinics.
Outcome measures
Overtreatment
We defined overtreatment as starting fertility treatment too early when couples exhibited 
unexplained infertility and had a good prognosis of a natural conception within 1 year 
based on Hunault’s prediction model. Too early means that they started treatment within 
6 months after finalizing the fertility work up (date of the evaluation with the couple). To 
assess the process that leads to overtreatment we extracted a set of three quality 
indicators, based on the three steps that are necessary to follow guideline recommenda-
tions on TEM. Overtreatment is a result of at least one, or a combination of the following 
quality indicators.
Quality indicators
· The first indicator is failure to diagnose correctly and identify couples who are eligible 
for tailored expectant management, i.e. the prognosis of a natural conception within 1 
year was not calculated.
511305-L-bw-kersten
Processed on: 6-7-2017 PDF page: 71
71
Overtreatment in couples with unexplained infertility
4.1
· The second indicator is failure to advise the correct policy after finalizing the fertility 
work up, i.e. couples were not advised to undergo an expectant management of at least 
6 months or couples who started fertility treatment immediately.
· The third indicator is failure to complete the expectant period of at least 6 months after 
TEM was advised, i.e. couples were advised the correct policy but started fertility 
treatment within 6 months anyway.
Data collection
Overtreatment and quality indicators
Data to assess overtreatment and quality indicators were abstracted from medical 
records using a standardized audit form. If the couple fitted the inclusion criteria, we 
collected the diagnostic measures and treatment related measures. Diagnostic measures 
included the fertility work up outcomes (e.g. semen analysis, post-coital test, hystero-
salpingography, laparoscopy), the date of fertility work up completion/date of evaluation with 
couple (dd/mm/yy), initial diagnosis, and if calculation of prognosis was performed (yes/no). 
Treatment related measures included the course of treatment that was advised after fertility 
work up, the date of the start of treatment (mm/yy), treatment type and treatment 
outcome. We calculated the time interval between completion of fertility work up and 
start of treatment.
Patient and clinic characteristics
Data on patient characteristics were extracted from medical records using a standardized 
audit form. The patient characteristics are: female age(years), referral status (own initiative/
GP/specialist), female obstetric history, type of infertility for the couple (primary/secondary), 
duration of infertility (years) and female body mass index (BMI kg/m2). Furthermore, we 
extracted postal area code to derive the socio-economic status (SES) of the couples 
(obtained from the Dutch Institute for Social Research/SC based on the mean income 
level in a postal area code).
 Data on the clinic characteristics were obtained by sending a digital questionnaire to 
one gynaecologist, specialized in reproductive medicine, from each participating clinic. 
The questionnaire was divided in two parts. The first part contained questions about the 
local organization of the fertility care and the second part about the information provision. 
Characteristics on the organization of fertility care included IVF facilities (fully licensed/
intermediate/no IVF facilities), training clinic (yes/no), professional functions (e.g. fertility 
doctor, fertility specialized nurse, research nurse) present in the fertility team (yes/no and 
number), availability of a regular fertility team meeting (yes/no and frequency), mean 
number of fertility consultations per gynaecologist per week, and assignment of one lead 
physician to each infertile couple who is responsible for every in-between evaluation and 
decision-making with the couple (yes/no). Characteristics on information provision 
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included information available on TEM for couples with unexplained infertility (yes/no), 
and presence of checklists for information supply (yes/no).
Non-responders characteristics
Telephone interviews were performed to determine the characteristics of the non- 
responders by asking them the five questions that were in the information letter that was 
sent to all possible participants. The characteristics that we compared were female age 
(years), previous fertility treatment (yes/no), irregular menstrual cycle (yes/no), bilateral 
tubal pathology (yes/no), ICSI treatment (yes/no) and socio-economic status (high/
medium/low). In order to reach as much of the selected non-responders, they were 
called a maximum of four times in case of no response: at least twice during daytime 
and twice in the evening between 5 pm and 8 pm. All interviews were performed using 
a standardized interview questionnaire and were recorded.
Data analysis
Collected data were entered in a database using the Statistical Package for the Social 
Sciences (SPSS 20.0 for Windows, SPSS, Inc., Chicago, IL, USA). Descriptive analyses were 
performed for overtreatment and the quality indicators, and were expressed as 
percentages (median and range on clinic level).
 Descriptive analyses (frequencies and means) were also used to describe the patient 
and clinic characteristics. Series of multilevel univariate analysis were performed with 
overtreatment as the dependent variable. All patient and clinic characteristics acted 
separately as the independent variables. Variables with P < 0.20 in the univariate analysis 
were selected to perform correlation analysis with spearman’s rho to evaluate collinearity 
between the selected characteristics. In case of two strongly correlating variables (rho > 
0.6), only the clinically most relevant characteristic was included.
 Subsequently, to assess the extent to which overtreatment could be explained by 
patient and clinic characteristics and taking clustering of data into account, multilevel 
multivariate regression analyses with manual backward elimination was carried out with 
the couple (level 1) nested within the clinic (level 2). Significance for multivariate analyses 
was set at P < 0.05.
Results
Study population
Figure 1 presents the recruitment of eligible participants in the study. Of the 9819 invited 
infertile couples with an F11 code between March 2011 and February 2012, 4283 (43%) 
infertile couples responded. While 855 couples refused participation or considered 
themselves ineligible, the other 3428 (80%) couples were willing to participate. Based on 
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the answers to four of the questions in the information letter, 1965 couples were excluded 
prior to the medical record research. We excluded another 919 couples because medical 
record research revealed exclusion criteria. As a result, 544 infertile couples were included 
in the study. 
Figure 1  Recruitment of eligible couples for participation in the study
*A combination of exclusion criteria can occur within a couple. aFertility work up not completed: Spontaneous 
pregnancy before completion of fertility work up (n = 144), Fertility work up completed before or after the 
inclusion period (n = 76).bFemale infertility: Anovulation (n = 90), Tubal pathology (n = 11), Endometriosis (n = 14).
cNo infertility: recurrent miscarriage, molar pregnancy, uterine myoma, extra-uterine pregnancy, preimplantation 
genetic diagnosis, duration of active child wish less than a year. dOther: lesbian couple, weight reduction 
programme, oocyte vitrification.
9896 infertile couples from 25 clinics were sent  
an information letter with consent form
4283 responded
(4283/9819=44%)
3428 couples willing to participate
(3428/4283=80%)
No participation (n=855)
No response (n=5536)
Medical record research in 1463 couples
Excluded based on the four questions (n=1965)*
•  Previous fertility treatment (n=996)
•  Anovulation (n=1018)
•  Bilateral tubal pathology (n=123)
•  Severe male infertility (n=565)
 
 
 
 
544 couples included in the study
Excluded (n=919)
•  Fertility work up not completed (n=220)a
•  Previous fertility treatment (n=51)
•  Female infertility (n=115)b
•  Severe male infertility (n=176)
•  Prognoses < 30% (n=198)
•  No infertility/Unknown (n=47/n=115)c
•  Other (n=44)d
 
 
 
 
 
 
 
Undeliverable (n=77)
9819 infertile couples received the information  
letter with consent form
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Non-responders
In the six selected clinics 1403 couples did not respond. We tried to contact 290 of these 
non-responder couples (20%) and 190 (66%) were reached and willing to participate in the 
telephone interviews and 142 (49%) of them answered all the additional questions 
necessary to assess the background characteristics. We compared those background 
characteristics of the non-responders to the responders in all 25 participating clinics in 
this study (Table I). Two of the six characteristics showed a significant diﬀerence: 
non-responders more often had an irregular menstrual cycle compared with the 
responders (41.1 versus 28.9%, P < 0.01), and more had low socio-economic status 
compared with responders (20.6 versus 8.9%, P < 0.01). 
Overtreatment and quality indicators
The results of overtreatment in couples eligible for TEM and the three quality indicators 
are shown in Fig. 2. The overall overtreatment in the 25 clinics was 36.4%. There was a 
wide range of overtreatment between the clinics (16 to 81% of the couples). Couples with 
overtreatment started fertility treatment after a mean duration of 2.9 months after fertility 
work up was completed. 
 The first quality indicator, not calculating the prognosis of a natural conception within 
1 year, revealed that in 34.2% of all couples no prognosis was calculated, with a range from 0 
to 96% between the clinics. The second quality indicator, incorrect course of treatment 
advised (i.e. immediate fertility treatment or an expectant management period of 
Table I   Background characteristics of responders and non-responders
Characteristics Responders  
all clinics  
N=4283
Non-responders 
six clinics
N=142 
P
Mean female age (yrs) 32.7 32.4 0.30
Previous fertility treatment (%) 1150 (27.7) 41 (28.9) 0.65
Irregular menstrual cycle (%) 1194 (28.9) 58 (41.1) <0.01
Bilateral tubal pathology (%) 136 (3.3) 4 (2.8) 0.77
ICSI treatment (%) 633 (15.3) 23 (16.2) 0.77
Socio-economic status: <0.01
    High (%) 601 (14.2) 6 (4.3)
    Medium (%) 3259 (76.8) 106 (75.2)
    Low (%) 383 (8.9) 29 (20.6)
    Missing 39 1
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<6 months), occurred in 42.3% of the couples, ranging from 14 to 76% between the clinics. 
The third quality indicator showed that in case a correct expectant period of at least 
6 months after fertility work up was advised (n = 324), the expectant period was not 
followed in 16.2% of these couples (n = 51), ranging from 0 to 63% between the clinics. 
These couples started fertility treatment after a mean duration of 4.3 months after fertility 
work up.
 The overlap of couples between the three quality indicators and overtreatment is 
shown in Supplementary Fig. S1.
Outcome
Pregnancy data are shown in Table II. In the group of couples with overtreatment, 28% 
of couples had an ongoing pregnancy within 6 months and 42% of couples within 1 year. 
For couples who were not exposed to overtreatment, 31% of couples had an ongoing 
pregnancy within 6 months and 41% of couples within 1 year. Most of the couples with 
overtreatment had a pregnancy resulting from fertility treatments (90%) and most of the 
couples without overtreatment conceived naturally (91%). 
Figure 2   Overtreatment and quality indicators for TEM in couples eligible for TEM:  
an assessment in 25 Dutch fertility clinics.
Overtreatment: N 
group
 Range and median 25 clinics (%) Median 
[range] 
Patients 
N (%)
Treatment started within 
six months following 
conclusion of fertility 
work-up.
544
0 10 20 30 40 50 60 70 80 90 100
36.4 
[16-81]
198 
(36.4)
Quality  indicators: Range and median 25 clinics (%)
1. The prognosis of a 
natural conception was 
not calculated.
544
0 10 20 30 40 50 60 70 80 90 100
33.3 
[0-96]
186 
(34.2)
2. Incorrect course of 
treatment advised, 
i.e. immediate fertility 
treatment or an expectant 
period of less than six 
months.
544
0 10 20 30 40 50 60 70 80 90 100
40.7 
[14-76]
230 
(42.3)
3. In case correct 
treatment was advised 
(TEM > 6 months), couples 
still started treatment 
within six months.
314
0 10 20 30 40 50 60 70 80 90 100
16.7 
[0-63]
51 
(16.2)
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Patient and clinic characteristics and their association with overtreatment
Patient characteristics and their association with overtreatment in univariate multilevel 
analysis are shown in Table III. A longer duration of infertility (per year) and nulliparity 
(versus primi- and multiparity) are significantly associated with more overtreatment. 
 Clinic characteristics and their association with overtreatment in univariate multilevel 
analysis are shown in Table IV. One to three gynaecologists per clinic was associated with 
more overtreatment compared with clinics with more than three gynaecologists (OR 1.44; 
95% CI 1.0–2.1). No other characteristics were significantly associated.
 The correlation analysis showed that the type of infertility (primary) and the parity 
(nulliparous) were highly correlated (rho > 0.6). For the multivariate multilevel analysis the 
type of infertility was used as independent variable since we considered that the type of 
infertility was more clinically relevant. The results of the multivariate multilevel analysis 
showed that only patient characteristics were significantly associated with overtreatment 
(Table V). Couples with primary infertility have a higher risk of overtreatment compared 
with couples with secondary infertility (OR 1.12; 95% CI 1.02–1.24). A longer duration of 
infertility (per year) increases the risk of overtreatment (OR 1.11; 95% CI 1.03–1.20) and a 
higher female age (per year) is also significantly independently associated with more 
overtreatment (OR 1.02; 95% CI 1.00–1.03).
Table II   Pregnancy outcome after six and twelve months.
Outcome: Overtreatment
N=198
No overtreatment
N=346
No pregnancy within follow up 85 (42.9%) 105 (30.3%)
Unknown 10 (5.1%) 65 (18.8%)
Within six months:
Pregnancy 70 (35.4%) 136 (39.3%)
    Spontaneous 5 135
    Fertility treatment 65 1
Ongoing pregnancy 55 (27.8%) 108 (31.2)
Within one year:
Pregnancy 103 (52.1 %) 176 (50.9%)
    Spontaneous 10 161
    Fertility treatment 93 15
Ongoing pregnancy 84  (42.4) 140 (40.5)
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Discussion
In this study, we found that over one-third of couples with unexplained infertility who 
were eligible for tailored expectant management, i.e. couples with a good prognosis of a 
natural conception, were exposed to overtreatment. Overtreatment means that a fertility 
treatment was started within 6 months after the fertility work up was completed. 
Overtreatment occurs mainly because couples are not diagnosed and identified correctly 
as being eligible for TEM or that the expectant period is not followed despite TEM being 
advised. The highest risk for overtreatment was in childless couples with a higher female 
age and a longer duration of infertility. Furthermore, our data on pregnancy rates underline 
the justification of advising TEM.
 The findings in our study are congruent with literature from several countries and 
from other health care fields that suggest that ~30–40% of patients do not receive care 
based on the best available evidence and that 20–25% of provided health care is 
Table III   Patient characteristics and their association with overtreatment in  
multilevel univariate analyses
 
Patient characteristics (n=544) Univariate B OR (95% CI)a P
Mean age in years (SD):
    Femaleb 30.7 (3.5) 0.01 1.01 [1.00-1.02] 0.11
    Male 33.2 (4.9) 0.00 1.00 [0.99-1.01] 0.69
Type infertility:
   Primary 64.3 % 0.34 1.41 [0.97-2.04] 0.07
   Secondary 35.7 % ref
Mean duration of infertility in years (SD)b 1.39 (0.57) 0.08 1.09 [1.00-1.18] 0.04
Obstetric history :
    Nulliparous 77 % 0.46 1.59 [1.03-2.45] 0.04
    Primi/multiparous 23% ref
Socio-economic status:
    High 13.4 % 0.21 1.23 [0.62-2.46] 0.56
    Medium 73.5 % 0.03 1.03 [0.59-1.78] 0.92
    Low 13.1 % ref
Mean BMI (SD) 23.8 (4.4) 0.00 1.00 [0.99-1.01] 0.76
a OR > 1 means a positive association with overtreatment (more overtreatment) 
b Per year increase in the female age the risk of overtreatment increases with an OR of 1.04
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Table IV   Clinic characteristics and their association with overtreatment in multilevel 
univariate analyses.
Clinic characteristics (25 clinics) n (%) Univariate B OR [95% CI] P
Clinic type
IVF facilities:
    Fully licensed 6 (24) 0.35 1.42 [0.85-2.35] 0.18
    Intermediate 11 (44) 0.18 1.19 [0.79-1.81] 0.41
    None 8 (32) ref
Training clinic:
    Yes 9 (36) 0.04 1.04 [0.72-1.51] 0.82
    No 14 (64) ref
Fertility Team (functions present) 
Fertility doctor* 17 (68) -0.01 1.00 [0.67-1.47] 0.98
Fertility specialized nurse* 19 (76) 0.42 1.52 [0.91-2.53] 0.11
Research nurse* 13 (52) -.26 0.77 [0.54-1.09] 0.15
Number of gynaecologist per clinic that provide fertility care:
    1-3 14 (56) 0.37 1.44 [1.01-2.06] 0.04
    >3 11 (44) ref
Organisation
Daily fertility meeting:
    Yes 6 (24) 0.37 1.44 [0.88-2.37] 0.15
    No 19 (76) ref
Number of fertility consultations per gynaecologist per week :
    >20 7 (28) 0.29 1.33 [0.90-1.98] 0.15
    0-20 18 (72) ref
Assignment of a lead physician for each couple:
    Yes 5 (20) ref
    No 20 (80) 0.44 1.55 [0.96-2.53] 0.08
Information material
Information folder available on TEM:
    Yes 2 (8) ref
    No 23 (92) 0.55 1.73 [0.94-3.2] 0.08
Checklist present for information supply:
    Yes 7 (28) 0.29 1.34 [0.90-1.97] 0.15
    No 18 (72) ref
* Reference is function not present.
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considered unnecessary and potentially harmful (Grol 2001; Schuster, McGlynn, and Brook 
2005). Furthermore, our study shows that the development and dissemination of current 
clinical guidelines has not improved the adherence to TEM and that overtreatment still 
occurs as frequently or even more than previous studies on TEM report (van den Boogaard 
et al. 2011). Extra eﬀorts to implement guideline recommendations on TEM are necessary 
(Grol 2001; Grimshaw et al. 2004; van den Boogaard et al. 2011). In 2013, insurance 
companies and the Dutch government have tried to make TEM obligatory as part of a 
plan to improve the cost-eﬀectiveness of fertility care. We think that to implement TEM 
fully, a good understanding of the factors leading to overtreatment is necessary. Our 
results show that a large part of the problem lies in correctly diagnosing and identifying 
couples who are eligible for TEM. Therefore, it is important to make doctors aware of the 
guideline recommendations on TEM and encourage them to calculate the prognosis for 
couples with unexplained infertility and advise TEM if the prognosis is good. To support 
doctors in taking these steps, it is important that tools will be available, such as a local 
protocol for TEM and providing the prognostic model with easy access.
 Advising TEM to couples is in the hands of the professionals, adhering to the expectant 
period of at least 6 months also relies on the couple. If the couple does not believe that 
TEM is the best option, they can put pressure on the professional to start treatment sooner 
or they can try to get fertility treatment elsewhere. Our results underline that it is very 
important that we need to tackle the barriers for TEM on both patient and professional 
level (van den Boogaard et al. 2012). More information about the calculation of the 
prognosis and the reason for TEM is required for couples, and doctors need tools to help 
them counsel patients on TEM. These tools can include a communication training on TEM 
and/or a website, with the prognostic model, information on TEM, and information on 
ways to optimize the chance of natural conception, that can be accessed by both patients 
and professionals.
 The need for more information on the prognostic model and TEM also shows in the 
patient characteristics that we found to be associated with overtreatment, i.e. higher 
Table V   Multilevel multivariate analysis; association of patient and hospital 
 characteristics and overtreatment
Characteristics Univariate B OR [95% CI] P
Primary infertility* 0.14 1.10 [1.02-1.20]  0.01
Higher female age (per year) 0.02 1.02 [1.01-1.04] <0.01
Longer duration of infertility (per year) 0.10 1.11 [1.03-1.20] <0.01
* Reference is secondary infertility
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female age, a longer duration of infertility and primary infertility. Remarkably, all three 
associated patient characteristics are factors that are already being weighed in the 
calculation of the prognosis. In couples with primary infertility, the woman has not been 
pregnant and the pressure to start fertility treatment might be higher because their faith 
in their ability to conceive naturally might be less. However, it is the only characteristic that 
has not previously been reported to be associated with overtreatment (van den Boogaard 
et al. 2011).
 In contrast to findings in previous studies on TEM, we did not find any clinic charac-
teristics to be independently significantly associated with overtreatment (van den 
Boogaard et al. 2011). This might be explained by the fact that in the study that reports 
this, no multilevel analysis was done to correct for the clustering of couples by clinic. Our 
results are congruent with another study on guideline adherence in fertility care, which 
also performed a multilevel analysis, that showed that guideline recommendations are 
rarely influenced by clinic characteristics and mostly by patient characteristics (Hermens 
et al. 2011).
 Our study has several strengths. First, we were able to do a large national evaluation 
of overtreatment in couples with unexplained infertility. We were able to include 544 
infertile couples from 25 clinics across the Netherlands, ensuring representativeness of the 
Dutch unexplained infertile population. Second, this is the first time that underlying 
processes that lead to overtreatment are assessed with quality indicators. Third, by 
including such a varied group of couples from diﬀerent types of clinics we were able to do 
a multilevel analysis to evaluate the relationship of characteristics on both patient and 
clinic level to overtreatment. This will be of help to develop an implementation strategy that 
can target these specific characteristics to reduce overtreatment.
 However, some limitations in this study should be considered. First, the response rate 
was lower compared with other fertility studies (Troude et al. 2012; Van Dongen et al. 2012; 
Huppelschoten et al. 2013). The non-response research showed that the responders less 
often were women with anovulation and couples with a lower socio-economic status. 
Since anovulation was an exclusion criteria , this is not expected to have influenced the 
results. The higher SES of the responders might not have influenced the results either, 
since the univariate analysis showed that SES was not associated with overtreatment. 
However, we cannot exclude that there might be a response bias in the non-response 
research as well. Second, we only looked at the steps that lead to overtreatment in a 
clinical setting. To what extent the couples were correctly, meaning not too soon, referred 
and informed on the possibility of TEM by the GP has not been measured. Third, 
we looked at overtreatment in Dutch fertility care and not in an international setting. 
Various European guidelines also make recommendations on TEM (Fields et al. 2013). 
However, the incentive to start treatment might be higher in other countries because 
there are diﬀerent reimbursement policies towards fertility care. Moreover, guidelines are 
well known and imbedded in Dutch fertility care, which may lead to an overestimation of 
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guideline adherence for a broader perspective. More investigation is needed to assess 
overtreatment in other European countries and evaluate if they face the same problems 
concerning TEM.
 In conclusion, this study showed that in the Netherlands, overtreatment occurs in 
over one-third of all infertile couples eligible for TEM. Meaning that there is room for 
improvement in guideline adherence, specifically in calculating the prognosis, advising a 
period of expectant management, and adhering to the expectant period. This is especially 
the case in childless couples with a higher female age and a longer duration of infertility. 
To improve future care and prevent couples from being exposed to unnecessary fertility 
treatment, the next step is to develop and evaluate an implementation strategy that 
targets this problem at multiple levels.
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Gelderse Vallei, Ede), W.K. Kuchenbecker (Isala Klinieken, Zwolle) and J.M. van der Ploeg 
(Maasziekenhuis Pantein, Boxmeer).
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Samenvatting
Doel: De implementatie in kaart brengen van het advies uit de ‘Landelijke netwerkrichtlijn 
subfertiliteit’ om bij paren met onverklaarde subfertiliteit 6-12 maanden af te wachten 
alvorens een vruchtbaarheidsbehandeling te starten.
Opzet: Retrospectief cohortonderzoek in 25 ziekenhuizen.
Methode: Uit de dossiers van 25 ziekenhuizen die fertiliteitszorg bieden, selecteerden wij 
paren met onverklaarde subfertiliteit en een goede kans op spontane zwangerschap 
binnen 1 jaar. Primaire uitkomstmaat was overbehandeling, gedefinieerd als een vrucht-
baarheidsbehandeling gestart binnen 6 maanden na het oriënterend fertiliteitsonderzoek 
(OFO). Secundaire uitkomstmaat was naleving van de richtlijn aan de hand van 3 indicatoren: 
geen prognose berekend; geen afwachtend beleid geadviseerd; afwachtend beleid 
geadviseerd maar behandeling toch binnen 6 maanden gestart. De invloed van patiënt- 
en ziekenhuiskenmerken is geanalyseerd met behulp van multilevel regressie analyse. 
Trialnummer NTR 3405.
Resultaten: Wij includeerden 544 paren, waarvan er 198 (36%) overbehandeld werden. 
De ziekenhuizen verzuimden bij 186 paren (34%) de prognose te berekenen en bij 230 
paren (42%) minimaal 6 maanden afwachtend beleid te adviseren. Van de 314 paren (58%) 
die dat advies wél kregen, werden er 51 (16%) alsnog binnen 6 maanden behandeld. 
Voortijdige behandeling vond vaker plaats wanneer de vrouw nog niet eerder zwanger 
geweest was of een hogere leeftijd had, en naarmate de subfertiliteit al langer bestond.
Conclusie: De implementatie van het advies voor afwachtend beleid zoals dat 
geformuleerd is in de ‘Landelijke netwerkrichtlijn subfertiliteit’ kan beter. De eerste stap 
om die verbetering te realiseren is het evalueren van een implementatiestrategie die 
gericht is op de genoemde knelpunten.
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Inleiding
Er zijn goede redenen om kritisch te kijken naar de kosteneﬀectiviteit van vruchtbaar-
heidsbehandelingen. Door de toenemende zorgconsumptie stijgen de kosten van de zorg 
en wordt het steeds belangrijker om kosteneﬀectief te werken (Appleby 2012). Dat geldt 
a fortiori voor de voortplantingsgeneeskunde (Ferraretti et al. 2013). Van veel vruchtbaar-
heidsbehandelingen is niet bewezen dat ze leiden tot betere zwangerschapscijfers en is 
het dus onduidelijk of zij hun geld wel waard zijn (Custers et al. 2012; Steures et al. 2006; 
Bensdorp et al. 2007; Veltman-Verhulst et al. 2012). Vruchtbaarheidsbehandelingen brengen 
bovendien gezondheidsrisico’s met zich mee en zijn vaak lichamelijk en psychisch belastend 
(Verhaak et al. 2002; Helmerhorst et al. 2004; Verberg et al. 2008). Het zou goed zijn als het 
aantal ineﬀectieve vruchtbaarheidsbehandelingen kon worden teruggedrongen. Dat kan 
door vooraf de paren te selecteren die baat hebben bij zo’n behandeling (Van Geloven 
et al. 2013; Brandes et al. 2011). 
 Men spreekt van subfertiliteit als een paar een jaar lang onbeschermde gemeenschap 
heeft gehad zonder dat de vrouw zwanger is geworden. Vruchtbaarheidsbehandelingen 
zijn bewezen eﬀectief als de subfertiliteit een duidelijke oorzaak heeft, zoals slechte 
zaadkwaliteit, een afwijking aan beide eileiders, ernstige endometriose of een ovulatie-
stoornis (Brandes et al. 2010). Bij ongeveer 30% van de subfertiele paren is echter geen 
duidelijke oorzaak te vinden en voor veel paren met onverklaarde subfertiliteit is een 
vruchtbaarheidsbehandeling overbodig (Custers et al. 2012; Brandes et al. 2010). Er is een 
prognostisch model waarmee men de kans op een spontane zwangerschap in het eerst - 
volgende jaar kan berekenen (Hunault et al. 2004). Is deze kans ≥ 30%, dan is afwachtend 
beleid van 6-12 maanden minstens zo eﬀectief gebleken als een vruchtbaarheidsbehandeling 
met intra-uteriene inseminatie en hormonen (Steures et al. 2008; Custers et al. 2012). 
 Het advies om bij paren met onverklaarde subfertiliteit minstens 6 maanden te 
wachten alvorens een vruchtbaarheidsbehandeling te starten is overgenomen door de in 
2010 verschenen multidisciplinaire ‘Landelijke netwerkrichtlijn subfertiliteit’, waaraan 
huisartsen (NHG), gynaecologen (NVOG), urologen (NVU), klinisch embryologen (KLEM en 
NVKC), een psycholoog (LVMP), een bedrijfsarts en 2 patiëntvertegenwoordigers (Freya) 
hebben meegewerkt. De richtlijn adviseert om bij paren met onverklaarde subfertiliteit 
die aanspraak doen op een vruchtbaarheidsbehandeling allereerst de kans op spontane 
zwangerschap binnen 1 jaar te berekenen. Dit gebeurt aan de hand van het prognostisch 
model van Hunault, waarin rekening gehouden wordt met 4 factoren: de leeftijd van de 
vrouw, de duur van de subfertiliteit, al dan niet een eerdere spontane zwangerschap en 
het percentage beweeglijkheid van het zaad. Paren bij wie de kans 30% of hoger is, 
zouden volgens de richtlijn minimaal 6-12 maanden moeten wachten met een vrucht-
baarheidsbehandeling.
 Veel paren kunnen zich echter niet vinden in zulk afwachtend beleid, en behandelend 
artsen blijken vaak moeite te hebben hen te overreden dat toch te doen (van den 
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Boogaard, Oude Rengerink, et al. 2011; van den Boogaard, van den Boogaard, et al. 2011). 
Een van de voornaamste redenen is gebrek aan informatie: vaak weet het paar niet dat 
afwachtend beleid óók perspectief biedt en overschat het de kans van slagen van een 
vruchtbaarheidsbehandeling (van den Boogaard et al. 2012). 
 Om de implementatie van afwachtend beleid te verbeteren, is het nodig informatie 
te verzamelen over de manier waarop de landelijke netwerkrichtlijn momenteel wordt 
nageleefd en te achterhalen in hoeverre kenmerken van het paar of de kliniek van invloed 
zijn op de beslissing tot afwachtend beleid (van den Boogaard, Oude Rengerink, et al. 
2011; Hermens et al. 2011; Schouten et al. 2005; Fine et al. 2002). Doel van ons onderzoek 
was inzicht te krijgen in de huidige fertiliteitszorg en in de factoren die daarop van invloed 
zijn, en zo te komen tot een betere strategie voor het toepassen van afwachtend beleid 
bij paren met onverklaarde subfertiliteit (van den Boogaard et al. 2013). Dit artikel is een 
bewerking van ons onderzoeksverslag dat is verschenen in Human Reproduction (Kersten 
et al. 2015). 
Methode
Opzet
Retrospectief cohortonderzoek in het kader van NVOG Consortium 2.0, gebruikmakend 
van dossiergegevens van 25 Nederlandse ziekenhuizen. De medisch-ethische commissie 
van het Radboudumc verleende toestemming (CMO nr. 2012/130). Trialnummer NTR 
3405.
Deelnemers en uitkomstmaten
De figuur geeft een overzicht van de werving. Inclusiecriteria waren onverklaarde 
subfertiliteit of milde subfertiliteit ten gevolge van cervixfactor, enkelzijdige eileider-
afwijking, matige zaadkwaliteit of milde endometriose, bij een kans van ≥ 30% op 
spontane zwangerschap binnen 1 jaar. Exclusiecriteria waren een eerdere vruchtbaar-
heidsbehandeling, leeftijd van de vrouw 38 jaar of ouder, en subfertiliteit met een 
duidelijke oorzaak, zoals dubbelzijdige eileiderafwijking, slechte zaadkwaliteit, cyclus-
stoornis en ernstige endometriose. 
 Onze primaire uitkomstmaat was overbehandeling, gedefinieerd als een vruchtbaar-
heidsbehandeling die startte binnen 6 maanden na het oriënterend fertiliteitsonderzoek 
(OFO). Om de eﬀectiviteit van de behandeling te controleren bepaalden wij het percentage 
doorgaande zwangerschappen na afwachtend beleid en na overbehandeling.
 Onze secundaire uitkomstmaat was de naleving van de richtlijn, geanalyseerd aan de 
hand van 3 kwaliteitsindicatoren: het percentage paren met onverklaarde subfertiliteit bij 
wie de kans op spontane zwangerschap niet berekend werd; het percentage dat het 
advies kreeg direct of binnen 6 maanden na het OFO te starten met een vruchtbaarheids-
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behandeling; en het percentage paren dat ondanks een correct ingesteld afwachtend 
beleid toch een vruchtbaarheidsbehandeling kreeg binnen 6 maanden na het OFO.
Gegevensverzameling en analyse
Alle gegevens over de deelnemers waren afkomstig uit de medische dossiers van de 
25 deelnemende ziekenhuizen (tabel 1). In elk ziekenhuis vulde 1 gynaecoloog een 
digitale vragenlijst in over de organisatie van de kliniek en de fertiliteitszorg (tabel 2).
 Met beschrijvende statistiek analyseerden we het percentage doorgaande zwanger-
schappen en de kenmerken van de deelnemende paren en ziekenhuizen. Vervolgens 
keken we in een univariabele analyse naar de invloed van ieder afzonderlijk kenmerk op 
overbehandeling, waarbij we de analyse van de paren uitvoerden als multilevelanalyse 
Tabel 1   Kenmerken van 544 subfertiele paren in 25 ziekenhuizen, bij wie na een 
oriënterend fertiliteitsonderzoek in 2011-2012 al dan niet een vruchtbaar-
heidsbehandeling werd ingesteld
kenmerk gemiddelde, percentage (SD)
leeftijd (SD)
 vrouw 30.7 jaar* (3.5)
 man 33.2 jaar (4.9)
type subfertiliteit
 primair† 64.3%*
 secundair‡ 35.7%
duur van de subfertiliteit (SD) 1.39 jaar* (0.57)
obstetrische voorgeschiedenis
 nullipara 77%*
 primi- of multipara 23%
sociaal-economische status
 hoog 13.4%
 gemiddeld 73.5%
 laag 13.1%
BMI 23.8 (4.4)
* In de univariabele analyse werd een samenhang (p < 0,2) gevonden tussen deze variabele en 
overbehandeling, dat wil zeggen: een vruchtbaarheidsbehandeling binnen 6 maanden na het oriënterend 
fertiliteitsonderzoek bij een paar dat volgens de richtlijnen in aanmerking kwam voor afwachtend beleid. 
Deze variabele wordt meegenomen in de multivariabele analyse.
† De vrouw is nog niet eerder zwanger geweest.
‡ De vrouw is eerder zwanger geweest.
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Tabel 2  Organisatie en kenmerken van de fertiliteitszorg in 25 ziekenhuizen, 2011-2012 
kenmerk n (%)
organisatie
IVF-faciliteiten
 volledige faciliteiten 6* (24)
 transportkliniek 11 (44)
 geen faciliteiten 8 (32)
opleidingskliniek
 ja 9 (36)
 nee 14 (64)
fertiliteitsteam (functies aanwezig)†
 fertiliteitsarts 17 (68)
 fertiliteitsverpleegkundige 19* (76)
 onderzoeksverpleegkundige 13* (52)
 1-3 gynaecologen 14* (56)
 > 3 gynaecologen 11 (44)
fertiliteitszorg
dagelijkse fertiliteitsbespreking
 ja 6* (24)
 nee 19 (76)
consulten per gynaecoloog per week
 > 20 7* (28)
 0-20 18 (72)
hoofdbehandelaar voor ieder paar
 ja 5 (20)
 nee 20* (80)
folder over afwachtend beleid
 ja 2 (8)
 nee 23* (92)
checklist voor informatiemateriaal
 ja 7* (28)
 nee 18 (72)
*  In de univariabele analyse werd een samenhang (p < 0,2) gevonden tussen deze variabele en overbehandeling, 
dat wil zeggen: een vruchtbaarheidsbehandeling binnen 6 maanden na het oriënterend fertiliteitsonderzoek 
bij een paar dat volgens de richtlijnen in aanmerking kwam voor afwachtend beleid. Deze variabele wordt 
meegenomen in de multivariabele analyse.
† De samenhang is berekend met als referentie het afwezig zijn van de betreﬀende functie.
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omdat deze per kliniek ‘geclusterd’ waren. Als wij die samenhang aantroﬀen (p < 0,2), 
keken we vervolgens met een multivariabele multilevelanalyse naar de onafhankelijke 
invloed van dat kenmerk op overbehandeling.
 Alle analyses werden uitgevoerd in SPSS 20.0 voor Windows.
Resultaten
Van de 9819 paren die uitgenodigd waren om deel te nemen aan dit onderzoek reageerden 
er 4283 (43%). Van deze paren waren er 3428 (80%) bereid om deel te nemen. Uiteindelijk 
voldeden 544 paren aan onze inclusiecriteria (zie figuur 1).
Overbehandeling en naleving van de richtlijn
Van de 544 paren kregen er 198 (36,4%) binnen 6 maanden na het OFO een vruchtbaar-
heidsbehandeling, in afwijking van het richtlijnadvies. Bij 186 paren (34,2%) werd de 
prognose voor spontane zwangerschap niet berekend; 230 paren (42%) kregen het advies 
om binnen 6 maanden te starten met behandeling. En van de 314 paren die wél het 
advies kregen minimaal 6 maanden te wachten, startten er 51 (16%) alsnog voortijdig met 
die behandeling (tabel 3). Tabel 3 laat echter ook zien dat de spreiding tussen de 
deelnemende ziekenhuizen groot was op alle 4 de uitkomstmaten.
 Tabel 4 toont de resultaten van de multivariabele analyse van factoren die significant 
geassocieerd waren met overbehandeling (p < 0,2). Ons onderzoek identificeerde 3 
factoren: geen eerdere zwangerschap, hogere leeftijd van de vrouw en langere duur van 
de subfertiliteit. Geen enkele van de in aanmerking komende ziekenhuiskenmerken (zie 
tabel 2) bleek geassocieerd met overbehandeling.
Zwangerschapscijfers
Tabel 5 geeft een overzicht van het percentage doorgaande zwangerschappen. In de 
groep met overbehandeling had 42,4% van de paren binnen een jaar na het OFO een 
doorgaande zwangerschap, in de groep met afwachtend beleid was dat 40,5%. In de 
groep met overbehandeling was 10% van de zwangerschappen spontaan ontstaan, in de 
groep met afwachtend beleid 91%.
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Figuur 1   Inclusieprocedure van een onderzoek naar het beleid inzake 
 vruchtbaarheidsbehandelingen bij subfertiele paren in 25 Nederlandse 
ziekenhuizen, in de periode 2011-2012
*  Een paar kan aan meer dan 1 exclusiecriterium voldoen.
†  Afgebroken vanwege natuurlijke zwangerschap (n = 144) of afgerond buiten de inclusieperiode (n = 76).
‡  Herhaalde miskraam, molazwangerschap, uterus myomatosus, buiterbaarmoederlijke zwangerschap, 
 pre-implantatie genetische diagnostiek, actieve kinderwens minder dan 1 jaar
Informatiebrief verstuurd aan 
9896 paren in 25 ziekenhuizen
4283 paren (44%) hebben gereageerd
3428 paren (80%) waren bereid deel te nemen
geen deelname (n=855)
niet gereageerd (n=5536)
Dossier onderzoek bij 1463 paren (43%)
exclusie o.b.v. vragen in informatie brief (n=1965)*
•  eerdere fertiliteitsbehandeling (n=996)
•  anovulatie (n=1018)
•  tweezijdige eileiderstoornis (n=123)
•  ernstige mannelijke subfertiliteit (n=565)
 
 
 
 
544 paren (37%) geïncludeerd 
exclusie o.b.v. dossier onderzoek (n=919)
•  oriënterend fertiliteitsonderzoek niet afgerond (n=220)†
•  eerdere vruchtbaarheidsbehandeling (n=51)
•  anovulatie (n=90)
•  dubbelzijdige eileiderafwijking (n=11)
•  endometriose graad 3 of 4 (n=14)
•  slechte zaadkwaliteit (n=176)
•  kans op spontane zwangerschap binnen 1 jaar < 30% (n=198)
•  geen subfertiliteit (n=47)‡
•  onbekend n=115)
•  lesbisch paar, gewichtsreductie of invriezen van eicellen (n=44)
 
 
 
 
 
 
 
 
 
 
niet ontvangen (n=77)
9819 paren hebben de informatie brief ontvangen
511305-L-bw-kersten
Processed on: 6-7-2017 PDF page: 95
95
Overbehandeling in paren met onverklaarde subfertiliteit
4.2
Tabel 3   Naleving van de richtlijn inzake afwachtend beleid bij subfertiliteit:  
evaluatie van de fertiliteitszorg in 25 ziekenhuizen aan de hand van het 
percentage overbehandeling en 3 kwaliteitsindicatoren
uitkomstmaat n (%) mediaan en spreiding over  
de 25 ziekenhuizen
overbehandeling
behandeling gestart binnen 
6 maanden na afronding van 
het OFO 
198/544 
(36.4%)
36.4% 
(16-81%)
0 10 20 30 40 50 60 70 80 90 100
kwaliteitsindicatoren
kans op een spontane 
zwangerschap niet berekend
186/544 
(34.2%)
33.3% 
(0-96%)
0 10 20 30 40 50 60 70 80 90 100
incorrecte behandeling 
geadviseerd, dat wil zeggen 
meteen gestart of minder dan 
6 maanden afwachtend beleid
230/544 
(42.3%)
40.7% 
(14-76%)
0 10 20 30 40 50 60 70 80 90 100
correct beleid geadviseerd 
van minimaal 6 maanden 
afwachten, maar toch 
behandeling gestart binnen  
6 maanden
51/314 
(16.2%)
16.7% 
(0-63%)
0 10 20 30 40 50 60 70 80 90 100
Tabel 4   Kenmerken die samenhangen met overbehandeling van paren met onverklaarde 
subfertiliteit en ≥ 30% kans op spontane zwangerschap binnen 1 jaar*
kenmerk univariabele B oddsratio (95%-BI)
primaire subfertiliteit† 0.14 1.10 (1.02-1.20)
hogere leeftijd vrouw, per jaar 0.02 1.02 (1.01-1.04)
langere duur subfertiliteit, per jaar 0.10 1.11 (1.03-1.20)
*  Overbehandeling wil zeggen vruchtbaarheidsbehandeling gestart binnen 6 maanden na het oriënterend 
fertiliteitsonderzoek
† Ten opzichte van secundaire subfertiliteit.
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Beschouwing
Ons onderzoek laat zien dat, over alle ziekenhuizen gerekend, ruim een derde van de 
paren met onverklaarde subfertiliteit een vruchtbaarheidsbehandeling krijgt terwijl dat 
niet strikt noodzakelijk is. De kans op overbehandeling was het grootst bij paren die nog 
kinderloos waren, bij wie de vrouw een hogere leeftijd had en bij wie de subfertiliteit 
langer duurde. Deze bevindingen zijn in lijn met de literatuur, die laat zien dat 20-25% 
van alle zorg onnodig is en soms zelfs gevaarlijk kan zijn (Schuster et al. 2005). 
 Ons onderzoek laat ook zien dat de ‘Landelijke netwerkrichtlijn subfertiliteit’ niet 
heeft geleid tot het vaker instellen van afwachtend beleid; overbehandeling komt nog 
minstens zo frequent voor als vóór de publicatie (van den Boogaard, Oude Rengerink, et 
al. 2011). Extra maatregelen zijn nodig. De strikte handhaving van afwachtend beleid bij 
paren met een goede prognose maakt eveneens onderdeel uit van de ‘IVF-pakketmaat-
regel’, die in 2013 is ingevoerd om te besparen op vruchtbaarheidsbehandelingen zodat de 
3 vergoede IVF-cycli behouden kunnen blijven. Wellicht leidt de pakketmaatregel ertoe 
dat paren vaker een spontane zwangerschap afwachten, maar wij denken dat er pas echt 
verbetering zal optreden als de knelpunten niet van bovenaf, maar bij de paren en 
behandelaars zelf worden aangepakt.
Tabel 5   Zwangerschappen in de periode 2011-2012 bij 544 subfertiele paren na 
oriënterend fertiliteitsonderzoek, bij afwachtend beleid en bij overbehandeling*
uitkomst overbehandeling; n (%)
(n = 198)
afwachtend beleid; n (%)
(n = 346)
geen zwangerschap binnen 12 maanden 85 (42.9) 105 (30.3)
onbekend 10 (5.1) 65 (18.8)
zwangerschap binnen 6 maanden 70 (35.4) 136 (39.3)
 spontaan 5 135 
 behandeling 65 1
 doorgaande zwangerschap 55 (27.8) 108 (31.2)
zwangerschap binnen 12 maanden 103 (52.0) 176 (50.9)
 spontaan 10 161
 behandeling 93 15
doorgaande zwangerschap 84 (42.4) 140 (40.5)
Door overlap binnen de categorieën tellen de percentages op tot boven de 100%.
*  Overbehandeling wil zeggen vruchtbaarheidsbehandeling ondanks indicatie voor afwachtend beleid.
511305-L-bw-kersten
Processed on: 6-7-2017 PDF page: 97
97
Overbehandeling in paren met onverklaarde subfertiliteit
4.2
Het is belangrijk dat verwijzers en behandelaars op de hoogte zijn van de richtlijnadviezen 
omtrent afwachtend beleid bij subfertiele paren en aangemoedigd worden die na te 
leven: de prognose berekenen, zo nodig minimaal 6 maanden afwachtend beleid 
adviseren en in die periode dan ook daadwerkelijk afzien van een vruchtbaarheidsbehan-
deling. Met betrekking tot dat laatste is het ‘managen’ van de verwachtingen van het paar 
cruciaal: subfertiele paren moeten goed geïnformeerd en gecounseld worden (van den 
Boogaard et al. 2012). Dit zou in elk geval moeten gebeuren tijdens het eerste gesprek in 
het ziekenhuis, zodat het paar van tevoren rekening kan houden met de mogelijkheid van 
afwachtend beleid. Maar het zou nog beter zijn die mogelijkheid al in de eerste lijn te 
bespreken (van den Boogaard, van den Boogaard, et al. 2011). Indien een paar niet begrijpt 
dat afwachtend beleid werkelijk het beste is, zal het druk uitoefenen op de behandelaar om 
eerder te starten of zelfs proberen elders eerder behandeld te worden (Haagen et al. 2008; 
Verhaak et al. 2002) Momenteel wordt er in een clustergerandomiseerd onderzoek gekeken 
welke hulpmiddelen, zowel voor artsen als patiënten, eﬀectief zijn bij de counseling (van 
den Boogaard et al. 2013). 
 Een sterk punt van ons onderzoek is dat er 25 ziekenhuizen aan deelnamen, verspreid 
over Nederland, die bij elkaar ruim een kwart van de fertiliteitszorg in Nederland voor hun 
rekening nemen. Dit grote aantal klinieken en deelnemers stelde ons in staat een multi-
levelanalyse uit te voeren op ziekenhuis- en patiëntniveau. Een tweede sterk punt is dat 
we voor het eerst gebruikgemaakt hebben van kwaliteitsindicatoren die het inzicht 
vergroten in het proces dat leidt tot overbehandeling.
 Het onderzoek heeft ook beperkingen. Ten eerste was het responspercentage lager 
dan bij ander onderzoek in de voortplantingsgeneeskunde (Huppelschoten et al. 2013). 
Wij vonden echter geen verschillen tussen ‘non-responders’ en ‘responders’ die invloed 
zouden kunnen hebben op onze uitkomstmaten. Ten tweede is dit onderzoek uitsluitend 
in de tweede lijn uitgevoerd en hebben we dus niet kunnen kijken naar de invloed van 
verwijzers uit de eerste lijn. Een derde beperking is dat wij het percentage doorgaande 
zwangerschappen als maat hebben genomen voor de eﬀectiviteit van afwachtend 
beleid. Strikt genomen is dat niet juist omdat dit geen gerandomiseerd gecontroleerd 
onderzoek was, maar onze bevindingen zijn wel in lijn met die van eerdere onderzoeken 
waarin de eﬀectiviteit van afwachtend beleid is aangetoond (Custers et al. 2012; Steures 
et al. 2008). Het percentage doorgaande zwangerschappen in de groep met afwachtend 
beleid verschilde niet significant van dat in de groep met overbehandeling, maar wel 
kwam in de groep met afwachtend beleid 90% van de zwangerschappen spontaan tot 
stand, versus 10% in de groep met overbehandeling.
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Conclusie
Ons onderzoek laat zien dat er ruimte is voor verbetering in de naleving van de ‘Landelijke 
netwerkrichtlijn subfertiliteit’ voor wat betreft afwachtend beleid. Een aantal jaren na de 
publicatie van deze richtlijn wordt nog steeds ruim een derde van de paren met 
onverklaarde subfertiliteit onnodig blootgesteld aan vruchtbaarheidsbehandelingen. 
Verbetering in deze situatie is vooral te verwachten door extra aandacht te besteden aan 
kinderloze paren met langer bestaande subfertiliteit van wie de vrouw al wat ouder is. De 
eerstvolgende stap zal de evaluatie zijn van een implementatiestrategie die specifiek 
gericht is op de genoemde knelpunten.
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Abstract
Study question: Do couples who were eligible for tailored expectant management 
(TEM) and did not start treatment within 6 months after the fertility work-up, have diﬀerent 
experiences with the quality of care than couples that were also eligible for TEM but 
started treatment right after the fertility work-up?
Summary answer: Tailored expectant management of at least 6 months in couples with 
unexplained infertility is not associated with the experiences with quality of care or trust 
in their physician.
What is known already: In couples with unexplained infertility and a good prognosis of 
natural conception within 1 year, expectant management for 6–12 months does not 
compromise ongoing birth rates and is equally as eﬀective as starting medically assisted 
reproduction immediately. Therefore, TEM is recommended by various international 
clinical guidelines. Implementation of TEM is still not optimal because of existing barriers 
on both patient and professional level. An important barrier is the hesitance of professionals 
to counsel their patients for TEM because they fear that patients will be dissatisfied with 
care. However, if and how adherence to TEM actually aﬀects the couples’ experience with 
care is unknown. Experiences with the quality care can be measured by evaluating the 
patient-centredness of care and the patients’ trust in their physician.
Study design, size, duration: This is a retrospective cross-sectional study. A survey with 
written questionnaires was performed among all couples who participated in the 
retrospective audit of guideline adherence on TEM in 25 Dutch clinics.
Participants/materials, setting, methods: Couples were eligible to participate if they 
were diagnosed with unexplained infertility and had a good prognosis (>30%) of natural 
conception within 1 year based on the Hunault prediction model. We used patient’s 
questionnaires to collect data on the couples’ experience with the quality of care and 
possible confounders for their experiences other than having undergone TEM or not. 
Multilevel regression analyses were performed to investigate case-mix adjusted 
association of TEM with the patient-centredness of care (PCQ-Infertility) and the patients’ 
trust in their physician (Wake Forest Trust Scale).
Main results and the role of chance: Couples who adhered to TEM experienced the 
quality of care on the same level as couples who were exposed to early treatment, i.e. 
started fertility treatment within 6 months after fertility work-up. There were no 
associations between adherence to TEM and the patient-centredness of care or the 
patients’ trust in their physician.
Limitations, reasons for caution: Because this study is retrospective, recall bias might 
occur. Furthermore, we were unable to measure the diﬀerence in experience with care 
over time. Therefore, our results have to be interpreted carefully.
Wider implications of the findings: Prospective research on couples undergoing TEM 
have to be performed to provide more detailed insight in the patients’ experiences with 
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the decision making process and subsequently the expectant period. Tackling the barriers 
surrounding TEM, i.e. better counselling and more patient information material, could 
further improve patient experiences with the quality of care for couples who are advised 
TEM.
Study funding/competing interest(s): Supported by Netherlands Organisation for 
Health Research and Development (ZonMW). ZonMW had no role in designing the study, 
data collection, analysis and interpretation of data or writing of the report. Competing 
interests: none.
Trial registration number: www.trialregister.nl NTR3405.
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Introduction
Unexplained infertility is a common diagnosis in fertility care (Brandes et al. 2010). For 
couples with unexplained infertility, the prognosis of spontaneous conception within 1 
year can be calculated by the prognostic model of Hunault (Hunault et al. 2004). For 
couples with a calculated prognosis over 30%, a tailored expectant management (TEM) of 
6–12 months does not compromise ongoing birth rates compared to starting medically 
assisted reproduction (MAR) immediately (Steures et al. 2006; Custers et al. 2012). 
Furthermore, TEM is more cost-eﬀective, has lower multiple pregnancy rates, and 
minimizes the significant physical and psychological burdens that accompany MAR 
(Verhaak et al. 2002; Verberg et al. 2008; Brandes et al. 2009; Wu et al. 2013). Therefore, 
national Dutch guidelines have formulated recommendations for TEM (NVOG 2010).
 Unfortunately, the implementation of TEM is still incomplete; over one third of 
couples eligible for TEM are exposed to early treatment, i.e. starting treatment within 
6 months after basic fertility work-up (van den Boogaard et al. 2011a; Kersten et al. 2015). 
This is due to barriers on both the professional and patient level (van den Boogaard et al. 
2012). For patients, a lack of confidence in natural conception, perception that TEM is a 
waste of time, inappropriate expectations prior to the first consultation, and an 
overestimation of treatment success rates were mentioned as barriers. Management of a 
couple’s expectations from the first visit is essential in order to create the opportunity to 
counsel couples for TEM after completing the basic fertility work-up. Among professionals, 
limited counselling skills on TEM have also been recognized as a barrier. Both patients and 
professionals regarded the absence of patient information material as the main barrier 
(van den Boogaard et al. 2011a,b).
 If these barriers on TEM are not addressed properly, it can lead to uncomfortable situations 
between couples and their physicians when TEM is advised and it can finally result in 
non-adherence. Furthermore, it can cause conflicts between patients and their physicians, 
patients dissatisfied with the care they receive, shopping for fertility treatment in other 
clinics, and even discontinuation of care (Brandes et al. 2009). In order to avoid such 
situations, it is plausible that physicians can be reluctant to advise TEM, as they aim to 
maintain a good relationship with their patients and want them to experience good care. 
The question is, do couples who were eligible for TEM and did not start treatment within 
6 months after the fertility work-up, have experienced their quality of care in a diﬀerent 
way than couples that were also eligible for TEM but started treatment right after the 
fertility work-up?
 To answer this question it is necessary to compare the experiences with quality of 
fertility care between the two groups. In the Netherlands, the standard for the 
measurement of patient experiences in healthcare is the Consumer Quality Index (CQI) 
(Delnoij et al. 2010). This is a questionnaire, which asks clients about their concrete 
experiences and how much they value certain aspects of care. In fertility care the CQI is 
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the validated Patient Centeredness Questionnaire-Infertility (PCQ-Infertility) (van Empel et 
al. 2010). Because a main barrier in adherence to TEM is communication, we will also 
evaluate the patients’ trust in their physician since this is an important determinant for 
experiences with communication (Haywood et al. 2010). Furthermore, trust is associated 
with satisfaction with the physician, adherence to treatment, and continuity of care 
(Pearson and Raeke 2000; Ommen et al. 2008; Bachinger et al. 2009).
 Therefore, we will investigate the association between having undergone or not 
under - gone TEM and patient-centredness of care and patients’ trust in their physician to 
evaluate the eﬀect of TEM on couples’ experiences with the quality of fertility care.
Materials and Methods
Study design
This is a retrospective cross-sectional study. A survey with written questionnaires was 
performed among all couples who participated in the retrospective audit of guideline 
adherence on TEM in 25 Dutch clinics (Kersten et al. 2015). To ensure national representa-
tiveness of data, 6 fully IVF licensed centres, 11 intermediate centres and 8 centres without 
IVF facilities participated. Initial fertility work-up, ovulation induction (OI) and intrauterine 
insemination (IUI) can be carried out in all Dutch clinics. Intermediate clinics can start and 
monitor the in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) treatment. 
However, the laboratory phase of IVF and embryo transfer has to be carried out in a fully 
licensed fertility clinic.
Ethical approval
The institutional ethics committee of Radboud university medical center provided ethical 
approval for this study (CMO no.2012/130).
Setting
The basic insurance coverage for each Dutch citizen fully reimburses all treatment cycles 
of ovulation induction (OI) and intrauterine insemination (IUI), with or without controlled 
ovarian hyperstimulation, as well as a maximum of three IVF and/or ICSI cycles per ongoing 
pregnancy. Clinical guidelines are well known and used in Dutch fertility care, specifically 
the Dutch Network Guideline Infertility 2010 (NVOG 2010). This guideline, just as the 
NICE (‘National Institute for Health and Care Excellence’) clinical guideline makes 
 recommendations on expectant management for couples with unexplained infertility 
(Fields et al. 2013).
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Study population
We aimed to include a representative Dutch patient group of couples with unexplained 
infertility with a good prognosis of a natural conception within 1 year (>30%), based on 
Hunault’s prediction model, i.e. couples who were eligible for TEM (Hunault et al. 2004).
 The female partner of the couple had to be between 18 and 38 years. The diagnosis 
of unexplained infertility included, apart from no cause found during the fertility work-up, 
one-sided tubal pathology (diagnosed by HSG or laparoscopy), cervical factor (i.e. Post 
coital test abnormal/negative with normal semen), mild male infertility (i.e. total motile 
sperm count [TMSC] 3–10 million), and/or mild endometrioses (American Society of 
Reproductive Medicine stage I/II). Couples with a previous fertility treatment (before 
March 2011) or with infertility based on bilateral tubal pathology, anovulation, severe 
endometrioses (American Society of Reproductive Medicine stage III/IV) or severe male 
factor (TMSC < 3 million) were excluded.
Recruitment
In the Netherlands each clinic has a financial DBC (Diagnosis/Treatment Combination code) 
registration database. In this national database, all patients undergoing diagnostics or 
treatment for infertility are identified with a specific Fertility-code for new patients. In order 
to select as many participants as possible we recruited all couples who had an active 
Fertility-code for new patients between March 2011 and February 2012. Nine thousand eight 
hundred and nineteen couples were sent an information letter and an informed consent 
form. Three thousand four hundred and twenty-eight couples gave informed consent, we 
performed medical record searches to assess if they indeed fitted the in- and exclusion 
criteria. This resulted in 544 couples, eligible for this survey study. The details of the study 
population and recruitment have been described in detail previously (Kersten et al. 2015).
 We sent all 544 couples a questionnaire by post between November 2012 and June 
2013. Two weeks after the initial mailing we sent a reminder card to non-responders. 
Couples received a second copy of the questionnaire if they did not return the first 
questionnaire within 4 weeks. To ensure the highest response rate the questionnaire had 
a maximum completion time of 25 min.
Data collection
Data collection was obtained from medical records and written patient questionnaires. 
These questionnaires consisted of five parts. Three parts were based on the confounding 
factors that could influence the experience with care (see confounders beneath). Two 
parts included validated questionnaires about patient-centredness of fertility care 
(PCQ-Infertility (van Empel et al. 2010)), and patients’ trust in the physician (Wake Forest 
Trust scale (WFTS) (Bachinger, Kolk, and Smets 2009)) (see outcome measures beneath). 
Data on the clinic characteristics were obtained by sending one gynaecologist, specialized 
in reproductive medicine, from each participating clinic a digital questionnaire.
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TEM versus early treatment
We obtained information about the fertility work-up, diagnosis, course of treatment, and 
treatment outcome from the medical record search, performed as part of the audit on 
guideline adherence on TEM. With this information, we divided the couples in two groups; 
couples who adhered to tailored expectant management (TEM), and couples who were 
exposed to early treatment. Couples were considered to adhere to TEM if they did not 
start treatment within 6 months after the basic fertility work-up. Early treatment meant that 
the couple started treatment immediately or within 6 months after the fertility work-up.
Confounders
Previous studies showed that several demographic characteristics, type of treatment 
received, mental health status (quality of life), several clinic characteristics, and the amount 
of information provision can influence the experience with fertility care (Haagen et al. 
2008; Hermens et al. 2011; Mourad et al. 2010; van Empel et al. 2011; Aarts, Huppelschoten, 
et al. 2012). We added two quality indicators for TEM to the possible confounders. We 
investigated the role of the following possible confounders.
Baseline characteristics
The baseline characteristics of couples consisted of female and male age, socio-economic 
status measured by postal code, country of birth (female and male), highest educational 
level (female and male), duration of infertility (in months), type of treatment last received 
(none/IUI with or without mild ovarian hyperstimulation/IVF), mean number of treatment 
cycles received (no. IUI and IVF/ICSI cycles), and live birth achieved since 1st visit to the 
clinic or currently pregnant (yes/no).
Quality indicators on TEM
To assess the process that leads to adherence to TEM we extracted two quality indicators 
from medical record research. 
· The first indicator is the percentage of couples for which the prognosis of a natural 
conception within 1 year was calculated by the physician after the fertility work-up.
· The second indicator is the percentage of couples that were advised an expectant 
management of at least 6 months by their physician after the fertility work-up.
Quality of life
We used the core module of the standardized FertiQol questionnaire to assess quality of 
life specific to infertility (see also www.fertiqol.org,(Boivin, Takefman, and Braverman 
2011)). The FertiQoL was only measured in couples with an unfulfilled childwish. A higher 
score on the FertiQol means a better quality of life. The reliability of this questionnaire was 
good with Cronbach’s alpha >0.8 in our sample.
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Clinic characteristics
Clinic characteristics included the type of clinic (none/intermediate/fully licensed clinics), 
academic clinic (yes/no), fertility doctor present (yes/no), specialized fertility nurse present 
(yes/no), local protocol on expectant management available (yes/no), and did couples 
have digital access to their personal medical record (yes/no).
Information provision
Information provision included items on education and counselling, based on what 
patients have mentioned as either barriers or facilitators on TEM in a previous study (van 
den Boogaard et al. 2011a,b). ‘Has the physician talked about the possibility of TEM during 
the first visit?’, ‘Did the physician explain the factors of the prognostic model?’, ‘Did the 
physician provide information about the risks and complications of fertility treatments?’, 
‘Did the physician compare the chances of conception with TEM and with other fertility 
treatments?’, ‘Did you look at the prognostic model yourself, with or without the 
physician?’. All questions were multiple-choice questions (yes/no/I don’t remember).
Outcome measures on patient experiences with quality of care
PCQ-Infertility
The patient-centredness of fertility care was measured with a modified version of the 
PCQ-Infertility questionnaire (PCQ-I) (van Empel et al. 2010). This validated instrument 
measures patient-centredness of fertility care by asking patients about their experiences 
with care. It consists of 46 questions and 7 subscales: Accessibility (2 items, e.g. ‘Was it a 
problem for you to contact staﬀ if you had any questions?’); Information (11 items, e.g. 
Have you been informed about the various treatment options?’); Communication (7 items, 
e.g. ‘Did the physician listen to you attentively?’); Patient involvement (3 items, e.g. ‘Was it 
possible to make a shared-decision with the physician about your treatment?’); Respect 
for patients’ values (7 items, e.g. ‘Was your physician sympathetic to your emotions and 
current situation?’); Continuity and transition (7 items, e.g. ‘How often did you receive 
contradictory information or advice?’); and Competence (6 items, e.g. ‘How often was 
your physician well prepared for an appointment?’). A higher score on the total PCQ-I scale 
or one of the subscales (range 0–3) indicates a higher level of experienced patient- 
centredness (van Empel et al. 2010). We excluded some questions from the categories 
Information (5 out of 11), Communication (1 out of 7) and Respect for patients’ values 
(3 out of 7) because the questions overlapped with specific questions about information 
and communication on TEM. To assure the internal consistency of the subscales and the 
total PCQ-I scale, we computed Cronbach’s alpha coeﬃcients, all were alphas higher than 
0.6 and considered acceptable.
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Wake Forest Trust Scale
The WFTS is a validated instrument measuring patients trust in their physician with 
10 items on a 5-point-Likert scale (‘totally agree’ = 1, to ‘totally disagree’ = 5), e.g. ‘Your 
doctor will do whatever it takes to get you all the care your need’, and ‘You completely 
trust your doctor’s decision about which medical treatments are best for you’. A higher 
score indicates more trust. An overall trust score is obtained by averaging the responses 
(sum of scores/10) (Bachinger, Kolk, and Smets 2009). The reliability of this questionnaire 
was good with Cronbach’s alpha > 0.7 in our sample.
Statistical analyses
The background characteristics, the mean total FertiQol score, and the scores on the 
information provision items between couples who adhered to TEM and couples who 
were exposed to early treatment were compared. We used the t-test for the continuous 
variables and the chi-square test for categorical variables. We performed multilevel 
analyses to take into account the clustering of couples by clinic with compound symmetry 
as covariance structure. First of all, linear mixed models were used to estimate the 
relationship between TEM and the outcome of the total PCQ-I, the seven subscales of the 
PCQ-I, and the WFTS, respectively (dependent variables). Series of multilevel univariate 
analysis were performed with the PCQ-I and the WFTS as the dependent variable. 
All possible confounders acted separately as independent variables. Variables with 
P < 0.20 in the univariate analysis were selected to perform correlation analysis with 
spearman’s rho to evaluate collinearity between the selected characteristics. In case of 
two strongly correlating variables (rho > 0.6), only the clinically most relevant characteristic 
was included in the multivariate analyses. Four highly correlated (R > 0.5) items on 
education and counselling were aggregated (not informed = 0 and informed = 1, SUM/4) 
into one continuous variable ‘the couple was educated on the medical and psychological 
consequences of MAR’ for the multivariate analyses. In addition to adherence to TEM, 
we put the possible confounders in the multivariable analyses. Manual backward 
elimination was used to select confounders with a P-value <0.05, separately for the total 
PCQ-I and the WFTS. The FertiQoL can only be measured in couples with an unfulfilled 
childwish. Therefore, we did a second analysis, which only included the couples with an 
unfulfilled childwish. Analyses were performed with SPSS (version 20.0 for Windows, 
SPSS Inc., Chicago, IL, USA).
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Results
Couple and clinic characteristics
In total, 384 of 544 invited couples completed the questionnaire (response rate 71%). 
Table I presents the background characteristics comparing couples with TEM and couples 
with early treatment. The mean duration between completing the fertility work-up and 
filling in the questionnaire (follow-up period) was similar between both groups (15.5 
months versus 15.0 months). The percentage of couples that went to another clinic 
because they were not satisfied with the care they received or wanted a second opinion 
is comparable between both groups, 4.1% in the group with early treatment versus 4.7% 
in the group with TEM, P = 0.5. Overall, the percentage of couples that were exposed to 
MAR during the follow-up period was significantly lower in couples who adhered to 
TEM of at least 6 months compared with couples exposed to early treatment (IUI (+mild 
ovarian hyperstimulation): 25.8 versus 69.6%, P < 0.01, IVF/ICSI: 6.4 versus 30.4%, P < 0.05). 
The mean prognosis of natural conception is significant higher in couples with TEM 
compared with couples with early treatment, 43.1 versus 39.8%, P < 0.05. Couples who 
adhered to TEM more often had a live birth since the first visit to the clinic or were pregnant 
at time of completing questionnaire, compared with couples with early treatment (64.4 
versus 54.1%, P < 0.05). The clinic characteristics were all comparable between both 
groups.
Information provision
Table II presents couples’ scores on the information provision items. Couples with TEM less 
often received information on the diﬀerence in chances of pregnancy with TEM and 
MAR (42.7 versus 57.5%, P < 0.01), the medical risks of MAR (44.6 versus 73.6%, P < 0.01), 
the higher chance of multiple pregnancy with MAR (54.4 versus 97.3%, P < 0.01), the 
complications in multiple pregnancy (38.5 versus 74.8%. P < 0.01), and the psychological 
consequences of MAR (45.0 versus 60.5%, P < 0.01), compared with couples with early 
treatment. 
PCQ-Infertility
Results in Table III show that there is no univariate association between TEM and the 
outcome of the total scale PCQ-I, couples who adhered to TEM scored 2.28 and couples 
with early treatment 2.29 (OR 1.02; 95% CI 0.96–1.08). We also analysed the seven subscales 
of the PCQ-Infertility, which shows that TEM is positively associated in univariate analyses 
with the subscale ‘Accessibility’ (OR 1.25; 95% CI 1.05–1.49) and ‘Continuity and transition’ 
(OR 1.14; 95% CI 1.02–1.27). The other five subscales were comparable between both 
groups. 
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Tabel I   Couple and clinic characteristics, comparing couples who adhered to TEM and 
couples who were exposed to early treatment
Characteristics Early treatment
N=148 (39.5%)
TEM 
N=236 (61.5%)
At first visit to clinic: 
Mean female age, years (SD) 30.5 (3.4) 30.4 (3.2)
Mean  male  age, years (SD) 33.1 (4.7) 33.1 (4.6)
Non-Dutch ethnic background a 22 (14.9%) 23 (9.7%)
Education level per couple:b High 105 (71.0%) 173 (73.3%)
 Medium/Low 43 (29.0%) 63 (26.7%)
Socio-economic status: High 23 (15.8%) 29 (12.5%)
 Medium 105 (71.9%) 177 (76.3%)
 Low 18 (12.3%) 26 (11.2%)
After finalizing fertility work-up:
Type of infertility: Primary 102 (68.9%) 148 (62.7%)
 Secondary 46 (31.1%) 88 (37.3%)
Mean duration of infertility in years (SD) 1.45 (0.6) 1.34 (0.5)
Mean prognosis of natural conception  (SD) 39.8% (8.2) 43.1% (9.0)*
Prognosis calculated by physician 98 (66.2%) 157 (66.5%)
Expectant period of 6-12 months advised (TEM advised) 37 (25.0%) 186 (78.8%)*
At moment of completing questionnaire: 
Mean duration follow up (month [range])c 15.0 [5-25] 15.5 [5-25]
Type of treatment last received:
   None 0 157 (66.5%)*
   IUI with or without mild ovarian hyperstimulation 103 (69.6%) 61 (25.8%)
   IVF/ICSI 45 (30.4%) 15 (6.4%)
Mean no. of treatment cycles received during follow up:
   IUI with or without mild ovarian stimulation (SD) 3.8 (2.4) 0.86 (1.7)*
   IVF/ICSI (SD) 0.30 (0.7) 0.03 (0.3)*
Live birth achieved or currently pregnant d 80 (54.1%) 152 (64.4%)*
FertiQol [range] (only if childwish not  yet fulfilled ) 68.8 [35-91] 65.6 [32-97]
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Tabel I  Continued
Characteristics Early treatment
N=148 (39.5%)
TEM 
N=236 (61.5%)
Clinic characteristics 
Academic clinic 54 (36.5%) 81 (34.4%)
Type of clinic (IVF facilities): None 40 (27.0%) 61 (25.8%)
 Intermediate 70 (47.3%) 124 (52.5%)
 Fully licensed 38 (25.7%) 51 (21.6%)
Fertility doctor present 106 (71.6%) 180 (76.3%)
Specialized fertility nurse present: 119 (80.4%) 176 (74.6%)
Local protocol on expectant management available 137 (92.6%) 226 (95.8%)
Digital access to personal  medical record 5 (3.4%) 14 (5.9%)
a:  Ethnic background of the couples was determined by the origin of both partners: Dutch = one or both 
partners are of Dutch origin; non-Dutch= both partners are not of Dutch origin
b:  Education level of the couples was determined by the highest education level of both partners: Primary or 
lower vocational education; intermediate = secondary or intermediate vocational education; High = 
higher professional education or university.
c:  Follow up: (date finalizing fertility work-up until  date entering data questionnaire in SPSS) – 1 month.
d:  Fulfilled child wish: The woman is currently pregnant (at time of completing the questionnaire) or had a live 
birth since the first visit to the clinic.
*P<0.05
Tabel II   Education and counselling on TEM, compared between couples exposed to 
early treatment and couples who were not (TEM). 
Items on education and counselling Couples with 
overtreatment
N=148
Couples with
TEM
N=236
TEM was discussed during 1st visit 101 (68.2%) 173 (73.6%)
Received explanation on the items included in  
the prognostic model
99 (66.9%) 150 (63.8%)
Couple used the prognostic model themselves. 19 (12.9%) 38 (16.2%) 
Chances of pregnancy compared for TEM and MAR. 88 (57.5%) 100 (42.7%)*
The couple was educated on:
- Risks of MAR 109 (73.6%) 103 (44.6%)*
- Multiple pregnancy chance 144 (97.3%) 126 (54.5%)*
- Complications in multiple pregnancy 110 (74.8%) 89 (38.5%)*
- Psychological consequences of MAR 89 (60.5%) 104 (45.0%)*
*P<0.05
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Multivariable analyses
Table IV shows the results of the multivariable analyses. TEM has no significant association 
with the PCQ-I score after adjustment for case-mix. Confounders for a significantly higher 
outcome of the PCQ-I are fulfilment of childwish, higher female age, TEM was discussed 
during the first visit to the clinic, and the education on medical and psychological 
consequences of MAR. A lead physician for each couple in a clinic was negatively 
associated with the PCQ-I score. The multivariate analysis that only includes couples with 
an unfulfilled childwish, shows that a higher score on the FertiQol, and education of the 
couple on the psychological consequences of MAR were significantly associated with a 
higher outcome of the PCQ-I. A lead physician for each couple in a clinic and the presence 
of a local protocol were negatively associated with the PCQ-I score.
Tabel III   Couples scores in the patient-centeredness of fertility care (PCQ-Infertility)  
and patients’ trust in the physician (Wake Forest Trust Scale) questionnaires 
according to whether they had TEM or received early treatment and  
the association of the scores with TEM expressed as the odds ratio (OR)  
from multilevel univariate analyses
Experience with care: Couples with
overtreatment
N=148
Couples with 
TEM
N=236
Difference
Patient-centeredness of care: Mean (SD) Mean (SD) OR [95% CI]a
PCQ-Infertility total score [0-3] 2.28 (0.38) 2.29 (0.39) 1.02 [0.96-1.08]
     Accessibility 2.35 (0.79) 2.58 (0.61) 1.25 [1.05-1.49]
     Information 1.95 (0.71) 1.83 (0.78) 0.90 [0.78-1.03]
     Communication 2.67 (0.50) 2.68 (0.48) 1.01 [0.92-1.11]
     Patient Involvement 2.48 (0.61) 2.49 (0.56) 1.02 [0.91-1.14]
     Respect for patient’s values 2.22 (0.82) 2.28 (0.77) 1.06 [0.94-1.20]
     Continuity and transition 2.06 (0.57) 2.16 (0.57) 1.14[1.02-1.27]
     Competence 2.46 (0.39) 2.45 (0.41) 1.00 [0.92-1.08]
Trust in Gynaecologist/fertility doctor:
Wake Forest Trust Scale [0-5] 4.10 (0.66) 4.10 (0.86) 0.97 [0.89-1.06]
a OR > 1 means a positive association with a higher PCQ-I or WFTS score.
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Wake Forest Trust Scale
Table III shows that there is no univariate association between TEM and the outcome of 
the WFTS. Couples who adhered to TEM and couples with early treatment had similar trust 
in their physician (WFTS score 4.1 (OR 0.97; 95% CI 0.89–1.06)).
Multivariate analyses
Table V shows the results of the multivariate analyses. It shows that TEM has no significant 
association with the WFTS score after adjustment for case-mix. Confounders for a 
significantly higher outcome of the WFTS are education on medical and psychological 
consequences of MAR, a clinic with none or intermediate IVF facilities (compared with fully 
licensed clinics), and the presence of a local protocol on expectant management. The 
second multivariable analyses (only couples with unfulfilled childwish) show that a higher 
score on the FertiQol, educating the couple on the psychological consequences of MAR, 
and a higher male age are significantly associated with a higher outcome of the WFTS.
Tabel IV   Case-mix adjusted association of TEM on the patient-centeredness of 
fertility care (PCQ- Infertility) in multilevel multivariate analyses. 
Determinants All couples 
N=384
Couples with an 
unfulfilled childwish 
N=150a
OR [95% CI]b P OR [95% CI]b P
TEM 1.04 [0.98-1.10] 0.20 1.02 (0.92-1.12] 0.57
Higher female age (per year)c 1.02 [1.01-1.03] <0.01 - N.S.
Low/medium educational level coupled 1.13 [1.05-1.21] <0.01 - N.S
Fulfilment of childwish 1.10 [1.03-1.17] <0.01 Non included
Higher FertiQol score (per point) Not included 1.01 [1.01-1.02] <0.01
TEM was discussed during first visit 0.11 [0.01-0.21] 0.03 - N.S.
Educated on  the consequences of MAR 1.29 [1.20-1.40] <0.01 1.30 [1.17-1.44] <0.01
None/intermediate IVF clinicse - N.S 1.23 [1.06-1.42] <0.01
a  The FertiQol can only be measured in women with an unfulfilled child wish. Therefore it is not possible to 
put the variables ‘fulfilment of childwish’ and ‘FertiQol score’ in the same model.
b  OR > 1 means a positive association with a higher PCQ-I score
c  Per year increase in the female age the chance of one point higher on the PCQ-I score [range 0-3] increases 
with an OR of 1.03.
d  Compared to couples with a high educational level.
e  Compared to fully licensed IVF clinics
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Discussion
This retrospective study shows that couples with unexplained infertility, who adhered to 
TEM evaluated their experiences with the quality of care in a similar way as couples who 
had treatment within 6 months after the basic fertility work-up. Furthermore, we did not 
find any associations between adherence to TEM and the patients’ trust in their physicians.
 The impact of expectant management on experience with care has to our knowledge 
not been investigated before in fertility care or in any other fields of medicine. Therefore, 
it is hard to compare our main outcome to other research. However, when comparing the 
outcome of the PCQ-I of our study population with previous research it is striking that our 
study population scores higher on the total score and almost all subscales of the PCQ-I 
(van Empel et al. 2010). The only subscale that scored lower is ‘Information’. This result 
underlines the previously mentioned barrier for TEM, i.e. the lack of patient information 
material for couples eligible for TEM (van den Boogaard et al. 2012).
 Previous research on the patient-centredness of fertility care has been focused on 
clinical and patient characteristics that influence the experience with care (Mourad et al. 
2010; Hermens et al. 2011; van Empel et al. 2011; Aarts, van den Haak, et al. 2012). Our 
Tabel V   Case-mix adjusted association of TEM on the patients’ trust in their physician 
(Wake Forest Trust Scale) in multilevel multivariate analyses. 
Determinants All couples 
N=384
Couples with an 
unfulfilled childwish 
N=150a
OR [95% CI]b P OR [95% CI]b P
TEM 1.01 [0.91-1.12] 0.85 0.85 [0.70-1.04] 0.11
Higher male age (per year)c - N.S. 1.03 [1.01-1.05] <0.01
Low/medium educational level coupled 1.14 [1.01-1.32] 0.047 - N.S
Higher FertiQol score Not included 1.02 [1.01-1.03] <0.01
Education on  the consequences of MAR 1.29 [1.09-1.53] <0.01 1.31[1.00-1.72] 0.047
None/intermediate IVF  clinicse 1.18[1.01-1.38] 0.02 - N.S.
 
a  The FertiQol can only be measured in women with an unfulfilled child wish. Therefore it is not possible to 
put the variables ‘fulfilment of childwish’ and ‘FertiQol score’ in the same model.
b  OR > 1 means a positive association with a higher WFTS score
c  Per year increase in the male age the chance of one point higher on the WFTS scale [range 1-5] increases 
with an OR of 1.03.
d  Compared to couples with a high educational level.
e  Compared to fully licensed IVF clinics
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findings in the multivariate analyses are partly congruent with the characteristics they 
found to be associated with experiences with care. We found four characteristics to be 
positively associated with both the patient-centredness of care and the patients’ trust in 
their physician: low/medium educational level, higher FertiQol score, type of clinic with 
no/intermediate IVF facilities, and education on the medical and psychological 
consequences or MAR. Last mentioned has the strongest association with experiences 
with care. This underlines the importance of education and information for these couples. 
However, if this also positively influenced adherence to TEM cannot be derived from our results, 
as couples with early treatment more often received information on the medical and 
psychological consequences of MAR. Since we do not know at what time this information 
was provided, before or after the choice of expectant management or fertility treatment 
or at the commencement of a fertility treatment, we cannot conclude from our results 
whether more or less information has an association with adherence to TEM. On the other 
hand, we already identified the lack of information material and counselling as a main 
barrier for adherence to TEM (van den Boogaard et a. 2011a,b) .
 This study has some limitations, mainly due to the retrospective design of the study. 
First, there is the possibility of recall bias when completing the questionnaire. For some 
couples, the time between the fertility work-up and filling in the questionnaire (follow-up 
period) was as long as 2 years. Despite the fact that our results show that the mean 
follow-up period is equal between couples that adhered to TEM and couples exposed to 
early treatment we do not know how their experiences with care might have changed 
over time. It is possible that during the expectant period couples had diﬀerent experiences 
with their care than they recalled at the time of completing the questionnaire. The second 
limitation is that the PCQ-I is specifically developed to measure experiences with the 
patient- centredness during fertility treatment. This questionnaire has not been validated 
for our specific study population, i.e. couples eligible for TEM. Many couples that 
completed the questionnaire for our study were not undergoing a fertility treatment at 
that time. We assured the internal consistency by computing Cronbach’s alpha coeﬃcients, 
all were higher than 0.6. However, how the diﬀerent study populations aﬀected the results 
of the PCQ-I is not known. The third limitation is that we specifically looked at TEM and 
experiences with care in the Netherlands. How our results will translate to other countries 
that have recommendations on TEM is diﬃcult to say (Farquhar et al. 2011; Fields et al. 
2013). The use of clinical guidelines is common practice in Dutch fertility care and most 
fertility treatments are reimbursed (NVOG 2010). In countries where providing fertility care 
according to guidelines is uncommon and the monetary or cultural incentive to start 
treatment is diﬀerent, it might be harder to advise TEM without negatively aﬀecting 
experiences with care.
 Otherwise, this study has several strengths. We conducted a large national multicentre 
study in almost one third of all Dutch fertility clinics. This ensures representativeness of 
Dutch fertility care. Furthermore, we used validated questionnaires to evaluate experiences 
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with care. This minimizes measurement errors and makes our outcomes comparable to 
other studies investigating experiences with care. Finally, the extent to which guideline 
adherence, specifically TEM, influences experiences with care has not been researched in 
fertility or other health care before. The eﬀect guideline adherence has on experiences 
with care is a very important aspect to improve guideline implementation. Physicians are 
given feedback on what aﬀect TEM actually has on the patients’ experiences with care.
 Our results underline that Dutch physicians should not be hesitant to advise TEM if 
they properly manage the couples expectations on TEM and fertility treatments. How you 
communicate and inform couples is very important, if this goes well, patients will 
experience better quality of care. This is congruent with the barriers mentioned earlier. 
Managing the expectations of couples on TEM and fertility treatments from the first visit, 
counselling and informing them on TEM, and providing more information material (paper 
or digital) could not only increase adherence to TEM but also provide better experiences 
with the quality of care. This knowledge is also important for other countries that make 
guideline recommendations on TEM. Results of this study may help to overcome barriers 
that professionals might have to advise an expectant management. However, as 
mentioned before, our study design was retrospective and therefore our results have to 
be interpreted carefully. Prospective research on couples undergoing TEM have to be 
performed to provide more detailed insight in the patients’ experiences with the decision 
making process and subsequently the expectant period.
 In conclusion, a tailored expectant management of at least 6 months in couples with 
unexplained infertility is not associated with the overall experiences with the quality of 
care or their trust in their physician. However, prospective research could provide more 
information on the cause-eﬀect relationship between patient experiences and TEM. 
Furthermore, tackling the barriers surrounding TEM, i.e. better counselling and more 
patient information material, could further improve patient experiences with quality of 
care for couples who are advised TEM.
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Abstract
Background: Prognostic models in reproductive medicine can help to identify subfertile 
couples who would benefit from fertility treatment. Expectant management in couples 
with a good chance of natural conception, i.e. tailored expectant management (TEM), 
prevents unnecessary treatment and is therefore recommended in international fertility 
guidelines. However, current implementation is not optimal, leaving room for improvement. 
Based on barriers and facilitators for TEM that were recently identified among professionals 
and subfertile couples, we have developed a multifaceted implementation strategy. 
The goal of this study is to assess the eﬀects of this implementation strategy on the 
guideline adherence on TEM.
Methods/design: In a cluster randomized trial, 25 clinics and their allied practitioners 
units will be randomized between the multifaceted implementation strategy and care as 
usual. Randomization will be stratified for in vitro fertilization (IVF) facilities (full licensed, 
intermediate/no IVF facilities). The eﬀect of the implementation strategy, i.e. the percentage 
guideline adherence on TEM, will be evaluated by pre- and post-randomization data 
collection. Furthermore, there will be a process and cost evaluation of the strategy. 
The implementation strategy will focus on subfertile couples and their care providers i.e., 
general practitioners (GPs), fertility doctors, and gynecologists. The implementation 
strategy addresses three levels: patient level: education materials in the form of a patient 
information leaflet and a website; professional level: audit and feedback, educational 
outreach visit, communication training, and access to a digital version of the prognostic 
model of Hunault on a website; organizational level: providing a protocol based on the 
guideline. The primary outcome will be the percentage guideline adherence on TEM. 
Additional outcome measures will be treatment-, patient-, and process-related outcome 
measures.
Discussion: This study will provide evidence about the eﬀectiveness and costs of a 
multifaceted implementation strategy to improve guideline adherence on TEM.
Trial registration: www.trialregister.nl NTR3405. This study is sponsored by ZonMW. 
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Introduction
Subfertility is defined as the absence of conception after one year of unprotected 
intercourse (Zegers-Hochschild et al. 2009). It aﬀects approximately 9% of all couples of 
reproductive age (Boivin et al. 2007; Gnoth et al. 2003). In approximately 50% of the 
couples, no major cause is found after the basic fertility work-up (ESHRE Capri Workshop 
Group 2009). In those couples, the chance of natural conception can be calculated via 
validated prognostic models (Hunault et al. 2004; van der Steeg et al. 2007). If the chance 
of natural conception within one year is good, meaning a probability of 30% or more, 
expectant management for 6 to 12 months is equally eﬀective as treatment (Steures et al. 
2006). Because this expectant management is restricted to couples with a good prognosis, 
we have called it tailored expectant management (TEM). 
 European Society of Reproductive Medicine (ESHRE) and National Institute of Health 
and Clinical Excellence (NICE) guidelines on the management of infertility both emphasize 
that couples should not be exposed to unnecessary risks or ineﬀective treatments and 
encourage that each subfertile couple should receive information about the estimate of 
their chance of natural conception (ESHRE 2001; NICE 2004). In the Netherlands, the 
national network guideline on infertility for gynaecologists and general practitioners (GPs) 
explicitly recommends the use of prognostic models and subsequent TEM for couples 
with unexplained or mild infertility (NVOG 2010). However, at this moment, implementation 
of TEM is poor. A recent Dutch multicenter cohort study showed overtreatment in 36% of 
the couples, i.e., 36% of the couples with a good prognosis eligible for TEM (>30% chance 
of natural conception in one year) already started medically assisted reproduction (MAR) 
(van den Boogaard et al. 2011a).
 This overtreatment in subfertile couples is worrisome for several reasons. First, fertility 
treatment still leads to a considerable number of multiple pregnancies, which are 
associated with a higher morbidity and mortality in both mothers and neonates 
(Helmerhorst et al. 2004). Second, fertility treatment carries a significant physical and 
psychological burden and accompanying productivity loss (Verberg et al. 2008; Verhaak et 
al. 2002; Verhaak et al. 2007; Bouwmans et al. 2008). Third, fertility treatment and its 
complications are expensive and put considerable financial strain on societies where MAR 
is reimbursed or on the subfertile couples in societies where MAR is not or only partially 
reimbursed (Custers et al. 2012). 
 The first step to improve guideline adherence on TEM and reduce overtreatment is to 
gain insight into barriers and facilitators for implementation of TEM and MAR reduction. 
Subsequently a tailored implementation strategy can be developed targeting obstacles 
to change, if necessary at diﬀerent levels (Curran et al. 2008; Grol and Grimshaw 2003). In a 
previous qualitative and quantitative study among patients and professionals, the main 
barriers among subfertile couples were lack of confidence in natural conception, 
perception that expectant management is a waste of time, inappropriate expectations 
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prior to the first secondary care consultation, and an overestimation of the success rates of 
treatment. Both couples and professionals regarded the lack of patient information 
materials as an important barrier. Among the professionals, limited knowledge about 
prognostic models and limited communication skills to convince the couple, both leading 
to a decision in favor of treatment, were recognized as main barriers. Facilitators 
experienced by the professionals were better management of patients’ expectations, 
local consensus, and the presence of a local protocol and local fertility meetings (van den 
Boogaard et al. 2011a,b).
 A multifaceted implementation strategy to improve guideline adherence on TEM has 
now been developed based on these data. The aim of this study is to evaluate eﬀectiveness 
and costs of this implementation strategy in a cluster randomized trial.
Methods
Setting
In the Netherlands, subfertile couples are usually referred by the GP to secondary care. 
GPs usually perform only limited basic fertility workup or no workup at all and they do 
not prescribe fertility drugs. Secondary and tertiary care is provided by three diﬀerent 
types of fertility clinics based on the kind of treatment they oﬀer. Initial fertility assessment, 
ovulation induction (OI), and intra-uterine insemination (IUI) are carried out in all Dutch 
clinics. In vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) treatments are 
only carried out in intermediate and licensed fertility clinics. Every Dutch citizen has a 
basic insurance coverage, which fully reimburses all treatment cycles of OI and IUI, with or 
without controlled ovarian hyperstimulation, as well as a maximum of three IVF or ICSI 
cycles.
Study design
We propose a cluster randomized trial in 25 clinics and their allied GP units with an eﬀect, 
process, and economic evaluation alongside the trial.
Randomization
The 25 participating clinics and their allied practitioners units will be randomized between 
the multifaceted implementation strategy and care as usual. Randomization will be 
stratified for IVF facilities (full licensed, intermediate/no IVF facilities) and will take place 
after all clinics have approval to participate. Randomization will be done by an independent 
physician and will be computer-generated. Results of the randomization will be personally 
communicated to all participating clinics.
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Effectiveness
For the eﬀectiveness, a baseline measurement will be performed in all participating 
clinics, including guideline adherence on TEM, and a range of organizational, professional, 
and patient characteristics (see outcome measures). Following baseline measurement, the 
multifaceted implementation strategy will be applied in the intervention clinics. After ten 
to twelve months of intervention exposure, the after measurement will be performed 
again in all 25 participating clinics.
Process evaluation
A process evaluation, according to Hulscher et al. (Hulscher et al. 2003), will be performed 
during and after the intervention to investigate the feasibility of the implementation 
strategy.
Intervention
The multifaceted implementation strategy, based on a barrier analysis among professionals 
and patients, will focus on three diﬀerent levels: patient, professional, and organizational 
level (van den Boogaard et al. 2011b). The three levels and all associated tools are successively 
described here.
Patient level
We will develop patient educational materials in three diﬀerent forms, a patient information 
leaflet, posters, and a website.
 The patient information leaflet will provide general background information on the 
fertility work-up procedure, prognostic factors that influence the chance on spontaneous 
conception, (dis)advantages of expectant management, and (dis)advantages of fertility 
treatment. In every intervention clinic, posters with information on the prognostic model 
and expectant management will be placed in the waiting areas. In the leaflet and on the 
posters, patients can find a code which is needed to gain access to the website. There is a 
diﬀerent code for each intervention clinic. The website will give more individualized 
information by access to a digital version of the prognostic model of Hunault (Hunault et 
al. 2004). Herewith, patients can calculate their chances of natural conception within one 
year and experience the influence of altering characteristics. It will also provide additional 
information on the basic fertility workup, the chance of natural conception versus the 
chance of conception after fertility treatment, (dis)advantages of expectant management, 
and (dis)advantages of fertility treatment. Furthermore, it advises patients what they can 
do to optimize their chances of spontaneous conception during the expectant 
management period, e.g., information on intercourse timing and frequency, weight 
regulation, and lifestyle. This information will be in accordance with the information 
provided in the Dutch national network guideline on infertility (NVOG 2010).
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This information material will be developed according to the International Patient Decision 
Aids Standards criteria for the dimensions ‘information’ and ‘probabilities’ (Elwyn et al. 2009), 
as well as according to the American Medical Association criteria (Winker et al. 2000).
Professional level (e.g., gynecologists (in training), fertility doctors, and GPs)
The strategy regarding the professionals contains audit and feedback, an education 
outreach visit, supportive consultation tools, and a video-based communication training.
The audit and feedback of the current care will consist of a feedback report based on the 
results of the baseline measurement. This feedback will report clinic’s guideline adherence 
on TEM in a twelve-month period prior to the randomization compared with the other 
participating clinics. It will give insight in how they are adhering to the guideline 
concerning the policy for couples with unexplained or mild infertility, e.g., use of prognostic 
models and subsequent TEM in case the prognosis is good. Furthermore, the report will 
provide feedback on patient-related measures like general experiences with fertility care, 
specific experiences with the prognostic model and TEM, quality of life, and trust in their 
physician.
 In addition to this audit and feedback, an educational outreach visit will take place 
with fertility doctors and gynecologists (in training), in which background information 
about how and when to use the prognostic model of Hunault, and subsequent TEM will 
be given and in which the results of the baseline measurement and local barriers will be 
discussed. The result of this visit will be an individualized action plan per clinic.
 The supportive consultation tools are developed containing a digital version of the 
prognostic model of Hunault on a website and we will provide professionals with a 
summary of the guideline on TEM in the form of a pocket card.
 Finally, a video-based training strategy will be provided to improve the communication 
techniques to counsel the patients on their chance of spontaneous conception versus 
conception after treatment, the (dis)advantages of expectant management versus fertility 
treatment, and on the reason for TEM (i.e., making clear it is not a waste of time). Consistent 
with functional models of medical communication described in the field (de Haes and 
Bensing 2009), the LEAPS Framework, a pneumonic for Listen, Educate, Assess, Partner 
and Support will be used to develop the intervention (Roter et al. 2012).
Organizational level (GP units and fertility clinics)
During the educational outreach visits an example of an up-to-date local protocol will be 
oﬀered to the fertility clinics that do not already have an updated protocol available. This 
local protocol will be based on the Dutch network guideline on infertility, and it will focus 
on the initial fertility assessment (diagnostics), identification of patients with mild or 
unexplained infertility, the use of the prognostic model of Hunault, and TEM (NVOG 2010). 
The clinics can adjust this protocol to their own lay out and they can distribute it either in 
the form of a hard copy or digital copy, depending on the preference of the professionals.
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Furthermore, we will provide the GPs allied to the intervention clinics with feedback on their 
referral behavior, e.g., were patients referred according to the guideline recommendations.
Study population/participants
To include a representative patient group, we will select potential participating couples 
retrospectively in each clinic by means of the clinics’ financial registration database 
(Diagnosis Treatment Combination code). In this nationwide registration system, patients 
undergoing diagnostics or treatment for infertility are identified with a specific fertility 
code (F-code). For the baseline measurement, we will invite couples that were given the 
code for new fertility patients (F-11) between February 2011 to March 2012 to participate in 
this study. For the after measurement, we will invite the couples that were given the F-11 code 
during the ten- to twelve-month intervention period. We will invite couples to participate 
by giving their permission for a medical record study and filling out a questionnaire.
 The couples are eligible to participate when they have been diagnosed with 
unexplained or mild infertility, have a good prognosis (>30%) according to Hunault’s 
prediction model, did not have previous fertility treatment, and the female age is between 
18 and 38 years. Couples with bilateral tubal pathology, severe male factor, or anovulation 
are not eligible to participate.
Sample size
The expected adherence to TEM in the control arm is estimated based on previous studies 
at 60% (van den Boogaard et al. 2011a). To increase this to 80% with an intra-class correlation 
(ICC) of 0.1, alpha at 5%, comparing two strategies, we estimate that with 25 clusters we 
would need a total sample size of 450 patients. This means we need to include 15 to 20 
patients per clinic in the baseline as well as in the after measurement.
Outcome measure
Primary outcome effectiveness
The primary outcome measure of the proposed study for eﬀectiveness will be the 
guideline adherence rate on TEM: the percentage of couples that are eligible for TEM 
(couples with mild or unexplained infertility with a prognosis of >30% of natural 
conception within one year) who actually agree upon the expectant management period 
of at least six months after the initial fertility assessment is concluded.
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Secondary outcomes effectiveness
1. Treatment-related measures: time to the start of fertility treatment and the number 
and types of fertility treatments that the couples received.
2.  Treatment outcome-related measures: (ongoing) pregnancy rate, miscarriage, extra 
uterine gravidity, multiple pregnancy rate, and time to pregnancy.
3.  Patient-related outcome measures : general experiences with fertility care such as 
information provision, respect for patients’ values and accessibility of care (to be 
measured with Patient Centeredness Questionnaire Infertility) (van Empel et al. 2010), 
specific experiences with the prognostic model and TEM, quality of life (estimated by 
FertiQoL) (Aarts et al. 2011), and trust in physician (measured by Wake Forest Trust 
Scale) (Bachinger et al. 2009).
4.  Process related measures: percentage transition of patients to another fertility center.
5.  Background characteristics that could influence guideline adherence (e.g., age, 
referral status, type of infertility, duration and cause of infertility).
Outcomes process evaluation
1.  Actual ‘exposure’ of patients and physicians to the diﬀerent elements of the 
implementation strategy.
2.  How frequently the website has been visited by patients and physicians.
3.  Experiences of patients and physicians with the diﬀerent elements of the 
implementation strategy.
Data collection
Effectiveness
Data collection will be performed from medical records and a patient questionnaire.
 Data abstraction from medical records will be performed using a standardized audit 
form. We will collect the background characteristics, treatment related measures, treatment 
outcome-related measures, and process-related measures.
 The questionnaire will be divided into four parts. The first part consists of background 
questions (e.g., highest educational level, country of birth). The second part regards 
the patients’ experience with the prognostic model and TEM as well as the patients’ 
trust in both the GP as well as the fertility doctor/gynecologist. The third part is the Patient- 
Centeredness Questionnaire-Infertility, a validated instrument measuring patient- centeredness 
of fertility care by asking about patients’ experiences with care. The last part is the FertiQol 
questionnaire, We will only use the Core module, which involves questions about mind- 
body, emotional, relational, and social aspects.
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Process evaluation
For the process evaluation, we will approach the local investigator during the intervention 
period to provide us with feedback about the implementation strategy. We will also keep 
track of how often the website is visited by logging data. At the end of the ten- to 
twelve-month intervention period, we will evaluate the strategy by means of a professional 
questionnaire and an addendum to the patients’ questionnaire in the after measurement.
Data analysis
To analyze the eﬀectiveness of the implementation strategy, descriptive statistics and 
multilevel analysis will be used. The statistical analysis will be performed using SPSS 
version 16.0 for Windows. The main outcome, the diﬀerence in baseline and after- 
measurement scores in guideline adherence on TEM, between the intervention and 
control group will be analyzed with the chi-square test. Descriptive analysis will be used to 
assess the diﬀerence in treatment-related, treatment outcome-related, and patient-related 
measurements between the intervention and control group. Furthermore, time to 
pregnancy and time to start fertility treatment will be analyzed using Kaplan Meier analysis 
with log-rank test. Univariate and subsequent multivariate logistic and Cox regression 
analyses will be used to analyze the relative contribution of the implementation strategy 
versus other predictive factors for guideline adherence on TEM.
Economic evaluation
We plan an economic evaluation alongside the clinical trial to investigate the cost- 
eﬀectiveness of the multifaceted implementation strategy to improve guideline 
adherence on TEM. This economic evaluation compares the multifaceted implementation 
strategy to usual care and is done from a societal perspective. A distinction will be made 
between costs of the development and introduction of the implementation strategy and 
the costs of maintaining the implementation strategy. The input of resources is assessed 
by collecting volumes of consumed resources (e.g., medical interventions like number IUI 
and IVF cycles and treatment related outcomes like ovarian hyperstimulation syndrome 
and multiple pregnancies) and multiplied by reported or guideline prices according to 
Hakkaart-van Roijen et al. (Hakkaart-van Roijen, Bouwmans 2010). To assess non-medical 
and indirect costs, we will build on the data collection and cost calculation frameworks 
from previous cost studies on IUI and IVF (Haagen et al. 2012). The incremental costs, 
expressed as costs/percentage guideline adherence to TEM, are determined by the 
diﬀerences in resource consumption and adherence rates between the intervention 
group and the control group. Robustness of the results (costs and health outcomes) 
for various assumptions and parameters estimates will be explored in sensitivity analyses 
and visualized in incremental cost-eﬀectiveness ratio graphs and cost-eﬀectiveness 
acceptability curves.
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Trial status
We are currently performing the baseline measurement in all participating clinics.
Discussion
This cluster RCT will compare a multifaceted implementation strategy to usual care on 
improving guideline adherence to TEM. If TEM is applied more frequently, it will reduce 
the number of performed IUI, IVF, and ICSI cycles, the incidence of treatment related 
complications (e.g., ovarian hyperstimulation syndrome and multiple pregnancies), and 
we expect it to reduce the physical and psychological burden. As a consequence, the 
costs for fertility treatment will decrease.
 Many diﬀerent interventions are available to implement guidelines, either focusing 
on professionals, patients, teams or organizational factors, and with variable eﬀects. A 
systematic review on interventions to improve guideline implementation showed that 
interventions tailored to prospectively identified barriers are more likely to improve 
professionals practice than only dissemination of guidelines (Grimshaw et al. 2004). The 
strategy that we developed is tailored to the recently identified barriers and facilitators for 
TEM, thus more likely to improve professionals practice, in this case, adherence to the 
guideline. Moreover, in general, combined interventions are believed to be more eﬀective 
than single interventions (Grimshaw et al. 2004). Therefore, to increase the potential 
eﬀectiveness of our implementation strategy, we developed a multifaceted intervention 
that targets the specific barriers for TEM at diﬀerent levels.
 For the specific interventions that will be used in the multifaceted implementation 
strategy, the review showed that audit and feedback and educational outreach visits can 
be eﬀective (small to moderate) (Grimshaw et al. 2004; Ivers et al. 2012; O’Brien et al. 2007) 
and patient-directed interventions such as educational materials may result in moderate 
to large eﬀects to increase adherence to recommended care (Grimshaw et al. 2004). 
Moreover, it has been proven that subfertile patients appreciate education and improved 
knowledge, and it has also been demonstrated to influence their healthcare decisions 
(Mourad et al. 2011; Kreuwel et al. 2012). In a systematic review, only the eﬀect of paper 
version materials was studied. However, because surveys have shown that online health 
information retrieval and eHealth activities are becoming increasingly common, especially 
within young and highly educated subfertile patients (Aarts et al. 2012; den Breejen et al. 
2012; Weissman et al. 2000; Haagen et al. 2003), we decided to oﬀer the patient information 
materials in both paper and digital forms (i.e., website and application). By doing so, and 
thus tailoring the patient-directed intervention to the infertility population, we hope to 
increase the eﬀect of this intervention even more.
 Aside from the multifaceted and barrier tailored aspects of the strategy, this study has 
several more strengths. First, the number of participating clinics is a great strength of this 
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study. One-quarter of all Dutch clinics from all over the country participate in this study, 
ensuring the representativeness of the Dutch infertility population as well as the 
professionals who provide fertility care. Second, the process evaluation provides us with 
more information on the eﬀectiveness and usefulness of the diﬀerent interventions used 
in the strategy and not only of the multifaceted implementation strategy as a whole. We 
know that the multifaceted aspect of the intervention does not necessarily make the 
intervention more eﬀective, therefore we need to assess the eﬀectiveness of each 
individual intervention separately as well (Kreuwel et al. 2012). This is of great value for 
further implementation research and development of implementation strategies. 
Furthermore, if the multifaceted implementation strategy proves to be eﬀective, it could 
also be generalized to improve implementation of other guidelines. Third, the cost 
evaluation that will take place is very important from a societal aspect. Healthcare is 
becoming increasingly expensive, and cost reduction is a very important and common 
topic in most governments and healthcare institutes. This economic evaluation will 
provide further information on how we can reduce costs in healthcare by following the 
current and already existing guidelines for best practice and care.
 A possible limitation of the study is the chance of contamination of the GPs between 
the intervention and control group. GPs can refer patients to more than one clinic; this 
makes it possible that a GP who is allied to an intervention clinic can also refer patients to 
a control clinic. However, we think that the occurrence of actual contamination will be 
very small because the participating clinics are very well spread over the country. In case 
contamination of GPs does occur, we expect the eﬀect on the outcome to be very small 
or even undetectable because the multifaceted intervention strategy is mostly targeted 
at the secondary and tertiary care.
 In summary, the main contribution of this study is that it seeks to identify the most 
eﬀective strategy for implementing the guideline on TEM in subfertile couples. Ensuring 
the appropriate uptake of guideline recommendations by both professionals and patients 
will improve the care for these patients.
Abbreviations
TEM: Tailored Expectant Management
ESHRE: European Society of Reproductive Medicine
NICE: National Institute of Health and Clinical Excellence
NVOG: Dutch Society for Obstetrics and Gynecology
MAR: Medically Assisted Reproduction.
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Abstract
Study question: What is the eﬀectiveness of a multifaceted implementation strategy 
compared to usual care on improving the adherence to guideline recommendations on 
expectant management for couples with unexplained infertility?
Summary answer: The multifaceted implementation strategy did not significantly 
increase adherence to guideline recommendations on expectant management compared 
to care as usual.
What is known already: Intrauterine insemination (IUI) with or without ovarian hyper-
stimulation has no beneficial eﬀect compared to no treatment for 6 months after the 
fertility work-up for couples with unexplained infertility and a good prognosis of natural 
conception. Therefore, various professionals and policy makers have advocated the use of 
prognostic profiles and expectant management in guideline recommendations.
Study design, size, duration: A cluster randomized controlled trial in 25 clinics in the 
Netherlands was conducted between March 2013 and May 2014. Clinics were randomized 
between the implementation strategy (intervention, n = 13) and care as usual (control, 
N = 12). The eﬀect of the implementation strategy was evaluated by comparing baseline 
and eﬀect measurement data. Data collection was retrospective and obtained from 
medical record research and a patient questionnaire.
Participants/materials, setting, methods: A total of 544 couples were included at 
baseline and 485 at the eﬀect measurement (247 intervention group/238 control group).
Main results and the role of chance: Guideline adherence increased from 49 to 69% 
(OR 2.66; 95% CI 1.45–4.89) in the intervention group, and from 49 to 61% (OR 2.03; 95% 
CI 1.38–3.00) in the control group. Multilevel analysis with case-mix adjustment showed 
that the diﬀerence of 8% was not statistically significant (OR 1.31; 95% CI 0.67–2.59). The 
ongoing pregnancy rate within six months after fertility work-up did not significantly 
diﬀer between intervention and control group (25% versus 27%: OR 0.72; 95% CI 0.40–1.27).
Limitations reasons for caution: There is a possible selection bias, couples included in 
the study had a higher socioeconomic status than non-responders. How this aﬀects 
guideline adherence is unclear. Furthermore, when powering for this study we did not 
take into account the unexpected improvement of adherence in the control group.
Wider implications of the findings: Generalization of our results to other countries with 
recommendations on expectant management might be questionable because barriers 
for expectant management can be very diﬀerent in other countries. Furthermore, due to 
a large variation in improved adherence rate in the intervention group it will be interesting 
to further analyse the process of implementation in each clinic with a process evaluation 
on professionals and couples’ exposure to and experiences with the strategy.
Study funding/competing interest(s): Supported by Netherlands Organisation for 
Health Research and Development (zonmw, project number 171203005). No competing 
interests.
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Trial registration number: Dutch trial Register, www.trialregister.nl NTR3405.
Trial registration date: 19 April 2012.
Date of first patient’s enrolment: 10 July 2012.
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Introduction
Many fertility treatments are performed without evidence that such treatments indeed 
increase pregnancy rates (Bensdorp et al., 2007). For couples with unexplained infertility, 
the last decade has shown an ongoing body of evidence that questions the eﬀectiveness 
of ART in couples who have good natural fertility prospects (Steures et al., 2006; 
Bhattacharya et al., 2008; Veltman-Verhulst et al., 2012). Several randomized trials have 
compared the eﬀect of intrauterine insemination (IUI) with or without ovarian hyper-
stimulation, with expectant management, and they showed no beneficial eﬀect of these 
treatments over no treatment for 6 months (Steures et al., 2006; Bhattacharya et al., 2008). 
Consequently, expectant management saved costs as compared to early fertility treatment, 
specifically in couples with a good prognosis for natural conception (Chambers et al., 
2007; Custers et al., 2012).
 Therefore, various professionals and policy makers have advocated the use of 
prognostic profiles and expectant management in guideline recommendations. The 
European Society of Human Reproduction and Embryology guidelines emphasize that 
couples should not be exposed to unnecessary risks or ineﬀective treatments, and 
encourage that each couple should receive information about the estimate of their 
chances of natural conception. The National Institute of Clinical Excellence guideline 
states that couples with unexplained infertility should not be oﬀered IUI with or without 
ovarian hyperstimulation and that IVF should only be oﬀered after at least 2 years of 
infertility (Fields et al., 2013).
 The Dutch Network Guideline Infertility published in 2010 recommends 6–12 months 
of expectant management for couples with unexplained infertility and a high chance of a 
natural conception within 1 year, also called tailored expectant management (TEM) 
(NVOG, 2010). Unexplained infertility occurs in 25% of couples who are referred for fertility 
care and based on previous research we expect that at least one in every eight couples 
with infertility in the Netherlands is eligible for TEM (Brandes et al., 2010; Kersten, et al., 
2015). Despite these guidelines, in the Netherlands one-third of all couples with 
unexplained infertility is still exposed to early treatment, i.e. starting fertility treatments 
within 6 months after the fertility workup (van den Boogaard et al., 2011a; Kersten et al., 
2015).
 Based on previously identified barriers and facilitators for expectant management we 
have developed a multifaceted strategy to improve adherence to guideline recommendations 
on expectant management (van den Boogaard et al., 2012). The strategy that we developed
focuses on improving the couple’s knowledge on expectant management and to create 
realistic expectations of possible benefits and complications of fertility treatments. In addition, 
it focuses on improving the communication and counselling skills of professionals on 
expectant management and emphasizing the guideline recommendations at an
organizational level.
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We performed a cluster randomized trial to evaluate the eﬀectiveness of the multifaceted 
strategy compared to care as usual on the adherence to the guideline  recommendations 
on expectant management.
Methods
Study design
The study was a cluster randomized controlled trial in 25 Dutch clinics evaluating the 
eﬀectiveness of a multifaceted implementation strategy versus usual care on the adherence 
to guideline recommendations on expectant management. The study protocol was 
published in 2013 (van den Boogaard et al., 2013). The institutional ethics committee 
of Radboud university medical center provided ethical approval for this study (CMO 
no.2012/130) and the Board of Directors of each clinic provided local approval. After all 
clinics gave their approval they were randomly assigned to intervention (implementation 
strategy) or control (care as usual) group. The intervention period lasted one year (between 
March 2013 and May 2014). The intervention was implemented at clinic level. The eﬀect of 
the implementation strategy was evaluated by comparing baseline and eﬀect measurement 
data of couples that were seen in the participating clinics. Data collection was retrospective.
Tailored expectant management
The multidisciplinary ‘Dutch Network Guideline on Infertility’, published in 2010, makes 
clear guideline recommendations on TEM that are divided in three steps (NVOG, 2010): 
(i) calculating the probability of a natural conception within 1 year for couples (female 
age <38 year) with unexplained infertility with the prognostic model of Hunault, 
(ii) recommending expectant management for at least 6–12 months for couples with a 
good prognosis (>30% in 1 year) and (iii) Adherence to the advised expectant management 
period of at least 6 months.
Settings
All Dutch clinics perform a basic initial fertility work-up, and provide (un)stimulated IUI, 
while 40 of them can commence and monitor the IVF and ICSI treatments. However, the 
laboratory phase of IVF and the embryo transfer is carried out in 13 fully licensed IVF 
clinics. In the Netherlands all treatment cycles of ovulation induction (OI), (un)stimulated 
IUI, and up to a maximum of three IVF or ICSI cycles are reimbursed by basic health 
insurance coverage mandatory for all Dutch citizens. To ensure that the 25 clinics were 
representative for Dutch fertility care, we invited six fully licensed IVF clinics, 11 intermediate 
fertility clinics and eight clinics without IVF facilities, spread across the county, to 
participate.
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Randomization
Randomization was done at clinic level and was stratified for IVF facilities (fully licensed, 
intermediate/no IVF facilities). Computer-generated randomization took place after clinics 
had given approval to participate, and was done by an independent physician. 
Randomization at patient level and blinding was not possible due to the nature of the 
intervention.
Participants
Inclusion and exclusion criteria
We studied only couples in whom natural conception was possible, i.e. couples with 
one-sided tubal pathology, mild male infertility (Total Motile Sperm Count 3–10 million), 
mild endometriosis (ASRM Stage I/II) or cervical factor as well as couples in whom no 
cause could be found during the fertility work-up. Apart from that, couples needed a 
good prognosis (>30%) for natural conception within one year based on the prediction 
model of Hunault et al., (2004). Couples who had previously achieved a pregnancy 
through fertility treatment, couples in whom the woman was >38 years as well as couples 
with bilateral tubal pathology, severe endometriosis (ASRM Stage III/IV), anovulation or 
severe male factor (Total Motile Sperm Count <3 million) were excluded.
Recruitment and consent
The participating clinics were recruited in 2011. To include eligible participants in the 
clinics, all potential couples were selected retrospectively by means of each clinic’s 
financial registration database. A specific code is given to all new patients undergoing 
diagnostics for infertility (F 11-code). For the baseline measurement, couples that had an 
active F 11-code between February 2011 and March 2012 were asked to participate. For 
the eﬀect measurement couples were asked to participate if they had an active F 11-code 
during the intervention period (March 2013–May 2014). We sent all couples a study 
information letter and an informed consent form with five questions, to cover some of the 
exclusion criteria. If couples gave written informed consent and were not excluded based 
on the five questions, medical record research was conducted to assess if the couple was 
eligible to participate.
Intervention
In the intervention group, the multifaceted strategy was implemented at clinic level and 
was targeted at couples, professionals and organization. The elements targeted at patients 
and at the counselling skills of the professional were developed in collaboration with 
patients with infertility and Freya (Dutch association for patients with infertility problems, 
www.freya.nl).
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Couples:
•  Access to a website, including a digital and clear version of the prognostic model (of 
Hunault), and information about optimizing natural pregnancy chances, TEM and 
fertility treatments.
•  A patient information leaflet about what could be found on the website and a clinic- 
specific code to gain access to the website.
Professional:
•  Audit and feedback (report) of the baseline measurement for each clinic.
•  An educational outreach visit to each clinic to discuss the feedback report, background 
information on expectant management, local barriers and to generate a concrete 
action plan.
•  Access to the same website that patients got access to. The website also contained 
information focused on the professional such as a summary of the guideline recom-
mendations.
•  Access to an E-learning communication module to improve counselling skills on expectant 
management. The module contained three diﬀerent video scenarios showing a professional 
counselling a couple for expectant management. The quality of the counselling ranged 
from poor to excellent. The scenarios were written with a team of experienced 
professionals and actual couples with infertility. The scenarios were taped with a real 
experienced fertility care professional and actors to portray the couple.
Organization:
•  Availability of a local protocol based on the guideline recommendations.
• Pocket cards with a summary of the guideline recommendations on expectant 
management and the clinics’ code to gain access to the website.
Clinics that participated in the control group were not exposed to the tools of the 
multifaceted strategy and continued care as usual.
Primary outcome
The primary outcome was adherence to TEM, i.e. the percentage couples that were 
advised an expectant management period of at least 6 months and completed the 
advised period or had a natural conception in the expectant period. This percentage was 
calculated using all couples with a prognosis of >30% of natural conception within 1 year.
Secondary outcomes
We measured quality indicators that further assessed the adherence to TEM on clinic level.
-  The first indicator was based on correctly diagnosing and identifying couples who were 
eligible for TEM, i.e. the percentage of all included couples with unexplained infertility 
for whom the prognosis of a natural conception within 1 year was calculated.
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-  The second indicator was based on advising the correct policy after finalizing the 
fertility work-up, i.e. the percentage of all included couples that were advised an 
expectant management of at least 6 months by their doctor if this was appropriate.
-  The third indicator was based on following the expectant period of at least 6 months 
after TEM was advised, i.e. the percentage of couples that were advised an expectant 
period of at least 6 months after the fertility work-up, and who did not start fertility 
treatment within these 6 months anyway.
Treatment (outcome)-related measures
We evaluated treatment (outcome)-related measures such as type of treatment, number 
of treatment cycles received, complications, achievement of conception, mode of 
conception, ongoing pregnancy rate and the occurrence of multiple pregnancies.
Possible confounders
We investigated potential confounders that could be associated with guideline adherence 
on TEM. The selection of confounders was based on fertility related literature and included 
background characteristics and diagnostic outcomes (Mourad et al., 2010; Hermens et al., 
2011). For all confounders see Table I. We extracted postal area code to derive the 
socioeconomic status (SES) of the couples (obtained from the Dutch Institute for Social 
Research/SC based on the mean income level in a postal area code).
Data collection
Data collection was performed retrospectively by using medical records and a patient 
questionnaire. At baseline measurement, information was collected using paper case 
report forms (CRF’s). For the eﬀect measurement, we used electronic CRF’s (eCRF’s), based 
on the paper version of the CRF. To complete the data on the treatment-related outcomes 
and possible confounders we sent all participating couples a questionnaire (including two 
reminders in case of non-response). Collected data from the CRF’s were entered in a 
database using SPSS (SPSS 20.0 for Windows, SPSS, Inc., Chicago, IL, USA). The eCRF’s were 
entered into Oracle Clinical Database© and converted using MS Access (2007), before 
export to SPSS could be performed and data analysed.
Data analysis
All analyses were done at cluster (clinic) level because clinics were randomized, and not 
patients. Therefore, we used the generalized estimating equation approach with robust 
estimator covariance, and exchangeable correlation matrix. To analyze the primary outcome, 
percentage guideline adherence on expectant management in the eﬀect measurement, 
we used the binary logistic regression model. Included in the model were intervention, 
all couple characteristics (possible confounders), and baseline guideline adherence on 
expectant management. Data were presented as odds ratios and corresponding 95% 
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Figure 1   Flowchart and recruitment of the study
* Excluded based on; 1) Couples did not give consent. 2) The five questions in the information letter that were 
based on some of the exclusion criteria. 3) Couples do not fit the in- and exclusion criteria as mentioned in the 
method section.
25 Clinics included
Pre-randomisation data collection
Couples invited, n=9819
Response  
n=4283 (43%)
Medical record research
n=1463
Excluded*:
1. n=855  
2. n=1965
Excluded*:  
3. n=919
Randomisation
Within strata
INTERVENTION
13 clinics:
4 no IVF facilities
6 intermediate IVF  
3 fully licensed IVF
CONTROL
12 clinics:
4 no IVF facilities
5 intermediate IVF
3 fully licensed IVF
After measurement  
Couples invited: n=4133
Response  
N=1851
Medical record research
N=730
After measurement
Couples invited: n=4872
Response  
N=2094
Medical record research
N=718
Couples included
N=247
Couples included
N=238
Excluded*:
1. n=289
2. n=993
Excluded*:
3. n=480
Excluded*:
1. n=295
2. n=825
Excluded*:
3. n=483
Couples included at  
baseline n=544
March 2013  
– May 2014
26 Clinics approached
1 refused to  
participate
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confidence intervals. We carried out secondary analyses using appropriate methods for 
the outcomes, binary logistic regression for all outcomes except for the number of 
treatment cycles (Poisson log linear regression), controlling for the same covariates as 
the primary outcome and adjusting for the clustered nature of the study.
Sample size
Previous studies from the Netherlands indicated that the expected adherence to TEM 
at baseline was estimated at 60%. To detect a 20% increase in adherence, which we 
considered clinically relevant, at the 5% significance level with 80% power (with a two- 
sided test) and an intra class correlation (ICC) of 0.1 to account for potential cluster eﬀects, 
we estimated that with 25 clusters we would need a total sample size of 450 couples for 
both baseline and eﬀect measurement. We based the ICC on a previous study on guideline 
adherence in fertility care (Mourad et al., 2011).
Cost evaluation
In the protocol for this c-RCT, we included a cost-eﬀectiveness analyses of the implementation 
strategy in case of significant eﬀectiveness of the implementation strategy. Due to the 
lack of significant eﬀect we performed a cost-consequence analyses. The results can be 
found in Supplementary data, Table S1.
Results
Study population
Figure 1 presents the recruitment of clinics and eligible couples. All but one fully licensed 
IVF clinic agreed to participate in the study. For the baseline measurement we sent 
9819 couples the information letter. A total of 4283 couples responded (43%) and 
3428 couples consented to participate. Based on the questions in the information letter, 
1965 couples were excluded. After assessment of the medical records, another 919 couples 
were excluded. Eventually, 544 couples were eligible to participate. In the eﬀect measurement, 
we sent 9005 couples the information letter. A total of 3945 couples responded (44%), and 
3361 couples consented to participate. Based on the questions in the information letter, 
1818 couples were excluded. After medical record research another 963 couples were 
excluded. Eventually, 485 couples were eligible to participate. Background characteristics 
of the participating clinics and couples are shown in Table I.
Primary outcome
The results of guideline adherence on TEM between the intervention versus control group 
are presented in Table II. In the intervention group the guideline adherence increased 
from 49 to 69% (OR 2.66; 95% CI 1.45–4.89); in the control group from 49 to 61% (OR 2.03; 
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95% CI 1.38–3.00). Multilevel analysis with case-mix adjustment showed that the diﬀerence 
in adherence in the eﬀect measurement of 8% was not statistically significant (OR 1.31; 
95% CI 0.67–2.59). The results of the guideline adherence for each clinic separately show 
that there is a large variation between clinics, especially in the intervention group (Fig. 2).
Secondary outcomes
Three quality indicators on expectant management
Table II also shows the adherence to the three quality indicators on expectant management. 
The adherence to the first quality indicator, calculating the prognosis of natural conception, 
was significantly higher in the intervention group compared to the control group in the 
eﬀect measurement (20.2%, OR 2.61; 95% CI 1.44–4.71). The adherence to the second and 
third quality indicators were not significantly diﬀerent between the intervention and 
control group.
Treatment-related measures
Table III shows an overview of treatment outcome related measures within 6 months after 
the fertility work-up. None of the treatment outcome measures showed a significant 
diﬀerence between intervention and control group in the eﬀect measurement. It did 
show a significant reduction in the number of treatment cycles per couple in the eﬀect 
measurement compared to the baseline measurement in both groups (intervention: OR 
0.61; 95% CI 0.40–0.93, control: OR 0.69; 95% CI 0.52–0.90). The ongoing pregnancy rate did 
not significantly diﬀer between the baseline and eﬀect measurement in both groups 
(intervention 26–25%: OR 0.98 [0.66–1.41], control 34–27%: OR 0.75 [0.46–1.20]) but the 
method of conception did show a significant increase in the percentage of spontaneous 
conceptions in both groups (intervention 69–86%: OR 3.0 [1.65–5.45], control 68–79%: OR 
2.05 [1.21–3.47]).
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Discussion
This study shows that the use of a multifaceted implementation strategy did not significantly 
increase adherence to the guideline regarding expectant management compared to care as 
usual. The adherence to the guideline recommendations increased in the intervention 
group but the control group also had an unforeseen improved adherence.
 A strength of our study is that we performed a large cluster randomized trial in order 
to evaluate the multifaceted strategy that targets couples, professionals and organization 
and to avoid risk of contamination between the intervention and control group. We 
assured representativeness of the Dutch fertility population because a quarter of all clinics 
in the Netherland that perform fertility care participated in this trial. Furthermore, the 
participating clinics were spread across the country and the various types of clinics were 
represented (IVF facilities no/intermediate/yes).
 A second strength of our study is that we recruited new couples that were registered 
in a financial database with fertility problems and not a preselected group who were 
already labelled as being eligible for expectant management. The first step of guideline 
adherence is correctly diagnosing and identifying couples that are eligible for expectant 
management. We could not assess adherence to the guideline recommendations if we 
would have recruited participants from a preselected group.
 The findings in this report also have limitations. First, the response rate of couples 
with fertility problems was lower compared to other fertility studies (van Empel et al., 
2010; Mourad et al., 2011). This might be a result of the recruitment process. We sent an 
information letter to all couples presented with fertility problems and not a preselected 
group of couples with unexplained infertility. After the baseline measurement we 
performed a non-response research which showed that the responding couples had a 
higher socio-economic status than nonresponders, other background characteristics 
were similar (Kersten et al., 2015). This means that there is a possible selection bias, but 
how this might aﬀect guideline adherence is unclear.
 A second limitation is that we did not take into account the unexpected improvement 
of adherence to expectant management in the control group when we calculated the 
sample size for this study. This is possible due to changes in usual care during the 
intervention period. As the Dutch government was looking for savings in fertility care, the 
Dutch Society for Obstetrics and Gynaecology (NVOG) tried to make expectant 
management obligatory as part of a strategy to improve the cost-eﬀectiveness of fertility 
care. Furthermore, a Hawthorn eﬀect could be possible; The inclination of people who are 
the subjects of an experimental study to change or improve the behaviour being 
evaluated only because it is being studied, and not because of changes in the experiment 
parameters or stimulus (Sedgwick and Greenwood, 2015). Clinics might have changed 
their behaviour towards expectant management as a motivational response to 
participating in this study.
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A final limitation is that this study was performed in the Netherlands which makes 
generalization of our results to other countries questionable because they might have 
diﬀerent policies concerning expectant management. We have based our strategy on the 
specific Dutch guideline recommendations and barriers and facilitators on expectant 
management (van den Boogaard, et al., 2011b, 2012). Perhaps the barriers are diﬀerent in 
other countries. For example, In the Netherlands each citizen has a compulsory basic 
health insurance that covers all OI/IUI and a maximum of three IVF/ICSI cycles. In other 
countries diﬀerent health insurance coverage might apply and, therefore, the incentive to 
start treatment may be very diﬀerent for both professionals and couples. Otherwise, the 
multifaceted strategy could prove to be more eﬀective in countries where there is no 
strong incentive from the government to abide by the recommendations on expectant 
management.
 The secondary outcomes, i.e. the quality indicators and the treatment-related 
outcomes, provide further insight in the impact of the strategy and/or the policy change. 
The first quality indicator showed that in the intervention group there was a significant 
improvement in the percentage of couples for whom a prognosis of natural conception 
was calculated compared to the control group (26.3% versus 6.1% [OR 2.61; 95% CI 
1.44–4.71]). This shows that the strategy has a positive eﬀect on correctly diagnosing and 
identifying couples who are eligible for expectant management. However, the lack of 
eﬀect on the other two quality indicators shows that this does not necessarily lead to a 
correct recommendation and follow-up on expectant management.
 When comparing the baseline and eﬀect measurement in both groups it was shown 
that the ongoing pregnancy rate was not significantly diﬀerent but that there were 
significantly more natural conceptions in the eﬀect measurement and that the number of 
treatment cycles per couple was also significantly reduced in the eﬀect measurement. 
This shows that improving the adherence to expectant management reduces the number 
of fertility treatments without negatively aﬀecting the pregnancy rate. 
 It is diﬃcult to compare the ongoing pregnancy rates of our study to ongoing 
pregnancy rates in other RCT’s on couples with unexplained infertility for two reasons 
(Steures et al., 2006; Bensdorp et al., 2015). First, we asked couples to participate in this 
study after they had already had the basic fertility work-up and possibly already started 
treatment, were advised an expectant management, or even achieved a pregnancy. It is 
possible that couples who already achieved a pregnancy were less inclined to respond 
compared to couples who were still trying to get pregnant. Second, we have missing data 
on the pregnancy rate because for some couples who were advised expectant 
management there was no follow-up contact after the fertility work-up and they did not 
respond to the questionnaire we sent. Both factors can potentially lead to an under-
estimation of the pregnancy rate in our study population.
 To design a potentially eﬀective strategy before disseminating it to other clinics, it is 
crucial to use a detailed breakdown of the implementation processes of this unsuccessful 
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intervention. Process evaluations can clarify the mechanisms responsible for the result 
obtained in the intervention group. It enables researchers and implementers to check 
actual exposure to the intervention, and describe the experience of those exposed 
(Hulscher et al., 2003). Our results showed that there is a great variance in improved 
adherence between the clinics in the intervention group (range: −19 to 62%). This shows 
that there are clinics that had a decrease in adherence despite the eﬀort to increase it. 
Therefore, it needs to be assessed if this is related to the level of exposure to the strategy, 
the usefulness of the diﬀerent tools, or other local barriers. Based on an extensive process 
evaluation, those tools that are potentially eﬀective and positively rewarded can be 
selected and used on a national scale.
 In conclusion, our results show that implementation of expectant management for 
couples with unexplained infertility is necessary and feasible. A policy change alone can 
be eﬀective in achieving improved implementation. In this study we did not find a 
significant additional eﬀect from a multifaceted implementation strategy.
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Supplementary table 1   Cost-consequence analyses: overview of all costs  
from a societal perspective, direct and indirect medical 
costs within six months after fertility work-up
Measurement Baseline Effect
Unit/unit 
pricea (€)
N=544 Intervention
(N=247)
Control
(N=238)
Intervention costsb (€)* (€)* (€)*
Audit and feedback
Medical record research Hour /27.79a,d - 4 335 -
Printing and shipping questionnaires 
(quality of care)
Questionnaire 
/3.20a,c
- 2 426 -
Developing individual feedback reports Hour/ 32.10a - 835 -
Printing and shipping feedback reports Report / 8.17a,c - 319 -
Educational outreach visits
Time expenses researcher Hour /32.10a,d - 1 042 -
Time expenses fertility care team Hour /20.61-
135.50aa,d
- 5 970 -
Other
Printing pocket cards Card / 1.06a - 111 -
Printing patient information flyers 5000 flyers / 
75.00a
- 75 -
Website licence License / 11.00 - 11 -
Publishing E-learning module Fixed / 48.00 - 48 -
Total costs intervention 15 172
Medical costs in six months after fertility work-up (direct + indirect) 
OI Cycle/182.75e 4 020 1 279 548
IUI Cycle/499.50f 71 429 16 983 24 975
IUI+MOH Cycle/1 129.59f 349 155 103 955 118 645
IVF/ ICSI Cycle/3 935.35g 51 160 78 71 11 806
Total costs 475 763 145 260 155 973
Total costs per couple. 875 588 655
*  All costs were adjusted to 2013 Euros by using the 2013 consumer price index as published by the Central 
Bureau of Statistics in the Netherlands (statline.cbs.nl/statweb)
a  Clinical data refers to empirical data collected in this study
b  Once-only study specific costs were excluded from analysis, including the costs for development of the 
website and the E-learning module. 
c  PostNL national mail delivery: www.postnl.nl/tarieven/partijenpost/binnenland
d  Recommended prices according to national guideline for cost calculations in health care by Hakkaart-van-
Roijen et al
e  Based on data direct and indirect medical costs from Moolenaar et al. 2014.
f  Based on data direct and indirect medical costs from Haagen et al. 2013. 
g  Direct medical costs based on data from van Rumste et al. 2014, Indirect medical costs based on data from 
Fiddelers et al. 2009
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Abstract
Study question: What is the relationship between the adherence to tailored expectant 
management (TEM) and couples’ and professionals’ exposure to an implementation 
strategy? 
Summary answer: The implementation strategy consisting of diﬀerent elements was 
oﬀered to all intervention clinics in an c-RCT but it was the task of the clinics to actually use 
the elements in their daily practice and expose their professionals and patients to them. 
Based on the actual exposure of the clinics to the diﬀerent elements of the strategy we 
divided them into three levels; minimal, medium, or high exposure. Compared to care as 
usual, minimal exposure to the strategy had no eﬀect at all on adherence to TEM, 
intermediate exposure had a significant increased eﬀect on adherence to TEM, and high 
exposure had a non significant eﬀect on adherence rate.
What is known already: An implementation strategy to improve adherence to tailored 
expectant management in couples with unexplained infertility did not have a significant 
eﬀect. However there was a wide range in adherence improvement per participating 
clinic. 
Study design, size and duration: We used a process evaluation with an observational 
design, performed alongside  the eﬀect measurement of a previously performed cluster 
randomised controlled trial in 25 clinics in the Netherlands.  
Participants/materials, setting and methods: We studied a total of 485 couples with 
unexplained infertility, 247 couples in the intervention group (13 clinics) and 238 couples 
in the control group (12 clinics). The intervention group was provided with a multifaceted 
implementation  strategy, including audit and feedback (report and outreach visit), a local 
protocol, pocket cards, an E-learning communication module, and an informational 
website for professionals and an information flyer and access to an informational website 
for patients. The control group provided care as usual. A multivariate multilevel analyses 
was performed to assess the eﬀectiveness of the implementation strategy on adherence 
to expectant management in the three exposure groups compared to usual care. 
Furthermore, questionnaires evaluated the professionals’ and patients’ experiences with 
the diﬀerent strategy elements.
Main results and the role of chance: Compared to the control group (48.8% to 60.9% 
adherence), clinics with minimal exposure had no increase in adherence, 57.6% to 58.0% 
(OR 0.54; 95%CI 0.26-1.14), clinics with intermediate exposure had a significant increased 
adherence, 34.0% to 76.9% (OR 3.70;95%CI 1.47-9.36), and clinics with high exposure had a 
non significant increased adherence, 54.4% to 74.1% (OR 1.44; 95%CI 0.64-3.24). Professionals 
who completed the E-learning communication module had very positive experiences 
with the module. However, overall ranking of all the strategy elements according to the 
professionals’ experiences, showed that elements such as audit and feedback, availability 
of a local protocol, and the website were most useful in improving adherence to TEM. 
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Patients’ experiences with the information flyer and the website showed that both 
elements achieved their goals, i.e. getting couples to visit the website and informing 
couples about their chances of natural pregnancy and expectant management. However, 
the website needs improvement in user-friendliness and comprehensibility.
Limitations, reason for caution: We were not able to statistically test the importance of 
the exposure to each diﬀerent elements. Due to the clustered nature of the study, we 
lacked power.
Wider implications of the findings: The implementation strategy can have a significant 
eﬀect on adherence to tailored expectant management. To implement the strategy on 
a national and international scale it is important to address the barriers for exposure to 
the strategy, such as attitude of professionals and organization towards the guideline 
 recommendations on TEM and the implementation of the strategy elements. Furthermore, 
the informational website should be improved to increase user friendliness and compre-
hensibility for patients. 
Study funding/competing interest(s): Supported by Netherlands Organisation
for Health Research and Development (ZonMW). ZonMW had no role in designing the 
study, data collection, analysis and interpretation of data or writing of the report. 
Competing interests: none.
Trial registration: www.trialregister.nl NTR3405
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Introduction
In couples with unexplained infertility there is no specific medical cause found for their 
unfulfilled childwish and therefore an evidence-based treatment cannot be recommended 
and expectant management should be considered, especially for couples that still have 
a good chance to conceive naturally (Custers et al. 2012; Steures et al. 2006).
 To determine which couples have a good chance of natural conception the prognostic 
model of Hunault can be used to calculate the chance of a natural pregnancy within one 
year (Hunault et al. 2004). For couples with a good prognosis of natural conception (> 30%), 
expectant management of six to twelve months (tailored expectant management, TEM) 
does not compromise ongoing birth rates compared to starting fertility treatment 
immediately (Steures et al. 2006). Therefore, diﬀerent (inter)national fertility guidelines have 
formulated recommendations for expectant management (NHG 2010; Fields et al. 2013). 
 Despite the Dutch guideline recommendation on TEM previous research has shown 
that over one third of couples eligible for expectant management in the Netherlands 
receive treatment too soon, i.e. within six months after the basic fertility work-up (van den 
Boogaard et al. 2011; Kersten et al.). Therefore, we recently performed a cluster randomized 
controlled trial (c-RCT) to test if an implementation strategy, targeted at known barriers for 
TEM, would improve adherence to expectant management (van den Boogaard et al. 2013; 
van den Boogaard et al. 2012; Kersten et al. 2017). The strategy elements aimed at the 
professionals of the intervention group included audit and feedback of actual care 
(feedback report and educational outreach visit), a local protocol, pocket cards, an 
E-learning communication module, and an informational website. Patients received an 
information flyer and access to an informational website on expectant management. 
The results of the c-RCT showed no significant eﬀect of the implementation strategy 
compared to usual care on adherence to expectant management (Kersten et al. 2017). 
The intervention group increased its adherence to TEM with 20% but the control group 
also showed an unexpected increased adherence of 12%. Furthermore, results showed 
that there was a wide range in adherence improvement per participating clinic in the 
intervention group (from minus 19% to 62%).
 To assess why the implementation strategy did not have the anticipated eﬀect and 
why the adherence rates varied so much, we undertook a process evaluation to understand 
the ‘black box’ of the intervention (Saunders, Evans, and Joshi 2005; Hulscher, Laurant, and 
Grol 2003). An in-depth assessment of both professionals’ and couples’ level of exposure 
to and experiences with the diﬀerent elements of the implementation strategy will give 
insight into which elements of the strategy can possibly contribute to improved adherence 
to expectant management (Hulscher, Laurant, and Grol 2003). Moreover, both the 
assessment of exposure and experience can help to modify the strategy so that it will be 
eﬀective before implementing it on a larger scale (Hulscher, Laurant, and Grol 2003; 
Saunders, Evans, and Joshi 2005).
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Therefore the aim of this study was to evaluate the relation between the adherence to 
expectant management and couples’ and professionals’ exposure to the implementation 
strategy as a whole and the diﬀerent elements of the strategy. Furthermore, we aimed to 
assess the couples’ and professionals’ experiences with the diﬀerent strategy elements.
Materials and methods
Study design
This process evaluation is an observational study that is performed alongside the eﬀect 
measurement of a recently performed c-RCT on the improvement of adherence to TEM 
(Kersten et al. 2017). With this process evaluation we wanted to determine clinics’ exposure 
to the implementation strategy that we developed in the c-RCT to improve adherence 
to TEM and subsequently assess the association between exposure and adherence to 
TEM. Furthermore, we wanted to assess professionals’ and couples’ experiences with the 
diﬀerent elements of the implementation strategy. 
 For the eﬀectiveness of the strategy on adherence to TEM we used the data of the 
previously performed c-RCT in 25 Dutch clinics that were spread across the country and 
included all types of fertility clinics (fully licensed IVF, intermediate, and no IVF facilities). In 
the baseline measurement of the c-RCT 544 couples were included. Subsequently, 13 
clinics were exposed to the implementation strategy for one year and 12 clinics continued 
care as usual. In the eﬀect measurement 485 couples were included of which 247 in the 
intervention group and 238 in the control group. 
Ethical approval
The institutional ethics committee of Radboud university medical center provided ethical 
approval for this study (CMO no.2012/130). The board of directors of each of the 
participating hospitals approved the study.
Setting
The basic insurance coverage for each Dutch citizen fully reimburses all treatment cycles 
of ovulation induction and intrauterine insemination with or without controlled ovarian 
hyperstimulation, as well as a maximum of three IVF and/or ICSI cycles per ongoing 
pregnancy. Based on the study of Steures et al. 2006, the Dutch Network Guideline 
Infertility 2010 recommends expectant management for at least six months for couples 
with unexplained infertility and a good  prognosis of a natural conception, also referred to 
as TEM (NHG 2010).
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Study population 
We included couples with unexplained infertility and a good prognosis (>30%) for natural 
conception within one year based on the prediction model of Hunault (Hunault et al. 2004).
 According to the ‘Dutch Network Guideline Infertility’ (www.nvog.nl) the couples’ 
diagnosis was unexplained infertility if the fertility work up showed no cause for the 
infertility or if it showed mild abnormalities that were not significant enough to obstruct 
a natural conception (see Kersten et al. 2017). 
Recruitment
Couples were asked to participate in the c-RCT if they had been undergoing diagnostic 
tests or treatment for infertility (F 11 code) in one of the participating clinics between 
February 2011 and March 2012 (baseline measurement) or during the intervention period 
between March 2013 and May 2014 (eﬀect measurement). Couples were sent an 
invitational letter and an informed consent form with five questions, to cover some of the 
exclusion criteria. If patients gave written informed consent and were not excluded based 
on the five questions, medical record research was conducted to assess if the couple 
actually fulfilled all the in- and exclusion criteria and was eligible to participate. More 
details on the recruitment process can be found in Kersten et al. (submitted). 
 For this process evaluation, couples that were included in the intervention clinics in 
the eﬀect measurement received an additional questionnaire on their experiences with 
the diﬀerent patients’ elements of the implementation strategy (flyer & website). 
Intervention 
The implementation strategy was implemented on clinic level and targeted three diﬀerent 
levels and included several diﬀerent elements; audit and feedback (feedback report), 
educational outreach visit, access to informational website, E-learning communication 
module, and pockets cards with information on TEM (all professional level), patient information 
leaflet and access to previously mentioned informational website (all patient level), 
and availability of a local protocol on TEM (organizational level) (Kersten et al. 2017). 
The control group was not exposed to the elements of the implementation strategy. 
Outcome measures
Effect evaluation
Adherence to tailored expectant management (TEM) 
The primary outcome of the c-RCT was the percentage of guideline adherence to TEM on 
a clinic level. This means the percentage of couples (with unexplained infertility with a 
prognosis of >30% of natural conception within one year) that were advised an expectant 
management period of at least 6 months and completed the advised period or had a 
natural conception in the expectant period. 
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Process evaluation
Exposure to different strategy elements
To analyse the relationship between adherence to TEM and exposure to the implementation 
strategy, we divided the participating clinics of the intervention group into three strategy 
exposure levels. For four elements of the strategy we could not objectively assess clinics’ 
exposure levels: the audit and feedback, educational outreach visit, availability of a local 
protocol, and pocket cards for professionals. All four elements were made available to 
them but we could not assess to what extent they were exposed to it or made use of the 
elements. The exposure to the remaining three elements of the strategy per clinic 
included: professionals’ exposure to the E-learning communication module, professionals’ 
and couples’ exposure to the informational website, and couples’ exposure to the 
information flyer. The exposure of professionals to the E-learning communication module 
was the percentage of professionals who attended the educational meeting per clinic 
and that opened and finished the module. 
 The exposure to the website was the percentage of all new couples per year per clinic 
that visited the website (at home alone or in the clinic with a professional). Finally, the 
exposure to the flyer is the percentage of couples per clinic who reported in the additional 
questionnaire that they had received the information flyer. 
Experiences with different strategy elements
We also evaluated the implementation strategy by having both professionals and patients 
giving their opinion on the diﬀerent strategy elements. We asked professionals what 
their experiences were with the E-learning communication module with respect to user- 
friendliness, usefulness, and if it achieved its goal. Furthermore, professionals were asked 
to rate the diﬀerent strategy elements from most useful to not useful at all to improve 
implementation of guideline recommendations on expectant management. We asked 
patients what their experiences were with the patient information flyer and the 
informational website with respect to comprehensibility, suﬃcient information, easy-view 
and if it reached its goal.
Data collection
Effect evaluation
Data on the adherence rate to TEM per clinic were collected from the original c-RCT’s 
database. This database was based on medical record research. 
Process evaluation, exposure to strategy elements
The professionals’ exposure to the E-learning communication module was gathered from 
the module itself. Moreover, the module included a questionnaire for professionals on their 
clinical background. The data on exposure to the website were gathered from the logging 
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data from the website; it was visible per clinic (diﬀerent code per clinic) how many times 
professionals logged in and how many patients logged in. The data on couples exposure to 
the information flyer was gathered from a patient questionnaire that was send to all included 
couples in the after measurement. Couples from intervention clinics received an extension 
of the questionnaire with question specifically on the information flyer and website. 
Process evaluation, experience with strategy elements
The professionals’ experiences with the E-learning communication module was gathered 
from the module itself through a questionnaire. To obtain the professionals’ experiences 
with all the diﬀerent elements of strategy we sent out one questionnaire to a gynaecologist 
in each clinic after the intervention period. Couples’ experiences with the information 
flyer and the website was also obtained from the above mentioned questionnaire. 
Data analyses
To analyse the relationship between adherence to expectant management and exposure 
to the strategy elements, the intervention clinics were divided into three exposure levels; 
minimal, medium, or high exposure to the implementation strategy. At first, per strategy 
element we divided the clinics in tertiles (0-33,3%/33,3-66,6%/66,6%-100%) based on the 
percentage exposure to the element. Consequently, we scored each clinic from 0-2 based 
on the tertile the clinic ranked in. For example, if a clinic was ranked in the lowest tertile 
we scored it 0 points for that element and if a clinic ranked in the highest tertile we scored 
them 2 points for that element. We added up all the scores, resulting in a total sum score 
between 1-6. Based on these total scores we finally divided the intervention clinics into 
three exposure levels (0-2 minimal exposure, 3-4 medium exposure, 5-6 high exposure). 
The clinics in the control group had no exposure to the strategy at all (exposure level zero). 
For all levels we calculated the patients’ baseline characteristics that could influence the 
adherence to expectant management (e.g. mean female age, primary/secondary infertility, 
and duration of infertility). For the primary outcome we used the binary logistic regression 
model to assess the association between exposure level and adherence to TEM in the 
after measurement. Included in the model were the four levels of exposure to the strategy, 
background characteristics, and baseline adherence to expectant management. Data 
were presented as odds ratios and corresponding 95% confidence interval. To get insight 
into the influence of the diﬀerent elements we assessed the exposure to the diﬀerent 
elements in the three levels that had minimal to high exposure to the strategy, i.e. 
percentage exposure to the communication module, exposure to the website, and 
exposure to the information flyer.
 Diﬀerences in professionals experiences with the E-learning communication module 
were determined by calculating frequencies per domain of appreciation. To asses 
professionals’ experiences we had them rank the elements from least useful to most 
useful to increase adherence to expectant management in general and we calculated the 
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mean score of importance of the elements to improve adherence in their own clinic. 
Diﬀerences in couples’ experiences with the information flyer and the website were 
determined by calculating frequencies per domain of appreciation. Analyses were 
performed with SPSS (version 20.0 for Windows, SPSS inc., Chicago, IL, USA).  
Results
Figure 1 shows the study’s flowchart. In the baseline measurement 544 couples were 
included in the 25 clinics. In the eﬀect measurement of the c-RCT 485 couples were 
analyzed. Of the 247 couples in the intervention group we received a completed 
questionnaire from 186 couples.
Exposure to the strategy and influence on adherence to TEM
Evaluation of exposure of both professionals and couples within one clinic to the diﬀerent 
elements of the implementation strategy revealed that the intervention clinics were 
exposed in very diﬀerent levels to the strategy (1= low exposure level, 2=intermediate 
exposure level, 3= high exposure level). Table I shows the baseline characteristics of the 
Figure 1   Study profile
25 Clinics
Randomisation
Within strata
INTERVENTION
13 clinics:
4 no IVF facilities
6 intermediate IVF  
3 fuly licensed IVF
CONTROL
12 clinics:
4 no IVF facilities
5 intermediate IVF
3 fully licensed IVF
Couples included
N=247
Couples included
N=238
Couples included at  
baseline n=544
Intervention:
March 2013 – May  
2014
Questionnaire completed
N=186
Questionnaire completed
N=182
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clinics and couples per exposure group in the eﬀect measurement. When comparing the 
three exposure groups with the control group we found significant diﬀerences in female 
age and the socio-economic status of the couple. The other characteristics of the couples 
did not significantly diﬀer between the control group and the three exposure groups. 
Table I   Background characteristics per exposure group in the after measurement 
Exposure Control Intervention
Exposure group 1 
(low)
2 
(intermediate)
3 
(high)
N couples (n clinics) 238 (12) 88 (5) 78(5) 81(3)
Characteristics clinics
Median no of new 
patients per year (range)
314 (148-898) 257 (182-470) 351 (132-501) 426 (120-447)
Median no of included 
couples (range)
21.5 (5-31) 19 (9-25) 17 (8-22) 31 (6-44)
Characteristics couples:
Mean age in years (SD)a
     Female 
     Male
31.5 (3.8)
34.5 (5.3)
30.2 (3.4)*
33.7 (4.7)
30.7 (4.1)
33.7 (5.3)
30.6 (3.2)
33.6 (4.6)
Type of infertility (%)b
     Primary
     Secondary
58.0
42.0
68.2
31.8
50.0
50.0
58.0
42.0
Median duration of 
subfertility in years (iqr)c
1 (1-2) 1 (1-2) 1 (1-2) 1 (1-2)
History ≥1 miscarriage (%) 23.1 17.0 28.2 24.7
Mean prognosis (%) of 
natural conception (SD)
40.5 (7.4) 42.7 (9.6) 40.6 (7.5) 42.0 (8.7)
Median BMI woman (iqr) 23.0 (21.0-25.0) 23.0 (20.9-25.8) 22.8 (20.4-25.4) 22.2 (21.0-26.8)
Socio-economic status 
(%)d
     High
     Medium
     Low
16.8
69.7
13.5
10.2*
84.1
5.7
10.3
71.8
17.9
8.6
81.5
9.9
*  Compared to the control group, significant diﬀerence, p<0.05
SD=Standard deviation, Iqr= Inter quartile range
a   Age calculated at the start of basic fertility work-up. 
b  Type of infertility was determined for the couple. 
c  Duration of infertility was defined as the period between the start of regular unprotected sexual intercourse 
   and the end of the basic fertility work-up when the diagnosis/prognosis was determined. 
d  Socio-economic status was based on the mean income level in a postal code area based on the Dutch 
institute for Social Research/SC.
511305-L-bw-kersten
Processed on: 6-7-2017 PDF page: 171
171
Implementing tailored expectant management: a process evaluation study
8
Table II shows the adherence rate to TEM per group in baseline and eﬀect measurement. 
After case-mix adjustment (baseline diﬀerence and diﬀerent background characteristics), 
the increase in adherence to TEM of 42.9% in group 2 compared to 12.1% in the control 
group is significant (OR 3.70;95%CI 1.47-9.36). Group 1 shows almost no increase in 
adherence of 0.4% (OR 0.54; 95%CI 0.26-1.14) and group 3 shows a non significant increased 
adherence of 19.7% compared to the control group (OR 1.44; 95%CI 0.64-3.24).
Exposure to the different strategy elements within exposure groups
Table III shows the exposure to the diﬀerent strategy elements within the three exposure 
groups. It shows that group 1 had minimal exposure to all elements of the strategy 
(information flyer 14.4%, website 10.1%, communication module 22.5%). Group 2 had 
three to four times more exposure to both the information flyer and the website (47.1% 
and 45.3%), and minimal more exposure to the communication module (28.5%). Group 3 
had high exposure to all elements (flyer 63.2%, website 71.0%, communication module 
81.0%). 
Professional experiences: E-learning communication module
A total of 37 professionals (nurses n=10, ultrasound technicians n=2, nurse practitioners 
n=3, fertility doctors n=9, gynaecologists in training n=2, and gynaecologists n=11) from 
eleven clinics completed the communication module online. The experiences with the 
Table II   Changes in adherence to expectant management in participating  
clinics during study period, adjusted for background characteristics and 
baseline variance
Exposure 
group 
(n clinics)
Control 
(12)
1 Low
(5)
2 Intermediate
 (5)
3 High
(3)
Baseline/After 
measurement
B A ∆ B A ∆
OR*
[95% CI]
B A ∆
OR*
[95% CI]
B A ∆
OR*
[95% CI]
N couples 244 238 118 88 103 78 79 81
Adherence 
expectant 
management 
(%)
48.8 60.9 12.1 57.6 58.0 0.4
0.54
[0.26-1.14]
34.0 76.9 42.9
3.70
[1.47-
9.36]
54.4 74.1 19.7
1.44
[0.64-3.24]
*  Odds ratio from binary logistic models adjusting for couples’ background characteristics (possible 
confounders) and baseline variance (only for eﬀectiveness of intervention).
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Table IV   Professionals experience with the E-learning communication module
Experience: disagree neutral Agree
The module:
- Was easy to use 5.4 0 94.6
- Showed video’s that are realistic enough to  
learn from
0 0 100
- I would recommend it to colleagues 2.7 18.9 78.4
- Has reached it goal* 2.7 5.4 91.9
disagree Not 
applicable
Agree
After having seen the video’s I expect I will:
Use the prognostic model more often 18.9 27.0 54.1
Complete the prognostic model more often 
with the couple
10.8 27.0 62.2
Be able to better explain the reason for 
expectant management 
16.2 16.2 67.6
Be able to better explain the couples’ natural 
pregnancy changes
16.2 18.9 64.9
Be able to better explain the pregnancy chances 
with and without treatment
18.9 16.2 64.9
Be able to better motivate couples to follow 
expectant management
13.5 13.5 73.0
More easily carry out expectant management 18.9 21.6 59.5
Have a better relation with these couples 29.7 13.5 56.8
Not applicable: Some nurses and ultrasound technicians do not counsel couples on expectant management 
and therefore these questions were not applicable for them. 
* goal of the module was to provide the professional with suﬃcient tools to counsel couples on expectant 
management.
Table III   Exposure to diﬀerent strategy elements within exposure groups
Exposure Group: 1 2 3
Exposure to different elements:
Information flyer 14.4% 47.1% 63.2%
Website 10.1% 45.3% 71.0%
E-learning communication module 22.5% 28.5% 81.0%
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communication module are shown in table IV. The general consensus was that the 
module was easy to use (94.6%) and that the video content was realistic enough to learn 
from (100%). The majority of professionals (91.9%) thought that the module reached its 
goal of giving professionals suﬃcient tools to counsel couples on expectant management. 
The overall score that the professionals gave the module was a 7.7 on a scale of 1-10. 
Professionals scored their counseling skills on expectant management a 7.3 before seeing 
the video’s and a 7.9 after completing the module. 
Professional experiences: importance of different strategy elements.
Table V shows the ranking of self-reported importance of the strategy elements to 
improve adherence to guideline recommendation on expectant management in general 
and in their own clinic. Professionals rated the presence of a local protocol, the website, 
patient information flyer, and the audit and feedback as most important to influence 
adherence to TEM. The communication module was rated as least important. 
Patient experiences: information flyer and website
In the after measurement, 68 of the 186 responding couples (37%) received the information 
flyer and 62 couples (33%) read the flyer. The website was visited by 56 couples (30%). 
Table VI shows couples’ responses on statements concerning appreciation of the patient 
information flyer and website. Not every statement was applicable to each strategy 
element. It shows that almost 80 percent of couples who received the flyer visited the 
website as well (goal of the flyer) and that 93% thought that the website served its purpose 
well, i.e. giving information on chances of natural conception and expectant management. 
Table V   Professionals’ experiences; importance of the strategy elements to improve 
adherence to guideline recommendation on expectant management.
Strategy elements Ranking in general
(1 most, 7 least)
Contribution in own clinic 
(mean score, 0-5)
Presence of a local protocol 1 3.6
Website 2 3.2
Patient Information flyer 3 2.8
Educational outreach visit 4 3.1
Feedback report 5 3.3
Pocket cards 6 2.8
E-learning communication module 7 2.2
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Discussion
This process evaluation study reveals what happened within the ‘black box’ of a cluster 
randomized controlled trial that evaluated the eﬀect of an implementation strategy to 
increase adherence to expectant management in couples with unexplained infertility. 
Our results show that diﬀerent exposure levels to the strategy have a great influence on 
the eﬀectiveness of the strategy. Compared to the increased adherence rate in the control 
group (12%), clinics with minimal exposure to the strategy showed  no improvement in 
adherence rate at all, clinics with intermediate exposure had a significantly increased 
adherence rate (43%) compared to the control clinics, and clinics with high exposure had 
a non significantly increased adherence rate (20%). Regarding the experiences with the 
strategy we found that professionals that completed the E-learning communication 
module have positive experiences with this tool. However, gynaecologists in all 
Table VI   Couples’ experiences with the patient information flyer and website
Experience: No,  
not at all
Very  
little
Yes, 
considerable
Yes, 
completely
The flyer:
- Was comprehensible 1.5% 3.0% 30.3% 63.6%
- Discussed all relevant information 1.7% - - 95.3%
- Has reached it goal* 17.9% - - 79.1%
The website:
- Was comprehensible 0% 16.6% 70.4% 13.0%
- Discussed all relevant information 3.8% - 13.5% 82.7%
- Has an easy-view (clear) 0% 11.1% 51.9% 37.0%
- Was used to calculate our chance of 
natural conception (prognostic model) 
with my doctor
45.5% - - 54.5%
- Was used by us to calculate the 
chance of natural conception 
(prognostic model)
29.1 - - 70.9%
- Has reached its goal* 1.8 5.5% 63.6% 29.1%
*  goal of flyer was to get couples to visit the website. Goal of website was to inform couples about their 
chances of natural pregnancy and expectant management.
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intervention clinics rated the local protocol, feedback, educational meeting, and the 
website as most important in increasing adherence to expectant management. Couples’ 
experiences with the information flyer and website show that both elements achieved 
their goals, i.e. visit the website and  inform couples about their chances of natural 
pregnancy and expectant management. 
 To further explain the eﬀect of the diﬀerent exposure levels to the strategy on the 
eﬀectiveness of the strategy we looked at the baseline adherence to expectant 
management in all groups. The group with intermediate exposure to the strategy had a 
low baseline adherence (34%). Their improved adherence shows they were willing to 
change and use the elements to aﬀect improvement. The group with high exposure had 
a much higher baseline adherence (54%) and still managed to improve adherence with 
almost twenty percent. However, due to the lower baseline adherence in the control 
group (48.8%) and their overall increased adherence, the eﬀect of the strategy was not 
significant in the high exposure group. The group with minimal exposure had the highest 
baseline adherence of all the groups (57.6%) and did not improve adherence at all. This 
finding suggests that clinics in the low exposure group seem content with their audit and 
feedback of the baseline measurement and seem reluctant to further improve their 
behaviour towards expectant management. 
 The ranking of the strategy elements by professionals were based on a questionnaire 
to one gynaecologist per clinic. In the ranking the E-learning communication module was 
rated as least eﬀective. However, professionals (gynaecologists, fertility doctors, nurses 
etc.) that completed the E-learning communication module evaluated the module as very 
useful in improving guideline adherence to expectant management and scored the 
module very high on all items. There seems to be a discrepancy between the ranking and 
the evaluation of the module. This is possible due to the fact that not all gynaecologists 
who ranked the elements completed the communication module. In six of the intervention 
clinics none of the gynaecologists completed the module, this non-participation rate is 
comparable to other studies on the use of optional online communication training 
(Donovan et al. 2016; Nicastro et al. 2015). Furthermore, the module was mainly used in 
clinics in the high exposure group that already showed high adherence to expectant 
management before the intervention period. This may indicate that the professionals in 
these clinics were already quite eﬃcient in counseling and adhering to expectant 
management. Therefore, it seems that the module targeted the wrong group of 
professionals. In order to assess the eﬀectiveness and importance this needs to be 
evaluated among the more reluctant professionals. 
 The strategy elements that were targeted at patient level, the website and information 
flyer, reached only one third of couples in the after measurement. This is congruent with a 
previous RCT on improving guideline implementation in Dutch fertility care that showed 
that 37% of patients received an information leaflet (Mourad et al. 2011). The couples that 
were exposed to the website and flyer were satisfied with the information provided by 
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these elements on spontaneous pregnancy chances and expectant management. 
However, the comprehensibility and user friendliness of the website could be improved 
according to the couples.  
 A strength of this study is that is gives more insight into the black box of implementation. 
The link between the variations in adherence to expectant management and the actual 
exposure to the strategy elements is not apparent by only analysing the c-RCT outcome 
data. Previous research has shown how important it is to get a better understanding of 
which parts of an implementation strategy are actually useful and which ones are not 
(Huis et al. 2013; Legare et al. 2014; Kreuwel et al. 2012; Grimshaw et al. 2004; Baker et al. 
2015). Another strength is that this process evaluation was performed for a very large 
c-RCT which included one quarter of all clinics in the Netherlands that provide fertility 
care. This ensures a good representation of Dutch fertility care. Moreover, due to the 
clustered nature of the RCT, it was possible to assess the diﬀerent elements of the strategy 
on three levels, i.e. professional, couple, and organizational. 
 There are some limitations to this process evaluation as well. An important aspect of 
implementing change is the organizational culture. Previous research shows that main 
barriers to implementing supports for evidence-informed decision making are limited 
resources (money or staﬀ), time constraints, and negative attitude (or resistance) toward 
change (Ellen et al. ; Wensing et al. 2014; Huis et al. 2013; Flottorp et al. 2013). We did not 
asses these barriers in the process evaluation. However, in some clinics these barriers were 
noticed during the educational outreach visit. For future implementation we recommend 
to systematically evaluate and address these barriers. For example, ask all members of the 
fertility team to complete a questionnaire before the intervention period on their attitude 
towards the guideline recommendations on expectant management and what they 
expect from this study and their participation.
 A second limitation is that we did not take into account the changes in usual care 
during the intervention period of the c-RCT. The Dutch government in collaboration with 
the Dutch Society for Obstetrics and Gynaecology (NVOG) tried to make expectant 
management obligatory as part of a national plan to reduce costs in fertility care. 
Furthermore, there is the possible Hawthorn eﬀect; The inclination of people who are the 
subjects of an experimental study to change or improve the behaviour being evaluated 
only because it is being studied, and not because of changes in the experiment parameters 
or stimulus (Sedgwick and Greenwood 2015).  We expect that this influenced the results of 
the c-RCT but also this process evaluation. While the clinics in the control group increased 
their adherence rate with 12%, the minimal exposure group showed no increase at all, 
illustrating their reluctance to change. 
 The final limitation is that we were not able to statistically test the importance of the 
exposure to the diﬀerent elements. Due to the clustered nature of the study, adding these 
variables to the statistical analyses would result in too many small subgroups. A prospective 
trial with each strategy element in a diﬀerent arm would have been the optimal method 
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to evaluate the impact of each element. However, such a study is not feasible because of 
the large number of clinics and couples needed to power such a trial. 
 Most of the elements of the implementation strategy can be implemented on a 
national or even international scale. However, before doing so the website should be 
improved to be more user friendly and comprehensible for patients. We suggest to 
evaluate the current website with patients and ask them how the website could be 
improved. Consequently, for international use the language would have to be adapted. 
The use of the E-learning communication module was optional and our results show that 
few doctors of all participating intervention clinics have actually completed the module. 
Perhaps it is possible to make the module part of a training plan or stimulate doctors to 
complete it for accreditation points.  
 In conclusion, this study shows that our implementation strategy can be very eﬀective 
in increasing adherence to expectant management if clinics are willing to implement and 
make full use of the tools that are oﬀered to them. Most eﬀective are audit and feedback, 
availability of a local protocol, informational tools such as the website and the information 
flyer, and an educational outreach visit. 
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General discussion
This thesis focused on improving the implementation of the guideline recommendations 
on TEM in couples with unexplained infertility. In this final chapter, we present the main 
findings per chapter and will discuss these in light of methodological considerations and 
available literature. This chapter will conclude with implications for future research, policy, 
and practice of care.
Main findings
PART I:  Expectant management
In the first part of this thesis we began with studying the eﬀect of IVF compared to 
expectant management and we addressed a possible additional barrier for expectant 
management: the interpretation of couples’ expectations of the first consultation by their 
care professional.
1.  How does the cost-effectiveness of immediate IVF compared with postponing 
IVF for one year, depend on prognostic characteristics of the couple? 
Immediate IVF is most cost eﬀective for endometriosis (range 8,000 to 23,000 Euro), slightly 
depending on duration of infertility and female age. Immediate IVF is least cost-eﬀective 
for couples with unexplained infertility (range 15,000 to >60,000 Euro) because the chance 
of a natural conception is still considerable for these couples. The cost-eﬀectiveness in 
this group strongly depends on female age and the duration of infertility. With a higher 
female age and with a longer duration of infertility, immediate IVF becomes more cost-
eﬀective. 
2. To what extent exist differences in couples’ expectations of their first visit to a 
clinic for infertility problems and how professionals perceive these expectations?
There are diﬀerences in the couples’ expectations and how professionals perceive these 
expectations. The couples’ scored highest on the expectations ‘I made the appointment 
to have diagnostics’ and ‘I made the appointment because I want to get pregnant as soon 
as possible’. They scored lowest on the expectation ‘I made the appointment because I 
want to be treated’. Professionals mostly underestimated the couples expectations ‘I want 
to receive more information on diagnostic options and treatment options’, and ‘I want 
reassurance’. Professionals accurately interpreted that the couple made the appointment 
to get pregnant as soon as possible.
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PART II:  Tailored expectant management
In the second part of this thesis we aimed to provide an overview of the current status on 
adherence to tailored expectant management in fertility care in the Netherlands, and how 
TEM is experienced by patients. 
3. What is the percentage of overtreatment, i.e. fertility treatment started  
too early, in couples with unexplained infertility who were eligible for tailored 
expectant management and what are determinants for overtreatment?
We assessed the current implementation of guideline recommendations on TEM by 
calculating the percentage of couples who were eligible for an expectant management 
of at least six months but who started treatment earlier, i.e. overtreatment. We found 
that 36% of couples started treatment within six months after the fertility work-up was 
complete. In 34% of all couples no prognosis was calculated and in 42% expectant 
management was not recommended. Finally, 16% of the couples, for whom a correct 
recommendation of expectant management for at least 6 months was made, started 
treatment within 6 months anyway. Overtreatment was associated with childlessness of 
a couple, higher female age and a longer duration of infertility.  
4. To what extent do couples who were eligible for TEM and did not start 
treatment within six months after the fertility work-up, have different experiences 
with care than couples that were also eligible for TEM but started treatment 
right after the fertility work-up? 
Couples who adhered to TEM, i.e. did not start treatment within six months after the 
fertility work-up, experienced the quality of care on the same level as couples who were 
exposed to early treatment. Experiences with the quality of care were measured by 
evaluating the patient-centeredness of care (PCQ-Infertility questionnaire) and the 
patients’ trust in their physician (Wake Forest Trust Scale). 
PART III: Implementing tailored expectant management
In the third part of this thesis we studied the eﬀect of a multifaceted strategy to improve 
the implementation of TEM. The strategy was based on known barriers and facilitators 
for TEM and was aimed at the patient, professional, and organization.
5. What is the effectiveness of a multifaceted implementation strategy compared 
to usual care on improving the adherence to guideline recommendations on 
expectant management for couples with unexplained infertility? 
The results of the cluster randomized trial showed that the use of a multifaceted implemen-
tation strategy did not significantly increase adherence to the guideline recommendation 
regarding expectant management compared to care as usual. The adherence to the 
guideline recommendations increased in the intervention group (20%) but the control 
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group also had an unforeseen improved adherence (12%). There was a large variation 
between clinics in improved adherence in the intervention group. Most clinics performed 
better but there were also clinics that performed slightly worse in the eﬀect measurement. 
6. What is the relationship between the adherence to TEM and couples’ and 
professionals’ exposure to the implementation strategy? 
The process evaluation reveals what happened within the ‘black box’ of the cluster 
randomized trial that evaluated the eﬀect of an implementation strategy to increase 
adherence to expectant management in couples with unexplained infertility. It showed 
that diﬀerent exposure levels to the strategy had a great influence on the eﬀectiveness of 
the strategy. Compared to the increased adherence rate in the control group (12%), clinics 
with minimal exposure to the strategy showed no improvement in adherence rate at all, 
clinics with intermediate exposure had a significant increased adherence rate (43%), and 
clinics with high exposure had a non significant increased adherence rate (20%). 
Discussion of main findings
Current tailored expectant management care
Chapter 4 shows that despite the development and dissemination of the guideline 
 recommendations on TEM in 2010, two years later there were still many couples who were 
eligible for expectant management but started a treatment immediately after the fertility 
work-up anyway. This is congruent with previous findings in guideline implementation 
research; it shows that simply developing and disseminating new guideline recommendations 
is not enough for clinics and professionals to incorporate these new recommendations in 
clinical practice (Grol 2001; Grimshaw et al. 2004). Extra eﬀorts are needed to assess what 
the potential barriers and facilitators are to actually implement guideline recommendations 
(Baker et al. 2015; Chaillet et al. 2006). It is important to acknowledge that these barriers can 
lie on diﬀerent levels, i.e. organizational, professional, and patient. 
 In the guideline recommendations on TEM in particular it is important to recognize 
the barriers on all these levels. Organizations need to recognize the importance of expectant 
management and facilitate professionals to implement the recommendations. Professionals 
have to agree with the recommendations and be motivated to advise an expectant 
management to their patients. Finally, patients have to be willing to follow this advise after 
being informed. 
 Barriers and facilitators on TEM have been studied previously (van den Boogaard, van 
den Boogaard, et al. 2011). However, the results of the barrier and facilitator study were 
published after the guideline recommendations were already disseminated. Therefore, it 
was not possible for the guideline developers to take these barriers and facilitators into 
account to facilitate optimal implementation of the guideline recommendations. 
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Patients’ barriers
The main barriers on the patient level were a lack of confidence in natural conception, a 
perception that expectant management is a waste of time, inappropriate expectations 
prior to the first consultation, misunderstanding the reason for expectant management, 
and overestimation of the success rates of treatment. Furthermore, another study shows 
that couples’ appreciation of TEM was rated low (5.7 on a scale of 1-10) (van den Boogaard 
et al. 2012). Therefore, we wanted to evaluate if couples that followed TEM experienced 
care diﬀerently than couples who had immediate treatment. Chapter 5 shows that couples 
who adhered to TEM, i.e. did not start treatment within six months after the fertility 
work-up, experienced the quality of care on the same level as couples who were exposed to 
immediate treatment. This is important information for professionals who are worried that 
their patients will evaluate their care less if they advise them an expectant management. 
It shows that couples who are eligible for TEM will not evaluate care poorer if they were 
advised and followed an expectant management.
Professionals’ barriers
A main barrier on the professional level was better management of patients’ expectations. 
The importance of tackling this barrier to improve adherence to the guideline recommen-
dations on TEM is shown in chapter 3. The results in this chapter show that the manner 
of advising expectant management and more importantly managing the couples’ 
expectations is important to the couple. They like to be informed about the possibility of 
an expectant management as early as possible (preferably by their GP) but at least during 
the first consultation in the clinic. It also shows that when couples receive information on 
TEM early they are more likely to follow and understand the advise for TEM in a later stage 
(i.e. after the fertility work-up). Unfortunately, many couples were not asked about their 
expectations and were not informed about the possibility of TEM after the fertility work-up 
is concluded. This shows there is still extra attention needed to address this barrier to 
improve adherence to TEM.
 Other barriers for professionals were limited knowledge on the prognostic model 
and TEM and their counseling skills on expectant management. The main facilitator of 
implementation of expectant management that was mentioned by both couples and 
professionals was the availability of patient information materials on expectant management. 
 Based on the identified barriers and facilitators we developed the multifaceted strategy 
to improve guideline recommendations on TEM. The strategy focuses on improving 
the couples knowledge on expectant management and to create realistic expectations 
of possible benefits and complications of fertility treatments. In addition, it focuses on 
improving the professionals’ knowledge of the guideline recommendations on TEM and 
their communication and counselling skills on TEM.
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Implementation of tailored expectant management
Chapter 7 shows that the multifaceted implementation strategy did not significantly 
increase adherence to the guideline regarding TEM compared to care as usual. The 
adherence to the guideline recommendations increased in the intervention group but 
the control group also had an unforeseen improved adherence. 
 Besides preventing patients from being harmed by ineﬀective treatment the 
accompanying costs of these treatments is another important reason for optimizing 
implementation of TEM. Due to a lack in significance of eﬀect of the intervention we could 
not perform a complete cost-eﬀectiveness analysis with sensitivity analyses. However, 
we performed a cost-consequence analysis (supplementary data table I from chapter 7), 
which is important to the scope of this study. In the baseline measurement, direct (based 
on number of OI,IUI, and IVF cycles) and indirect medical costs (absence from work etc.) 
for the participating couples during six months after the fertility work-up were calculated 
at €475 763 (€875 per couple). In the eﬀect measurement, direct and indirect medical costs 
for the participating couples during six months after the fertility work-up were €130 088 
(€527 per couple) in the intervention group versus €155 974 (€655 per couple) in the 
control group. In the intervention group total intervention costs of the multifaceted 
strategy were €15 172. Therefore, total costs in the intervention group were €145 256 
(€588 per couple). Comparing the costs between the intervention and control group in 
the eﬀect measurement shows a diﬀerence of 67 Euro per couple. Comparing the costs 
per couple between the baseline and eﬀect measurement there is an average reduction 
of €253 Euro. This shows that if an investment is made for a multifaceted strategy, it might 
eventually save money due to a reduction in costs which come with fertility treatment. 
Furthermore, because the costs for developing this multifaceted strategy have already 
been made, implementing the strategy in a larger population can potentially achieve 
even more cost reduction. Based on our recruitment data we carefully estimate that there 
are on average at least 50 couples per clinic per year that are eligible for an expectant 
management. With 100 fertility clinics in the Netherlands and an average reduction of 
€67 per couple in the intervention group this could lead to a national cost reduction of 
€ 335 000 per year. When we compare the total costs between the baseline and eﬀect 
measurement it shows that the national measure and implementation strategy combined 
could nationally save €1 265 000. Potentially the cost reduction could be even higher 
because we calculated the reduced costs per couple over a period of only 6 months after 
the fertility work-up per year. 
 Recently, the National Health Care Institute Netherland (Zorginstituut Nederland) 
published data on the reduced fertility treatment cycles and costs in fertility care as a 
result of the national measure that was taken (making TEM obligatory) at the beginning of 
the intervention period (2013) to reduce cost in fertility care (https://www.zorgin-
stituutnederland.nl). The report shows that the number of treatment cycles (IUI and IVF/
ICSI) were reduced with 6% in 2013 and with 11% in 2014 compared to 2012. They stated 
511305-L-bw-kersten
Processed on: 6-7-2017 PDF page: 188
188
Chapter 9
that the reimbursed costs from health insurance companies for IUI and IVF/ICSI treatments 
were approximately 70 million Euros in 2012, 47 million Euros in 2013 and 54 million Euros 
in 2014. Meaning that the costs in 2013 were reduced with 23 million Euros and in 2014 
with 16 million Euros compared to 2012. The cost reduction that they published seems far 
greater than the cost reduction we illustrated above in our study. However, they did not 
take into account the diﬀerences in rates per treatment cycles between 2012, 2013 and 
2014. In 2013 the rates for fertility treatments went down a lot compared to 2012 and in 
2014 they went up again.  Therefore, it seems better to compare our results based on the 
reduced number of treatment cycles. Our results show that compared to the baseline 
measurement (between February 2011 and March 2012) the number of treatment cycles 
(OI,IUI(MOH),IVF/ICSI) were reduced with 32% in the eﬀect measurement (between March 
2013 and May 2014). When we only look at the control group (no exposure to the strategy 
only to the national measure) the reduction is 27%. This eﬀect seems larger than the eﬀect 
the National Health Care Institute reports. The discrepancies possibly lie in the fact that 
the National Health Care Institute reported on all fertility treatment cycles from all infertility 
patients in the Netherlands regardless of the cause of their infertility. However, tailored 
expectant management is only applicable for couples with unexplained infertility and a 
good prognosis of a natural conception. We explicitly assessed the treatment cycles for 
couples with unexplained infertility who were eligible for tailored expectant management. 
Because the national measure was targeted at this specific group of patients we found a 
greater reduction of fertility treatments in our study population. 
 To assess why the implementation strategy did not have the anticipated eﬀect and 
why the adherence rates between clinics varied so much, we undertook a process 
evaluation to understand the ‘black box’ of the intervention (Saunders, Evans, and Joshi 
2005; Hulscher, Laurant, and Grol 2003). An in-depth assessment of both professionals’ and 
couples’ level of exposure to and experiences with the implementation strategy gave us 
more insight into the usefulness of the strategy (Hulscher, Laurant, and Grol 2003). 
Our results showed that when clinics and their professionals are willing to use the strategy 
to their benefit, the eﬀect on adherence to the guideline recommendations on TEM 
is significant. However, there were also clinics in the intervention group that seemed 
reluctant to make use of the  elements of the strategy that were provided to them. These 
clinics showed no improvement in adherence at all. Therefore, it seems that there is an 
important barrier that was not tackled with our strategy. We expect that this barrier can 
be found in the organizational culture. Previous research shows that main barriers to 
implementing supports for evidence-informed decision making are limited resources 
(money or staﬀ), time constraints, and negative attitude (or resistance) toward change 
(Ellen et al. ; Wensing et al. 2014; Huis et al. 2013; Flottorp et al. 2013). We did not take these 
barriers into account when developing the strategy and we did not assess these barriers 
in the process evaluation. However, in some clinics these barriers were noticed during the 
educational outreach visit. For future implementation we recommend to systematically 
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evaluate and address these barriers. For example, ask all members of the fertility team to 
complete a questionnaire before the intervention period on their attitude towards the 
guideline  recommendations on expectant management and what they expect from this 
study and their participation. When barriers are detected discuss these with the team 
members and try to find a solution to tackle the existing barriers before implementing the 
strategy. 
Generalizability
It is diﬃcult to translate the main findings in this thesis on TEM to other countries. There 
are other countries that made recommendations on expectant management but they are 
slightly diﬀerent from the Dutch recommendations on TEM (Fields et al. 2013). For example, 
the NICE and ESHRE guidelines do not mention the use of a prognostic model to assess 
which couples with unexplained infertility are eligible for an expectant management, 
but instead advise all couples with unexplained infertility to try to conceive spontaneously 
for 2 years before IVF can be considered. This diﬀerence in recommendations on expectant 
management and a diﬀerent fertility care setting and reimbursement in other countries 
can lead to diﬀerent local barriers and facilitators for expectant management. For example, 
in the Netherlands each citizen has a compulsory basic health insurance that covers all OI/
IUI and a maximum of three IVF/ICSI cycles. In other countries diﬀerent health insurance 
coverage might apply and therefore the incentive to start treatment may be very diﬀerent 
for both professionals and couples. Otherwise, the multifaceted strategy could prove to 
be more eﬀective in countries where there is no strong incentive from the government 
to abide by the recommendations on expectant management. 
 Furthermore, the counseling on expectant management is diﬀerent when the advise 
is not based on a prognostic model. It might be easier for couples when their professional 
can explain why an expectant management is better based on some personal prognostic 
characteristics (age of woman, semen quality etc.) instead of solely basing it on the 
diagnosis unexplained infertility. It would be interesting to assess the experiences of 
couples who followed an expectant management abroad and compare it to couples 
who started treatment immediately. Perhaps they do evaluate their experiences with care 
diﬀerently. Furthermore, an extensive evaluation of local barriers and facilitators is necessary 
to tackle the local issues surrounding expectant management in diﬀerent countries 
(Flottorp et al. 2013).
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Methodological considerations
Study design
We choose to perform a cluster-RCT to evaluate the eﬀectiveness of the strategy on 
adherence to guideline recommendation on TEM because this is considered the ‘golden 
standard’ in implementation research (Ovretveit and Gustafson 2002). Furthermore, a 
clustered design with a randomization at clinic level was necessary due to the nature of 
the multifaceted implementation strategy that was targeted at organizational and 
professional level as well. Randomization at patient level would have been impossible 
without risking contamination of both study arms. Performing a c-RCT requires more 
patients to achieve suﬃcient study power. This can be achieved by either increasing the 
number of clusters or the number of patients per cluster. Previous studies from the 
Netherlands indicated that the expected adherence to TEM at baseline was estimated at 
60% (van den Boogaard, Oude Rengerink, et al. 2011). To detect a 20% increase in 
adherence, we knew that with 25 clusters we would need a total of 450 patients for both 
the baseline and eﬀect measurement. Per cluster we needed to include approximately 
15-25 couples per measurement. We expected this was achievable based on prior 
knowledge of the number of couples that could potentially be eligible for TEM. 
 However, while calculating the sample size we did not take into account the 
unexpected improvement of adherence to expectant management in the control group. 
We expect the improvement is possibly due to changes in usual care during the 
intervention period. As the Dutch government was looking for savings in fertility care, the 
Dutch Society for Obstetrics and Gynaecology (NVOG) made expectant management 
obligatory as part of a strategy to improve the cost-eﬀectiveness of fertility care (https://
www.rijksoverheid.nl). Furthermore, a Hawthorn eﬀect could be possible; The inclination 
of people who are the subjects of an experimental study to change or improve the 
behaviour being evaluated only because it is being studied, and not because of changes 
in the experiment parameters or stimulus (Sedgwick and Greenwood 2015). Clinics might 
have changed their behaviour towards expectant management as a motivational 
response to participating in this study. 
 With a larger study population we might have been able to detect a significant eﬀect 
of the strategy compared to usual care. However, including more patients or more clusters 
to achieve higher statistical power would have made the study less feasible. Data collection 
was already a very extensive task with the current clusters and patients. 
 There are also some other limitations to the study design we choose. Because the 
implementation strategy was targeted at the patient, professional, as well as the 
organizational level the actual exposure to the strategy was dependent on the cooperation 
of the intervention clinics and their professionals. In order to make optimal use of the 
strategy they needed to use specific elements themselves but also oﬀer the information 
flyer and website to their patients. Therefore, the success of this strategy is largely 
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dependent on the willingness to change of a clinic and their professionals. If the strategy 
was solely focused on patients and we could reach them directly without interference of 
the professionals, exposure levels of patients to the website and information flyer would 
probably have been a lot higher. 
 Another limitation is that we were not able to statistically test the importance of 
the exposure level to each diﬀerent strategy element. Due to the clustered nature of this 
study we lacked the power to perform this sub analysis. 
Data collection
The data collection in chapters 4, 5, 7 and 8 was done retrospectively. We asked patients 
to participate in these studies based on each clinic’s financial registration database. 
A specific code was given to all new patients undergoing diagnostics for infertility 
(F 11 code). For the baseline measurement (which was conducted starting in the fall of 
2012), couples that had an active F 11-code between February 2011 and March 2012 were 
asked to participate. For the eﬀect measurement (which was conducted starting June 
2014) couples were asked to participate if they had an active F 11-code during the 
intervention period (March 2013-May 2014). For the couples that we included, retrospective 
medical record research was conducted and questionnaires on their experiences with 
care were send out. We choose this method of data collection to recruit new couples that 
were registered in a financial database with fertility problems and not a preselected group 
who were already labelled as being eligible for expectant management. The first step of 
guideline adherence is correctly diagnosing and identifying couples that are eligible for 
expectant management. We could not assess adherence to the guideline recommenda-
tions if we would have recruited participants from a preselected group. 
 There are two possible limitations to this approach. The first limitation is that the 
response rate in the studies in chapter 4, 5, 7 and 8 was lower compared to other fertility 
studies (Mourad et al. 2011; van Empel et al. 2010). This might be a result of the recruitment 
process. We sent an information letter to all couples presented with fertility problems and 
not a preselected group of couples with unexplained infertility. Many couples receiving 
this letter were not under active treatment (anymore). Some couples never started 
treatment or already achieved a pregnancy. Perhaps couples who were not active in the 
fertility process (anymore) were less inclined to participate in a study. 
 The second limitation is the possibility of recall bias when completing the questionnaires 
(chapter 5 and chapter 8). For some couples, the time between the fertility work-up and 
filling in the questionnaire (follow up period) was as long as two years. Despite the fact 
that our results in chapter 5 show that the mean follow up period is equal between 
couples that adhered to TEM and couples exposed to overtreatment we do not know 
how their experiences with care might have changed over time. It is possible that during 
the expectant period couples had diﬀerent experiences than they recalled at the time of 
completing the questionnaire. 
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Implications for future research 
· Postponing IVF seems plausible for couples with unexplained infertility, with a small 
loss in live birth rate but saving a substantial amount of money. Ideally there should 
be an RCT between expectant management for a year and IVF treatment (3 cycles). 
The study population should consist of couples with unexplained infertility with a 
female age under 38 years and a duration of infertility of maximum three years.
· To evaluate the eﬀectiveness of the diﬀerent implementation strategy elements 
separately, a larger c-RCT with multiple intervention arms is necessary. However, this 
requires more clusters and more participating patients. This will decrease the feasibility 
of such a study. Perhaps a c-RCT with four arms is possible; control, patient targeted 
elements, professional targeted elements, and organizational targeted elements.
·  The process evaluation resulted in a mixed message on the usefulness of one of the 
strategy elements; the E-Learning communication module for professionals. Further 
assessment should be performed before implementing this element on a larger scale. 
It seems that during the c-RCT only professionals that were willing to make changes/
improvements concerning TEM completed the module. It would be interesting to see 
how professionals who are more reluctant to change will assess this element on its 
usefulness to counsel couples for TEM and how this eﬀects the couples that they 
counsel on TEM.
· More research should be conducted to assess the role of local organizational culture, 
team climate, and opinion leader to aﬀect change in improving guideline implementation. 
More barrier and facilitator research is necessary to get a better understanding of this 
barrier and how to tackle it. 
Implications for policy makers
· The strategy elements should be incorporated in the Dutch Guideline on Infertility. 
There should be links to the hosting website(s) and the E-learning communication 
module so that both elements are accessible for all professionals who counsel couples 
with infertility. The example of a local protocol for TEM should be added to the guideline 
so that clinics can easily adopt the protocol to their own clinical practice. 
· The Dutch Society for Obstetrics and Gynaecology (NVOG) should publish the updated 
Dutch Guideline on Infertility on their own website (www.nvog.nl). 
· The NVOG should encourage continuous monitoring of adherence to TEM and stimulate 
clinics to keep improving their adherence to the guideline recommendations. At this 
moment there is no register available that indicates whether couples had an expectant 
management and that makes continuous monitoring more challenging. Eﬀorts to 
perform medical record research on (a part of) all couples with unexplained infertility 
have to be made by clinics to assure monitoring. 
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· The Dutch association for patients with infertility problems, Freya, should publish the 
results of our study on their website and they should refer couples who want more 
information on the prognostic model and TEM to the information flyer and website that 
we developed. 
· Make the link to the website we developed available on www.thuisarts.nl in the segment 
on fertility diagnostics.
· Convey the importance of early expectation management for TEM to the Dutch College 
of General Practitioners (NHG). For couples with unexplained infertility it is important 
that they are informed about the possibility of expectant management as soon as 
possible, which is most often during a consultation with their general practitioner. 
 
Implications for clinical practice
· Keep encouraging clinics and professionals to adhere to the guideline recommen-
dations on TEM by continuous monitoring of adherence levels. This will require some 
eﬀort because with the current data systems it is hard to extract the correct data on 
expectant management. 
· Encourage professionals to use the strategy tools that help them counsel their 
patients on TEM and perhaps rewards them with credits for completing the E-learning 
communication module. 
· Encourage professionals to explore the couples’ expectations during the first consultation. 
· Inform new and young professionals on the guideline recommendations on TEM and 
help them developing the necessary counselling skills. There should be attention for 
this subject in the teaching curriculum.
· Patient information material such as the information flyer and the website should be 
readily available for patients. Professionals should make patients aware of the information 
they can find and encourage them to educate themselves on TEM.
Final conclusion 
In conclusion, we developed a multifaceted implementation strategy to improve 
adherence to the guideline recommendations on TEM. Despite an improvement of 
20% in the intervention group, we found no significant eﬀect due to an unforeseen 
improvement of 12% in the control group. This is probably due to a national measure that 
was taken to reduce costs in fertility care by making TEM obligatory. Because this measure 
was taken at the same time the intervention period of our c-RCT started, it is hard to 
distinguish the separate eﬀect of the measure and the participation in the c-RCT. However, 
our results show that improvement of guideline adherence was necessary and feasible. 
The lack of an overall eﬀect of the implementations strategy should not discourage policy 
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makers and professionals in fertility care to use the developed elements (protocol, website, 
information flyer, E-learning communication module) to implement TEM. The process 
evaluation showed that when the elements are optimally used it can help to adhere to 
guideline recommendations on TEM. Moreover, patients’ experiences with the information 
flyer and website were good.
 A continuous cycle of monitoring and encouraging clinics to adhere to the guideline 
recommendations on TEM is necessary to maintain higher adherence levels and to 
prevent couples from being exposed to unnecessary fertility treatments that do not 
increase their chances of conception. To help professionals counsel couples for TEM 
it is important to provide up to date patient information on the prognostic model and 
TEM and to stress the importance of exploring the couples expectations during initial 
consultation. The information on TEM should be easily accessible to all couples who deal 
with infertility. Because expectant management is increasingly being recommended in 
other European countries it is essential that patient information material is translated 
to accommodate professionals and patients abroad. 
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Summary
Chapter 1:  General Introduction
Chapter one provides background information on infertility, unexplained infertility, 
tailored expectant management (TEM), and treatment options such as intra-uterine 
insemination (IUI) and in vitro fertilization (IVF). The Dutch Network guideline for Infertility 
recommends an expectant management for six to twelve months for couples with 
unexplained infertility and a good prognosis of a natural conception within one year (more 
than 30%), this is called TEM. Previous research showed that TEM is equally eﬀective for these 
couples as treatment with IUI with mild ovarian hyperstimulation. The prognosis of a natural 
conception is based on the prognostic model of Hunault which takes into account four 
mandatory factors; female age, duration of infertility, type of infertility, and quality of semen. 
Three additional factors are optional; referred by general practitioner/own initiative/medical 
specialist, cervical factor, and diagnosis of one-sided tubal pathology. We discuss potential 
barriers and facilitators to implement the guideline recommendations on TEM. Furthermore, 
we discuss the approach to improve adherence to TEM and give an outline of this thesis. 
Chapter 2:   Cost-effectiveness of ‘immediate IVF’ versus ‘delayed IVF’:  
a prospective study
In this chapter we aimed to assess the cost-eﬀectiveness (CE) of immediate IVF treatment 
compared with postponing IVF for 1 year, depending on prognostic characteristics of 
the couple. A modelling approach was applied, based on the literature and data from 
a prospective cohort study among couples eligible for IVF or ICSI treatment, registered on 
a national waiting list in The Netherlands between January 2002 and December 2003. 
A total of 5962 couples was included. Chances of natural ongoing pregnancy were 
estimated from the waiting list observations and chances of ongoing pregnancy after IVF 
from follow-up data of all couples with primary infertility that began treatment. Prognostic 
characteristics considered were female age, duration of infertility, and diagnostic category. 
Costs of IVF were assessed from a societal perspective and determined on a representative 
sample of patients. Comparisons were made for strata determined by the prognostic 
factors. 
 The lowest CE ratio was just below €10 000 per live birth for endometriosis from 
age 34 onwards at 1 year duration and only slightly depends on female age and duration 
of infertility. The highest CE ratio reached €56 000 per live birth for unexplained infertility 
at age 30 and 3 years duration, dropping to values below € 30 000 per live birth from 
age 32 onwards. It reached values below €20 000 per live birth with 3 years duration at 
age 34 and older. 
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Therefore, the duration of infertility at which IVF becomes cost-eﬀective depends, firstly, 
on the level of society’s willingness to pay for one extra live birth, and secondly, given a 
certain level of willingness to pay, on the woman’s age and the diagnostic category. In 
current clinical guidelines, the chances of a natural conception should always be taken 
into account before deciding whether to start IVF treatment and at which time.
Chapter 3:   Expectations of the first consultation for infertility in a clinic: 
Patient and professional perspective
Management of expectations of couples with unexplained infertility was recognized as a 
main barrier by professional to implement TEM. Therefore, in this chapter we aim to 
answer the question: Are there diﬀerences between couples’ expectations of their first 
consultation to a clinic for infertility problems and how professionals perceive these 
expectations?
 We used a mixed-method study with the use of patients’ and professionals’ questionnaires 
on the patients’ expectations and semi-structured in-depth interviews on couples’ 
expectations and experiences in three Dutch clinics. We included 26 couples who were 
referred to secondary care for infertility problems by their general practitioner and did not 
have any prior known cause for the infertility. Outcomes were couples’ expectations, 
professionals perceptions of these expectations, and couples’ experiences with the first 
consultation. 
 We identified diﬀerences between how couples score their expectations on the first 
consultation compared to how professionals perceive these and how they score the 
couples’ expectations. Professionals underestimated the couples expectations to receive 
more information on diagnostic and treatment options, to be reassured, and to be treated. 
Professionals accurately interpreted that the couple made the appointment to get 
pregnant as soon as possible. Couples scored highest on the expectations that they made 
the appointment to have diagnostic tests and because they want to get pregnant as soon 
as possible. They scored the expectation ‘I made the appointment because I want to be 
treated’ lowest. Only one in five couples were asked about their expectations. In 65% of 
consultations couples were counseled for the possibility of an expectant management 
and appreciated this. They were also more likely to accept TEM if it would be advised to 
them than the couples who were not counseled for the possibility of TEM. 
 This study shows that there is a need for improvement for the professional to interpret 
and manage couples’ expectations. 
Chapter 4:  Overtreatment in couples with unexplained infertility
In chapter 4 we aimed to assess the current implementation status of the guideline 
 recommendations on TEM by calculating the percentage of overtreatment, i.e. fertility 
treatment started within six months after the fertility work-up, in couples with unexplained 
infertility who were eligible for tailored expectant management.
511305-L-bw-kersten
Processed on: 6-7-2017 PDF page: 201
201
Summary
10
We performed a retrospective cohort study in 25 participating clinics, with follow-up 
of all couples who were seen for infertility in 2011–2012. Couples were eligible to participate 
if they were diagnosed with unexplained infertility and had a good prognosis of 
natural conception (>30%) within one year based on the Hunault prediction model. 
Data to assess overtreatment were collected from medical records. Multilevel regression 
analyses were performed to investigate associations of overtreatment with patient and clinic 
 characteristics.
 Five hundred and forty-four couples eligible for expectant management were included 
in this study. Among these, overtreatment, i.e. starting medically assisted reproduction 
within six months, occurred in 36%. The underlying quality indicators showed that in 34% 
no prognosis was calculated and that in 42% expectant management was not recommended 
if appropriate. Finally, 16% of the couples for whom a correct recommendation of 
expectant management for at least six months was made, started treatment within six 
months anyway. Overtreatment was associated with childlessness, higher female age, 
and a longer duration of infertility. No associations between over treatment and clinic 
characteristics were found.
 Our results show that developing and publishing guideline recommendations on 
TEM is not enough and that fertility overtreatment still occurs frequently. Future research 
should focus on tailored eﬀorts to implement guideline recommendations on TEM.
Chapter 5:   Tailored expectant management in couples with  
unexplained infertility does not influence their experiences 
with the quality of fertility care
In chapter 5 we aimed to answer the question: Do couples who were eligible for TEM and 
did not start treatment within 6 months after the fertility work-up, have diﬀerent 
experiences with the quality of care than couples that were also eligible for TEM but 
started treatment right after the fertility work-up? 
 We performed a retrospective cross-sectional study. A survey was performed among 
all couples who participated in the retrospective audit of guideline adherence on TEM in 
25 Dutch clinics (chapter 4). Experiences with the quality of care were measured by evaluating 
the patient-centeredness of care and the patients’ trust in their physician. We used 
patient’s questionnaires to collect data on the couples’ experience with the quality of care 
and possible confounders for their experiences other than having undergone TEM or not. 
 Our results showed that couples who adhered to TEM experienced the quality of care 
on the same level as couples who were exposed to early treatment, i.e. started fertility 
treatment within 6 months after fertility work-up. There were no associations between 
adherence to TEM and the patient-centeredness of care or the patients’ trust in their 
physician. However, because this study is retrospective, recall bias might have occurred 
and we were unable to measure the diﬀerence in experience with care over time. 
Therefore, prospective research on couples undergoing TEM has to be performed to 
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provide more detailed insight in the patients’ experiences with the decision making 
process and subsequently the expectant period. 
Chapter 6:   Improving the implementation of tailored expectant 
management in subfertile couples: protocol for a cluster 
randomized trial
This chapter describes the study protocol of a cluster randomized trial (c-RCT) that will 
evaluate the eﬀectiveness of a multifaceted implementation strategy to improve the 
adherence to the guideline recommendations on TEM. A recent study showed that 
current implementation is not optimal. Tailored to barriers and facilitators for TEM 
that were recently identified among professionals and couples with infertility, we have 
developed a multifaceted implementation strategy. The implementation strategy 
addresses three levels: patient level: education materials in the form of a patient information 
leaflet and a website; professional level: audit and feedback, educational outreach visit, 
communication training, and access to a digital version of the prognostic model of Hunault 
on a website; organizational level: providing a protocol based on the guideline.
 In a cluster randomized trial, 25 clinics will be randomized between the multifaceted 
implementation strategy and care as usual. Randomization will be stratified for IVF facilities 
(full licensed, intermediate/no IVF facilities). The eﬀect of the implementation strategy, 
i.e. the percentage guideline adherence on TEM, will be evaluated by pre- and post- 
randomization data collection. Additional outcome measures will be treatment-, patient-, 
and process-related outcome measures. Furthermore, there will be a process and cost 
evaluation of the strategy. 
Chapter 7:   Implementing targeted expectant management in fertility 
care using prognostic modelling; a cluster randomized trial 
with a multifaceted strategy
This chapter describes the results of the cluster randomized trial mentioned in chapter 6. 
We aimed to assess the eﬀectiveness of the multifaceted implementation strategy 
compared to usual care on improving the adherence to guideline recommendations on 
TEM for couples with unexplained infertility.
 The results showed that guideline adherence increased from 49% to 69% in the 
intervention group, and from 49% to 61% in the control group. Multilevel analysis with 
case-mix adjustment showed that the diﬀerence of 8% was not statistically significant. 
Furthermore, the ongoing pregnancy rate within six months after fertility work-up did not 
significantly diﬀer between intervention and control group (25% vs. 27%). 
 In conclusion, the multifaceted implementation strategy did not significantly increase 
adherence to guideline recommendations on expectant management compared to 
care as usual. However, when powering for this study we did not take into account the 
unexpected improvement of adherence in the control group. The improvement is 
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possibly due to changes in usual care during the intervention period. As the Dutch 
government was looking for savings in fertility care, the Dutch Society for Obstetrics 
and Gynaecology (NVOG) tried to make TEM obligatory as part of a strategy to improve 
the cost-eﬀectiveness of fertility care. Furthermore, a Hawthorn eﬀect could be possible; 
clinics might have changed their behaviour towards TEM as a motivational response to 
participating in this study. 
 Our results showed a large variation in improved adherence rate in the intervention group. 
Therefore, it will be interesting to further analyse the process of implementation in each 
clinic with a process evaluation on professionals and couples’ exposure to and experiences 
with the strategy. 
Chapter 8:   Improving the implementation of expectant management  
in couples with unexplained infertility: a process evaluation 
of a cluster randomised trial
In this chapter we discuss the process evaluation of the c-RCT described in chapter 7. 
We aimed to assess the relationship between the adherence to TEM and couples’ and 
professionals’ exposure to the elements of the implementation strategy. We also evaluated 
professionals’ and couples’ experiences with the diﬀerent strategy elements.
 The implementation strategy was oﬀered to all intervention clinics in the c-RCT but it 
was the task of the clinics to actually use the elements in their daily practice and expose 
their professionals and patients to them. Based on the actual exposure of the clinics to the 
diﬀerent elements of the strategy we divided them into three levels; minimal, medium, 
or high exposure. The process evaluation was performed alongside the eﬀect measurement 
of the c-RCT. 
 Our results show that compared to the control group, clinics with minimal exposure 
had no increase in adherence, 57.6% to 58.0%, clinics with intermediate exposure had a 
significant increased adherence, 34.0% to 76.9%, and clinics with high exposure had a non 
significant increased adherence, 54.4% to 74.1%. Professionals who completed the 
E-learning communication module had very positive experiences with the module. 
However, overall ranking of all the strategy elements according to the professionals’ 
experiences, showed that elements such as audit and feedback, availability of a local 
protocol, and the website including the prognostic model were most useful in improving 
adherence to TEM. Patients’ experiences with the information flyer and the website 
showed that both elements achieved their goals, i.e. getting couples to visit the website 
and informing couples about their chances of natural pregnancy and expectant 
management. However, the website needs improvement in user-friendliness and com-
prehensibility. Unfortunately, due to the clustered nature of the study we were not able 
to statistically test the importance of the exposure to each diﬀerent element. 
 In conclusion, the implementation strategy can have a significant eﬀect on adherence 
to TEM. To implement the strategy on a national and international scale it is important 
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to address the barriers for exposure to the strategy, such as attitude of professionals and 
organizations towards the guideline recommendations on TEM and the implementation of 
the strategy elements. Furthermore, the informational website should be improved to 
increase user friendliness and comprehensibility for patients. 
Chapter 9: General discussion
In the final chapter, we present the main findings of the studies from the previous chapters 
and discuss them in light of available literature. In this chapter we also discuss the cost- 
consequence analyses of the c-RCT, which showed that if an investment is made for a 
multifaceted strategy it might eventually save money due to a reduction in costs which 
come with fertility treatment. Furthermore, because the costs for developing this 
multifaceted strategy have already been made, implementing the strategy in a larger 
population can potentially achieve even more cost reduction.
 It is diﬃcult to translate the main findings in this thesis on TEM to other countries. The small 
diﬀerences in guideline recommendations on expectant management and a diﬀerent fertility 
care setting and reimbursement in other countries can lead to diﬀerent local barriers and 
facilitators for expectant management. Therefore, an extensive evaluation of local barriers 
and facilitators is necessary to tackle the local issues surrounding expectant management 
in diﬀerent countries. Methodological considerations of the performed studies are taken 
into account while interpreting the main findings;  mainly the strengths and limitations of 
the study design chosen (c-RCT) and the limitations of retrospective data collection. 
 To further optimize the implementation strategy we made some suggestions for 
future research, such as evaluating the eﬀectiveness of diﬀerent elements separately in a 
large c-RCT with multiple intervention arms, further assessment of the usefulness of the 
E-learning communication module, and assessing the role of an additional barrier on 
organizational level, i.e. organizational culture and attitude towards change. To make sure 
the strategy finds its way to daily practice we describe policy and practice implications for 
healthcare providers as well as patients. For example incorporating the strategy elements 
in the Dutch guideline on Infertility to make sure that all professionals who work with 
couples with unexplained infertility have easy access to the elements. Furthermore, 
ensure easy access for patients to the developed website by placing a link to the website 
on the Dutch association for patients with infertility problem (Freya) and www.thuisarts.nl. 
Professionals should continuously be encouraged to adhere to the guideline recommen-
dations on TEM and counsel their patients optimally for TEM. 
 In conclusions, the lack of an overall eﬀect of the implementations strategy should 
not discourage policy makers and professionals in fertility care to use the developed 
elements (protocol, website, information flyer, E-learning communication module) to 
implement TEM. The process evaluation showed that when the elements are optimally 
used it can help to adhere to guideline recommendations on TEM. To help professionals 
counsel couples for TEM it is important to provide up to date patient information on the 
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prognostic model and TEM. This information should be easily accessible to all couples 
who deal with infertility.
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Samenvatting
Hoofdstuk 1:  Introductie
Hoofdstuk 1 bevat achtergrondinformatie over infertiliteit, onverklaarde infertiliteit, 
afwachtend beleid en behandelingsmogelijkheden zoals intra uteriene inseminatie (IUI) 
en in vitro fertilisatie (IVF). 
 De Landelijke Netwerkrichtlijn Subfertiliteit adviseert een afwachtend beleid van zes 
tot twaalf maanden voor paren met onverklaarde infertiliteit en een goede kans op 
natuurlijke conceptie binnen één jaar (meer dan 30%). Eerder onderzoek heeft aangetoond 
dat een afwachtend beleid van 6-12 maanden net zo effectief is als een behandeling met 
IUI met milde ovariële stimulatie. De kans op een natuurlijke conceptie binnen één jaar 
wordt berekend middels het prognostisch model van Hunault. Het model berekent de 
kans op basis van vier verplichte factoren; leeftijd van de vrouw, duur van de infertiliteit, 
type infertiliteit en kwaliteit van het zaad. Drie factoren kunnen eventueel worden 
toegevoegd: verwezen door huisarts/medisch specialist of op eigen initiatief, cervicale 
factor en gediagnosticeerde eenzijdige tubapathologie. 
 Voorts worden de mogelijke belemmerende en bevorderende factoren voor het 
implementeren van de richtlijnadviezen over afwachtend beleid besproken, evenals de 
aanpak om de naleving van afwachtend beleid te verbeteren. Het hoofdstuk eindigt met 
een overzicht van dit proefschrift.
Hoofdstuk 2:   Kosteneffectiviteit van ‘Directe IVF’ versus ‘vertraagde IVF’: 
een prospectieve studie
Dit hoofdstuk beschrijft een kosteneffectiviteitsanalyse waarin paren die direct met een 
IVF behandeling starten vergeleken worden met paren waarbij de IVF behandeling één 
jaar wordt uitgesteld. De berekening is gebaseerd op twee modellen die de kans op 
doorgaande zwangerschap berekenen. De modellen zijn gebaseerd op literatuur en data 
van een prospectieve cohortstudie onder 5962 paren, die in aanmerking kwamen voor 
IVF en die tussen januari 2002 en december 2003 in Nederland op de IVF wachtlijst 
stonden. De kans op een doorgaande zwangerschap na natuurlijke conceptie is berekend 
op basis van wachtlijst observatie en de kans op een doorgaande zwangerschap na IVF 
is berekend op basis van follow-up data van paren met primaire infertiliteit die een 
IVF behandeling waren gestart. Prognostische kenmerken in de modellen zijn leeftijd 
van de vrouw, duur van de infertiliteit en diagnostische categorie. Kosten van IVF werden 
benaderd vanuit een maatschappelijk perspectief.
 De laagste kosteneffectiviteitsratio (KE-ratio) ligt net onder €10 000 per levend-
geborene voor paren met infertiliteit sinds 1 jaar op basis van endometriose en waarvan 
de vrouw een leeftijd van 34 jaar of ouder heeft. Deze ratio wordt nauwelijks beïnvloed 
door een andere leeftijd en duur van de infertiliteit. De hoogste KE-ratio bereikt €56 000 
per levendgeborene voor paren met onverklaarde infertiliteit sinds 3 jaar en waarvan de 
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vrouw een leeftijd van 30 jaar heeft. Deze ratio zakt naar €30 000 in geval van een leeftijd 
van 32 jaar en naar €20 000 bij 34 jaar en ouder. 
 Dit laat zien dat de duur van infertiliteit waarbij IVF kosteneffectief wordt afhankelijk 
is van hoeveel de maatschappij bereid is te betalen voor de kosten van een extra 
levendgeborene, de leeftijd van de vrouw en de diagnostische categorie. De huidige 
klinische richtlijnen over IVF moeten rekening houden met de kans op natuurlijke 
conceptie alvorens te besluiten om IVF te starten en op welk moment.
Hoofdstuk 3:   Verwachtingen over het eerste consult voor  
infertiliteit in het ziekenhuis: perspectief van zowel  
patiënt als professional
Moeite met het managen van de verwachtingen van paren met onverklaarde infertiliteit 
wordt door professionals gezien als een belangrijke belemmerende factor om afwachtend 
beleid te implementeren. Daarom richten we ons in dit hoofdstuk op de vraag: Zijn er 
verschillen tussen de verwachtingen van het paar voorafgaand aan het eerste consult in 
het ziekenhuis voor fertiliteitproblemen en hoe de professional deze verwachtingen na 
het consult interpreteert?
 Om deze vraag te beantwoorden hebben we gebruikt gemaakt van een vragenlijst 
die door zowel paren als professionals zijn ingevuld. Deze vragenlijst bestaat uit zes 
vragen over verwachtingen van het paar, waarbij er op een schaal van 1 tot 5 kan worden 
aangegeven in hoeverre het gestelde een reden was om de afspraak in het ziekenhuis te 
maken. Daarnaast hebben we semigestructureerde interviews met de paren gehouden 
over hun verwachtingen en hun ervaringen in het ziekenhuis. Er zijn 26 paren geïncludeerd 
in drie verschillende ziekenhuizen, zij waren naar het ziekenhuis verwezen door de huisarts 
en er was nog geen oorzaak gevonden voor het uitblijven van de vervulling van de 
kinderwens. 
 De resultaten tonen verschillen tussen hoe paren hun verwachtingen voorafgaand 
aan het eerste consult scoren en hoe professionals deze interpreteren, en de verwachtingen 
van de paren na het consult scoren. Professionals onderschatten de verwachtingen van 
paren wat betreft het meer informatie willen over diagnostiek en behandeling, gerust 
gesteld willen worden en behandeld willen worden. Professionals schatten wel goed in 
dat paren de afspraak maken om zo snel mogelijk zwanger te worden. Paren scoren de 
verwachting dat zij de afspraak hadden gemaakt om diagnostiek te ondergaan en zo snel 
mogelijk zwanger te worden, het hoogst. Ze scoren de verwachting dat zij de afspraak 
maakten om behandeld te worden het laagst. Slechts één op de vijf paren werd tijdens 
het consult door de professional gevraagd naar hun verwachtingen. In 65% van de 
consulten werden paren geïnformeerd over de mogelijkheid van afwachtend beleid. 
Paren die hierover voorgelicht waren konden dit waarderen en waren meer bereid om 
een afwachtend beleid te accepteren als dit geadviseerd zou worden, vergeleken met 
paren die hierover niet waren voorgelicht. 
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Dit onderzoek laat zien dat er ruimte voor verbetering is wat betreft het interpreteren van 
verwachtingen van de paren door de professional.
Hoofdstuk 4:  Overbehandeling bij paren met onverklaarde infertiliteit
Het doel van het onderzoek beschreven in hoofdstuk 4 is om de implementatie in kaart te 
brengen van het advies uit de ‘Landelijke netwerkrichtlijn subfertiliteit’, om bij paren met 
onverklaarde subfertiliteit 6-12 maanden af te wachten alvorens een vruchtbaarheids-
behandeling te starten.
 We hebben een retrospectief cohortonderzoek uitgevoerd in 25 ziekenhuizen met 
follow-up van alle paren die voor fertiliteitsproblemen zijn gezien in 2011-2012. Uit de 
dossiers van 25 ziekenhuizen die fertiliteitszorg bieden, selecteerden wij paren met 
onverklaarde subfertiliteit en een goede kans op spontane zwangerschap binnen één jaar 
op basis van het prognostisch model van Hunault. De primaire uitkomstmaat is 
overbehandeling, gedefinieerd als een vruchtbaarheidsbehandeling gestart binnen zes 
maanden na het oriënterend fertiliteitsonderzoek (OFO). Secundaire uitkomstmaten zijn drie 
indicatoren over de naleving van de richtlijn: geen prognose berekend; geen afwachtend 
beleid geadviseerd; afwachtend beleid geadviseerd maar behandeling toch binnen zes 
maanden gestart. De invloed van patiënt- en ziekenhuiskenmerken werd geanalyseerd met 
behulp van multilevel regressieanalyse. Wij includeerden 544 paren, waarvan 36% 
overbehandeld werd. De ziekenhuizen verzuimden bij 34% van de paren een prognose te 
berekenen en bij 42% van de paren minimaal zes maanden afwachtend beleid te adviseren. 
Van de paren die dat advies wél kregen, werd 16% alsnog binnen zes maanden behandeld. 
Voortijdige behandeling vond vaker plaats wanneer de vrouw nog niet eerder zwanger 
geweest was of een hogere leeftijd had, en naarmate de subfertiliteit al langer bestond.
 De resultaten van dit onderzoek laten zien dat de implementatie van het advies voor 
afwachtend beleid zoals dat geformuleerd is in de ‘Landelijke netwerkrichtlijn subfertiliteit’ 
beter kan. De eerste stap om die verbetering te realiseren is het evalueren van een 
implementatiestrategie die gericht is op reeds bekende belemmerende factoren voor 
afwachtend beleid.
Hoofdstuk 5:   Afwachtend beleid bij paren met onverklaarde  
infertiliteit beïnvloedt niet hoe zij de kwaliteit van 
fertiliteitszorg ervaren
In hoofdstuk 5 hebben we de volgende vraag beantwoord: Hebben paren die een 
afwachtend beleid hebben gevolgd en dus geen behandeling zijn gestart binnen zes 
maanden na het OFO andere ervaringen met de kwaliteit van zorg, dan paren die ook 
in aanmerking kwamen voor afwachtend beleid maar die te vroeg zijn gestart met 
behandeling (dat wil zeggen binnen zes maanden na het OFO)?
 We hebben een retrospectieve cross-sectionele studie uitgevoerd. Een vragenlijst 
over de ervaringen met de zorg werd verstuurd naar alle paren die hadden deelgenomen 
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aan het onderzoek beschreven in hoofdstuk 4 van dit proefschrift. Ervaringen met de 
kwaliteit van zorg werd beoordeeld door patiëntgerichtheid van zorg en het vertrouwen 
van de patiënt in zijn/haar arts te meten.
 Onze resultaten tonen aan dat paren die zich aan het afwachtend beleid hielden de 
kwaliteit van zorg hetzelfde scoorden, als paren die te vroeg waren gestart met 
behandeling, Er zijn dus geen verbanden gevonden tussen de adherentie aan afwachtend 
beleid en de patiëntgerichtheid van zorg of het vertrouwen van de patiënt in zijn/haar 
arts. Doordat dit echter een retrospectief onderzoek is, kan het zijn dat er sprake is van 
herinneringsbias; we kunnen het verschil in ervaringen over de tijd niet meten. Het is 
daarom van belang dat er prospectief onderzoek wordt verricht onder paren die zich 
houden aan het afwachtend beleid om beter inzicht te krijgen in de ervaringen van deze 
patiënten met het beslissingsproces en vervolgens de afwachtende periode.
Hoofdstuk 6:   Verbeteren van de implementatie van afwachten  
beleid bij paren met onverklaarde infertiliteit: protocol 
voor een cluster gerandomiseerd onderzoek.
Dit hoofdstuk beschrijft het onderzoeksprotocol van een cluster gerandomiseerd 
onderzoek naar de effectiviteit van een meervoudige implementatie strategie die de 
adherentie aan de richtlijnaanbevelingen over afwachtend beleid moet verbeteren. 
Dit onderzoek is nodig omdat recent onderzoek heeft aangetoond dat de huidige 
implementatie niet optimaal is. De meervoudige implementatie strategie is gebaseerd 
op reeds bekende belemmerende en bevorderende factoren voor de implementatie van 
afwachtend beleid. De strategie richt zich op drie niveaus: patiënt niveau: voorlichtings-
materiaal in de vorm van een informatiefolder en een website; zorgverlener niveau: audit 
en feedback, voorlichtingsbijeenkomst, communicatie training en toegang tot een digitale 
versie van het prognostisch model van Hunault op een website; organisatie niveau: 
het aanbieden van een protocol gebaseerd op de richtlijn.
 Er zullen 25 Nederlandse ziekenhuizen worden gerandomiseerd tussen de 
meervoudige implementatie strategie en zorg als gebruikelijk, met stratificatie op IVF 
faciliteiten (geen, transport, IVF). Het effect van de implementatie strategie, met name het 
percentage richtlijn adherentie aan afwachtend beleid, wordt geëvalueerd door middel van 
een voor- en nameting. Aanvullende uitkomstmaten betreffen behandeling-, patiënt- en 
proces-gerelateerde uitkomstmaten. Daarnaast zal er een proces- en kostenevaluatie 
plaatsvinden.
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Hoofdstuk 7:   Implementeren van afwachtend beleid in de 
fertiliteitszorg met behulp van prognostische modellering: 
een cluster gerandomiseerd onderzoek met een 
meervoudige strategie
Dit hoofdstuk beschrijft de resultaten van het cluster gerandomiseerd onderzoek dat is 
beschreven in hoofdstuk 6. Het doel was om de effectiviteit van de meervoudige 
implementatie strategie (interventiegroep) te vergelijken met zorg zoals gebruikelijk 
(controlegroep) wat betreft het verbeteren van de adherentie aan de richtlijnaanbevelingen 
over afwachtend beleid voor paren met onverklaarde infertiliteit. 
 De resultaten tonen aan dat de richtlijn adherentie verbeterde van 49% naar 69% in 
de interventiegroep en van 49% naar 61% in de controlegroep. Multilevel analyse met 
case-mix correctie laat zien dat het verschil van 8% statistisch niet significant is. Er is wel 
een grote variatie in verbeterde adherentie percentages per ziekenhuis te zien in de 
interventie groep. Het percentage doorgaande zwangerschappen binnen zes maanden 
na het OFO was niet significant verschillend tussen de interventie en controlegroep (25% 
versus 27%).
 We kunnen concluderen dat de meervoudige implementatie strategie de adherentie 
van de richtlijnaanbevelingen over afwachtend beleid niet significant heeft verbeterd, 
vergeleken met zorg zoals gebruikelijk. Echter, bij de powerberekening voor dit onderzoek 
is geen rekening gehouden met de onverwachte verbetering in de controle groep. 
Deze verbetering komt mogelijk door veranderingen in de gebruikelijke zorg tijdens 
de interventie periode. De Nederlandse overheid wilde namelijk bezuinigen op de 
fertiliteitszorg. Als reactie hierop heeft de Nederlandse Vereniging voor Obstetrie en 
Gynaecologie (NVOG) geprobeerd het afwachtend beleid verplicht te maken, als deel van 
een strategie om de kosteneffectiviteit van de fertiliteitszorg te verbeteren. Tevens is er 
mogelijk sprake van het Hawthorne effect; de fertiliteitteams in de ziekenhuizen kunnen 
mogelijk hun houding ten opzichte van afwachtend beleid veranderen als motiverende 
reactie op deelname aan dit onderzoek. De grote variatie in verbeterde adherentie 
percentages per ziekenhuis in de interventiegroep, geeft aan dat het noodzakelijk is  om 
meer inzicht te krijgen in het implementatieproces in ieder ziekenhuis met behulp van 
een procesevaluatie. In deze evaluatie wordt gekeken naar zowel de blootstelling aan de 
strategie van professionals en paren, als naar de ervaringen met de strategie.
Hoofdstuk 8:   Het verbeteren van de implementatie van afwachtend 
beleid bij paren met onverklaarde infertiliteit:  
de procesevaluatie van een cluster gerandomiseerd 
onderzoek
In dit hoofdstuk bespreken we de procesevaluatie van het cluster gerandomiseerd 
onderzoek dat is beschreven in hoofdstuk 7. Het doel was om de relatie tussen de 
adherentie aan richtlijnaanbevelingen over afwachtend beleid en de mate van 
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blootstelling van paren en professionals aan de implementatie strategie te onderzoeken. 
Daarnaast zijn de ervaringen van professionals en paren met de verschillende elementen 
van de strategie geëvalueerd.
 De implementatie strategie, bestaande uit verschillende elementen, werd aangeboden 
aan alle ziekenhuizen in de interventiegroep, maar het was aan de ziekenhuizen zelf om 
de elementen te gebruiken in de dagelijkse zorg en om professionals en patiënten ermee 
in aanraking te laten komen. De ziekenhuizen zijn op basis van daadwerkelijk gebruik van 
de verschillende elementen van de strategie ingedeeld in drie groepen: minimale, 
gemiddelde en hoge blootstelling.  
 Onze resultaten laten zien dat vergeleken met de controlegroep, ziekenhuizen met 
minimale blootstelling geen verbetering in adherentie hadden (57.6% naar 58.0%), 
ziekenhuizen met gemiddelde blootstelling een significante verbetering hadden (34.0% 
naar 76.9%) en ziekenhuizen met hoge blootstelling een niet significante verbetering 
hadden (54.4% naar 74.1%). Professionals die de E-learning communicatietraining hebben 
doorlopen, hebben positieve ervaringen met deze training. Echter, de door professionals 
gemaakte ranglijst van de verschillende elementen toont dat audit en feedback, 
beschikbaarheid van een lokaal protocol en de website met het prognostisch model, 
het meest nuttig zijn om de adherentie aan afwachtend beleid te verbeteren. De 
ervaringen van patiënten met de informatiefolder en de website laten zien dat beide 
voorlichtingsmaterialen hun doel bereiken; d.w.z. het bezoeken van de website en het 
informeren van paren over hun kansen op natuurlijke zwangerschap en afwachtend 
beleid. Helaas zijn we door het geclusterde karakter van dit onderzoek niet in staat om het 
effect van blootstelling aan ieder afzonderlijk element te meten.
 De implementatie strategie kan dus een significant effect hebben op adherentie aan 
afwachtend beleid. Om de strategie op nationaal en internationaal niveau te kunnen 
implementeren, is het belangrijk om de belemmerende factoren voor blootstelling aan 
de strategie, zoals de houding van professionals en organisaties ten opzichte van de 
richtlijnaanbevelingen over afwachtend beleid en de implementatie van de strategie 
elementen, te bespreken. Bovendien zal de informatieve website verder verbeterd moeten 
worden wat betreft gebruikersvriendelijkheid en begrijpelijkheid voor patiënten.
Hoofdstuk 9:  Algemene discussie
In dit laatste hoofdstuk wordt ingegaan op de belangrijkste conclusies van de eerder 
besproken hoofdstukken. Voorts wordt verder ingegaan op de kosten analyse van het 
cluster gerandomiseerde onderzoek. Deze analyse laat zien dat als de investering wordt 
gedaan voor een meervoudige strategie, uiteindelijk geld kan worden bespaard door een 
reductie in kosten die gepaard gaan met fertiliteitsbehandelingen. Bovendien zal de 
implementatie van de strategie bij een grotere populatie mogelijk meer kosten besparen, 
omdat de kosten voor de ontwikkeling van de strategie reeds zijn gemaakt.
511305-L-bw-kersten
Processed on: 6-7-2017 PDF page: 213
213
Samenvatting
10
Het is moeilijk om de belangrijkste conclusies in dit proefschrift te vertalen naar andere 
landen. De verschillen in richtlijnaanbevelingen over afwachtend beleid, de opzet van de 
fertiliteitszorg en de vergoeding hiervan in andere landen, kunnen ervoor zorgen dat er 
andere belemmerende en bevorderende factoren zijn voor afwachtend beleid. Om de 
problemen rondom afwachtend beleid effectief aan te pakken is het van belang dat er 
een lokale evaluatie komt van deze factoren.
 Bij het interpreteren van de belangrijkste bevindingen in dit proefschrift is het 
belangrijk om rekening te houden met de methodologie van de onderzoeken, voornamelijk 
de sterke en zwakke kanten van de gekozen onderzoeksopzet (cluster gerandomiseerd) 
en de beperkingen van retrospectieve data verzameling. Om de implementatie strategie 
te optimaliseren worden enkele suggesties gedaan voor toekomstig onderzoek zoals het 
evalueren van de effectiviteit van de verschillende elementen in een groot cluster 
gerandomiseerd onderzoek met meerdere interventie groepen, het beoordelen van de 
zinvolheid van de E-learning communicatietraining en het evalueren van een aanvullende 
belemmerende factor op organisatie niveau, d.w.z. cultuur binnen de organisatie en 
bereidheid om te veranderen. Om ervan verzekerd te zijn dat de strategie daadwerkelijk 
gebruikt zal worden in de dagelijkse praktijk, wordt ingegaan op implicaties voor zowel 
beleidsmakers als professionals en patiënten. Bijvoorbeeld het inlijven van de strategie-
elementen in de ‘Landelijke netwerkrichtlijn subfertiliteit’, kan ervoor zorgen dat alle 
professionals toegang hebben tot de elementen. Daarnaast is het wenselijk dat patiënten 
gemakkelijk toegang hebben tot de ontwikkelde website, door bijvoorbeeld een link te 
plaatsen op de website van Freya (de vereniging voor mensen met vruchtbaarheids-
problemen) en www.thuisarts.nl. Bovendien zouden professionals continue aangemoedigd 
moeten worden om zich te houden aan de richtlijnaanbevelingen over afwachtend 
beleid en patiënten optimaal voor te lichten over afwachtend beleid.
 Het gebrek aan effectiviteit van de interventie strategie in het cluster gerandomiseerd 
onderzoek, moet beleidsmakers en professionals in de fertiliteitszorg niet ontmoedigen 
de ontwikkelde elementen (protocol, website, informatie folder, E-learning communicatie-
training) te gebruiken om afwachtend beleid te implementeren. De procesevaluatie laat 
zien dat wanneer de elementen optimaal gebruikt worden, het wel degelijk kan helpen 
om afwachtend beleid beter te implementeren. Om professionals te helpen patiënten 
goed voor te lichten over afwachtend beleid is het belangrijk de patiënt van up to date 
informatie te voorzien over het prognostisch model en afwachtend beleid. Deze 
informatie zou makkelijk toegankelijk moeten zijn voor alle paren die te maken krijgen 
met vruchtbaarheidsproblemen. 
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Ik wil beginnen met het bedanken van alle patiënten die hebben deelgenomen aan de 
studies die beschreven zijn in dit proefschrift. Zonder hun toestemming en medewerking 
was dit proefschrift nooit tot stand gekomen. 
Vervolgens wil ik mijn promotoren en copromotoren bedanken:
Beste prof. dr. D.D.M. Braat, beste Didi, al tijdens mijn coschap gynaecologie heb ik veel 
respect gekregen voor jou als arts, professor, en carrièrevrouw. Als promotor heb je al 
deze facetten ingezet om mij te begeleiden en het onderzoek tot een succes te maken. 
Ondanks dat je het ontzettend druk had maakte je tijd voor mij als het nodig was en kon 
ik met vragen even bij je binnenlopen. Ik heb ontzettend veel van je geleerd.
Beste prof. dr. B.W.J. Mol, beste Ben Willem, als promotor zorgde je ervoor dat de rode 
draad in de onderzoeken niet verloren ging en dat het tempo erin bleef. Gesprekken met 
jou zorgde vaak voor een nieuw perspectief en een dosis motivatie. Zelfs toen jij naar 
Adelaide vertrok zorgde je dat je een vinger aan de pols hield. Je bent een grote drijvende 
factor van het ontstaan en afronden van dit proefschrift geweest.
Dr. W.L.D.M Nelen, beste Willianne, zonder jou onaflatende begeleiding, inzet en steun 
was promoveren ongetwijfeld een stuk zwaarder geweest! Hoe druk je het ook had, je 
maakte altijd tijd om te vragen hoe het met me ging. Juist de combinatie van samen hard 
werken en je interesse in mij als persoon vond ik heel fijn. Je spoorde me aan om goed 
door te werken en op momenten dat het me weleens te veel werd luisterde je naar me en 
wist je me weer te motiveren. 
Dr. R.P.G.M. Hermens, beste Rosella, door jouw ervaring met implementatie onderzoek 
was jouw begeleiding bij het onderzoek en het schrijven van de artikelen onmisbaar. 
Daarnaast zorgde je ervoor dat ik rustig bleef in drukke periodes en dat ik niet te veel ging 
stressen. Dat was voor mij zo waardevol tijdens deze soms hectische periode. Mede door 
jouw gezelligheid, positiviteit en prettige manier van begeleiden heb ik een hele fijne 
promotietijd gehad! 
Beste prof. dr. M. Goddijn, beste Mariëtte, vanaf het begin ben je nauw betrokken geweest 
bij mijn promotieonderzoek en heb je meegeschreven aan bijna alle artikelen in dit 
proefschrift. Jij bent de schakel geweest tussen het Radboudumc en het AMC en maakte 
de samenwerking heel prettig. 
Veel dank gaat uit naar alle medeauteurs van de artikelen. In het bijzonder: Noortje van 
den Boogaard, van jou heb ik het stokje over mogen nemen en jouw bijdrage en 
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belangstelling gedurende mijn promotietraject waardeer ik enorm. Joanna in ’t Hout, 
zonder jouw hulp met de statistiek was ik er nooit uitgekomen. Martje Martens, samen 
hebben wij de E-learning communicatie module ontwikkeld en heb jij bijgedragen aan 
de procesevaluatie. Marije Bruinsma, voor de goede samenwerking met het ZRT. 
Ik wil natuurlijk ook alle 25 fertiliteitsteams van de deelnemende ziekenhuizen bedanken 
voor hun deelname en de tijd die zij in de studie gestoken hebben. Beste research-
medewerkers: Birgit van der Goes, Tessa de Vries, Corine Verhoeven, Marieke Linders, 
Ingrid van Hooﬀ, Lida Ulkeman en Henriette Hulsebos, bedankt voor jullie hulp en 
harde werk om dit onderzoek te laten slagen. Ook Nynke Spinder en Dirkje de Blauw, 
bedankt voor jullie hulp met de dataverzameling. 
Veel van het werk werd mede verricht door de studenten die ik tijdens mijn promotie-
traject heb mogen begeleiden bij hun wetenschappelijke stage. Ik vond het een plezier 
om met jullie samen te werken en heb ontzettend veel gehad aan jullie bijdrage. Michelle, 
Maaike, llse, David, Luka en last but not least Michelle heel erg bedankt!
Graag wil ik alle onderzoekers in de tuin bedanken. Er werd hard gewerkt maar er was ook 
tijd om publicaties te vieren, te waterskiën en om jaarlijks een gezellig weekendje weg 
te gaan. Door jullie werd het eenzame werk van promoveren toch heel gezellig!  
Lieve Aukje, Ik was vereerd om jouw paranimf te zijn en bedankt voor de vele tips en tricks 
voor de laatste loodjes. Lieve Marloes, de laatste jaren ben jij echt mijn buddy geweest 
in de tuin. De dag werd zoveel leuker als jij tegenover mij zat op een onderzoeks dag! 
Lieve Dana, ik weet zeker dat ik in de eerste jaren zonder jouw hulp en adviezen af en 
toe lichtelijk in paniek zou zijn geraakt. Daarnaast mocht ik jouw paranimf zijn na je 
vliegensvlugge en inspirerende promotietijd, wat een eer! Lieve Suzan, wat een topreis 
hebben we vier jaar geleden samen gemaakt. Heel veel succes met het afronden van je 
promotie!
Beste VPG collega’s: gynaecologen, verpleegkundigen, nurse practitioners, secretaresses, 
embryologen en analisten, bedankt voor de ontzettend fijne samenwerking! In het 
bijzonder de IVF-artsen, Aukje, Marloes, Ouijdane en Bea, wat een feestje was het om met 
jullie samen te werken! Lieve Angelique, je bent mijn vraagbaak geweest voor zowel 
medische als persoonlijk vragen, bedankt voor alles.
Lieve vrienden en familie, bedankt voor jullie steun, interesse en de nodige afleiding in 
de afgelopen jaren! Wat een geluk heb ik met zo’n fantastische mensen om me heen! 
Lieve Marieke, bedankt dat je altijd mijn klankbord bent. Zelfs tot in de puntjes van dit 
proefschrift heb je me bijgestaan.
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Lieve Lot en Soof, ik kan me geen lievere, leukere en gezelligere nichtjes wensen, ik ben 
super trots op jullie! Lieve Jan, bedankt voor je oneindige interesse in alles wat ik doe en 
de goede gesprekken die me altijd weer stof tot nadenken geven. 
Mijn paranimfen,
Loes, al sinds we klein waren paste je op mij en nam je mij als het nodig was onder je 
hoede. Je geeft me advies als ik het vraag en soms ook als ik het niet vraag. Vrijwel altijd 
heb je gelijk en brengt het me verder. Ik vertrouw op jou en voel me zelfverzekerd en 
rustig als jij in de buurt bent. 
Juul, jij staat al mijn hele leven voor mij klaar. Ondanks onze verschillende karakters 
begrijpen we elkaar goed en hebben we de grootste lol samen. We hebben het merendeel 
van mijn promotietijd samengewoond en dat was heerlijk thuiskomen. Bij jou kan ik 
helemaal mezelf zijn.
Lieve zussen, ik ben super blij en trots dat jullie straks naast mij staan.
Papa en mama, eindelijk is het dan zover, jullie jongste dochter gaat promoveren! Zonder 
jullie was me dit nooit gelukt. Jullie hebben mij gemaakt tot wie ik ben en door jullie durf 
ik te dromen, te doen en soms juist ook iets niet te doen. Het vangnet dat jullie bieden 
en het warme nest dat jullie gecreëerd hebben zijn van onbeschrijflijke waarde voor mij. 
Bedankt voor alles!
Victor, meeting you in San Francisco four years ago was the best thing that ever happened 
to me! Since then, we dated in Paris, Brest, and Venray, started living together, moved, 
got engaged, married, and had Anna. In the meantime, you also gave me the time and 
space to finish my thesis. Thank you for making compromises and for being so supportive. 
You make me intensely happy and proud, I love you!
Tot slot, lieve Anna, jij bent nog maar een paar maanden oud en hebt nog geen idee 
van het bestaan van dit boekje. Maar ooit zul je dit lezen en ik wil dat je weet dat jij de 
reden was voor mama om haar proefschrift eindelijk af te ronden. Je bent het liefste in 
mijn leven en ik ben nu al zo trots op jou! 
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Fleur Kersten werd op 17 november 1986, als jongste van drie dochters van Gerard en 
Manja Kersten, geboren te Vierlingsbeek en groeide op in Stiphout. In 1997 verhuisde het 
gezin naar Venray, waar zij in 2004 haar VWO diploma behaalde aan het Raayland College. 
Na de middelbare school werd zij ingeloot voor de studie geneeskunde en verhuisde naar 
Nijmegen waar zij de opleiding aan de Radboud Universiteit begon.
 Gedurende haar opleiding heeft zij gewerkt voor verschillende verpleeg- en verzorgings-
huizen en voor de thuiszorg in Nijmegen en Venray. Aan het eind van haar coschappen 
verbleef zij vier maanden in Ghana voor het coschap ontwikkelingslanden in het Holy 
Family Hospital in Techiman. Omdat zij tijdens haar coschappen enthousiast is geraakt over 
de gynaecologie heeft zij daar voornamelijk op de maternity ward gewerkt. Na terugkomst 
heeft zij gekozen voor een wetenschappelijke stage bij de afdeling Voortplantings-
geneeskunde in het Radboudumc. 
 In 2011 heeft zij haar artsenbul in ontvangst genomen en is zij als arts-onderzoeker 
gestart in het Radboudumc hetgeen geresulteerd heeft in dit proefschrift. Het onderzoek 
is een samenwerking met het AMC en maakt deel uit van het Consortium 2.0 (voorheen 
Verloskundig Consortium). In 2013 startte zij naast haar werk als onderzoeker als fertilteits - arts 
in het Radboudumc. 
 In 2016 is zij naar Frankrijk verhuisd. Zij is getrouwd met Victor Bouemar en zij wonen 
met hun dochter Anna (geboren in April 2017) in Puteaux, Frankrijk.
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